<?xml version="1.0" encoding="utf-8"?>
<iati-activities version="2.03" generated-datetime="2026-11-11T15:32:23+00:00">
  <iati-activity last-updated-datetime="2026-11-10T13:42:47+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-AGO-Z-UNDP-1</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>Supporting the National Response to HIV/aids, Tuberculosis and Malaria in Angola - Angola (01-Jul-2020-30-Jun-2021)</narrative>
    </title>
    <description type="1">
      <narrative>Angola, Multicomponent, United Nations Development Programme</narrative>
    </description>
    <description type="2">
      <narrative>Goals: Reduce by 60% the morbidity and mortality of malaria in the country by 2020 compared to baseline in 2016; Reduce the  malaria-related mortality (number of malaria deaths per 1000 population)  by 60% from 53,8% in 2016 to 21,5% by 2020; Reduce TB incidence by 20% by 2021 compared to 2015 level; Strengthening the national response for the control of STI/HIV and viral Hepatitis to ensure an HIV prevalence rate of less than 3% by 2022; Reduce TB mortality by 35% by 2021 compared to 2015 level. Objectives: By the end of 2020, at least 80% of the target population uses an adequate preventive measure against malaria; Detect 85% of estimated new cases of smear positive TB and achieve a treatment success rate of 85% of all forms smear positive TB cases by 2022; By the end of 2020, 100% of suspected malaria cases at health facility are tested before receiving treatment;; Increase the detection rate of MDR TB and treat 100% of diagnosed MDR TB cases by 2022; By the end of 2020, 100% of malaria cases testing positive are treated according to the national guidelines, at all levels of the national health pyramid; Ensure 90% of people living with HIV including key and vulnerable populations knows their status by 2022; Ensure 90% of all people diagnosed with HIV including key and vulnerable populations,  are enrolled, followed and receive timely and efficacious highly active antiretroviral therapy by 2022; Increase PMTCT coverage from 39% to 90% of HIV positive pregnant women by 2018  2021; By 2020, strengthen the epidemiology surveillance system, monitoring and evaluation and operational research for Malaria;; Ensure 90% of all people receiving the antiretroviral therapy including key and vulnerable populations ,attain sustainable viral suppression by 2022; By 2020, strengthen the management, technical and institutional capacities of the National Malaria Control Program (NMCP) at all levels, to enable efficient and sustainable implementation of the planned activities of the NMCP; Expand TB/HIV collaborative activities by ensuring that  90% of notified  TB patients are tested for HIV and  100%   who test HIV positive are put on ART promptly and managed; Strengthen management of a decentralised national TB/HIV response and institute an efficient and integrated M&amp;E system that ensures all indicators listed are tracked and reported timely.</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="40" role="2" crs-channel-code="41000">
      <narrative>United Nations Development Programme</narrative>
    </participating-org>
    <participating-org type="40" role="4" crs-channel-code="41000">
      <narrative>United Nations Development Programme</narrative>
    </participating-org>
    <other-identifier ref="AGO-Z-UNDPP01" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="4" />
    <activity-date type="1" iso-date="2020-07-01" />
    <activity-date type="2" iso-date="2020-07-01" />
    <activity-date type="3" iso-date="2021-06-30" />
    <activity-date type="4" iso-date="2021-06-30" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>Quentin De Hemptinne</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>quentin.dehemptinne@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="4" />
    <recipient-country code="AO" percentage="100">
      <narrative>Angola</narrative>
    </recipient-country>
    <sector vocabulary="1" code="12110" percentage="39.79">
      <narrative>Multicomponent, RSSH</narrative>
    </sector>
    <sector vocabulary="1" code="12262" percentage="27">
      <narrative>Malaria</narrative>
    </sector>
    <sector vocabulary="1" code="13040" percentage="22.51">
      <narrative>HIV</narrative>
    </sector>
    <sector vocabulary="1" code="12263" percentage="10.7">
      <narrative>Tuberculosis</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <tag vocabulary="3" code="3.8">
      <narrative>Achieve universal health coverage</narrative>
    </tag>
    <country-budget-items vocabulary="4">
      <budget-item code="e01f4fd6-8c63-4e47-bdc0-ebb6bdd52890" percentage="0.17">
        <description>
          <narrative>HIV -&gt; Comprehensive prevention programs for MSM -&gt; Other intervention(s) for MSM</narrative>
        </description>
      </budget-item>
      <budget-item code="9fdc34c6-16d4-416e-a973-ca9e1d75da86" percentage="0.12">
        <description>
          <narrative>HIV -&gt; Comprehensive prevention programs for sex workers and their clients -&gt; Addressing stigma, discrimination and violence against sex workers</narrative>
        </description>
      </budget-item>
      <budget-item code="57d69675-36b7-4f3f-b9a0-87b556fdd5a3" percentage="1.98">
        <description>
          <narrative>HIV -&gt; Comprehensive prevention programs for sex workers and their clients -&gt; Behavioral interventions for sex workers</narrative>
        </description>
      </budget-item>
      <budget-item code="01758736-3439-477b-a6cf-656487d1d8d2" percentage="0.01">
        <description>
          <narrative>HIV -&gt; Comprehensive prevention programs for sex workers and their clients -&gt; Community empowerment for sex workers</narrative>
        </description>
      </budget-item>
      <budget-item code="12c10825-fca4-465d-bf9e-f00782583623" percentage="0.05">
        <description>
          <narrative>HIV -&gt; Comprehensive prevention programs for sex workers and their clients -&gt; HIV testing services for sex workers</narrative>
        </description>
      </budget-item>
      <budget-item code="5069edaf-d26d-421b-ba0e-fdd19003aeef" percentage="0.04">
        <description>
          <narrative>HIV -&gt; Comprehensive prevention programs for sex workers and their clients -&gt; Other intervention(s) for sex workers and their clients</narrative>
        </description>
      </budget-item>
      <budget-item code="88e84f39-6ecb-44f6-8d85-0c0c6661a758" percentage="1.11">
        <description>
          <narrative>HIV -&gt; PMTCT -&gt; Other intervention(s) for PMTCT</narrative>
        </description>
      </budget-item>
      <budget-item code="43040121-7c59-4d93-9b1a-708f68d30073" percentage="0.1">
        <description>
          <narrative>HIV -&gt; PMTCT -&gt; Prong 1: Primary prevention of HIV infection among women of childbearing age</narrative>
        </description>
      </budget-item>
      <budget-item code="925d8e7c-f7a1-4507-b75d-6e254720fa3f" percentage="3.04">
        <description>
          <narrative>HIV -&gt; PMTCT -&gt; Prong 3: Preventing vertical HIV transmission</narrative>
        </description>
      </budget-item>
      <budget-item code="199097c3-8576-47ad-8496-edbc492fc089" percentage="0.1">
        <description>
          <narrative>HIV -&gt; PMTCT -&gt; Prong 4: Treatment, care and support to mothers living with HIV, their children and families</narrative>
        </description>
      </budget-item>
      <budget-item code="a043623f-0c87-42d4-8d1a-14144145ecb6" percentage="1.74">
        <description>
          <narrative>HIV -&gt; Prevention programs for adolescents and youth, in and out of school -&gt; Behavioral change as part of programs for adolescent and youth</narrative>
        </description>
      </budget-item>
      <budget-item code="c720b257-8368-4aff-acdb-5fc2ba3b9530" percentage="0.01">
        <description>
          <narrative>HIV -&gt; Prevention programs for adolescents and youth, in and out of school -&gt; Community mobilization and norms change</narrative>
        </description>
      </budget-item>
      <budget-item code="9548700f-d4e0-4aa8-b1f6-ebd43a163444" percentage="0.38">
        <description>
          <narrative>HIV -&gt; Prevention programs for adolescents and youth, in and out of school -&gt; Other intervention(s) for adolescent and youth</narrative>
        </description>
      </budget-item>
      <budget-item code="6ca32917-0d81-4c75-b2f9-b643a1b5793a" percentage="0.02">
        <description>
          <narrative>HIV -&gt; Prevention programs for general population -&gt; Other intervention(s) for general population</narrative>
        </description>
      </budget-item>
      <budget-item code="71178700-eb1a-4054-9c6a-ba203ed39cef" percentage="10.96">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; Differentiated ART service delivery</narrative>
        </description>
      </budget-item>
      <budget-item code="e53ba535-c657-45be-8818-ca510aadaba3" percentage="1.44">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; Other intervention(s) for treatment</narrative>
        </description>
      </budget-item>
      <budget-item code="a641d0ba-c0a0-4c16-b6a7-67f84f442628" percentage="0.82">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; Treatment adherence</narrative>
        </description>
      </budget-item>
      <budget-item code="c7d050d8-ddb8-42db-a948-04038ae9cd0f" percentage="0.41">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; Treatment monitoring - Viral load</narrative>
        </description>
      </budget-item>
      <budget-item code="d606bb50-d19c-42c6-8823-fd7c4c6af2d7" percentage="0.08">
        <description>
          <narrative>Malaria -&gt; Case management -&gt; Epidemic preparedness</narrative>
        </description>
      </budget-item>
      <budget-item code="4197e422-96a6-4932-904a-49da608a5206" percentage="23.46">
        <description>
          <narrative>Malaria -&gt; Case management -&gt; Facility-based treatment</narrative>
        </description>
      </budget-item>
      <budget-item code="98c1fef1-4b5b-406b-8d6e-f4fa0b0e1d08" percentage="0.62">
        <description>
          <narrative>Malaria -&gt; Case management -&gt; Other case management intervention(s)</narrative>
        </description>
      </budget-item>
      <budget-item code="7d6397ae-d18e-4d6b-8a76-bbb5ff7b7e61" percentage="1.51">
        <description>
          <narrative>Malaria -&gt; Specific prevention interventions (SPI) -&gt; Intermittent preventive treatment (IPT) - In pregnancy</narrative>
        </description>
      </budget-item>
      <budget-item code="7ffb4967-35e9-4f45-8504-d7dbf0b91468" percentage="1.33">
        <description>
          <narrative>Malaria -&gt; Vector control -&gt; IEC/BCC (Vector control)</narrative>
        </description>
      </budget-item>
      <budget-item code="955f4722-71fb-4b46-8bd2-2d741fdad76b" percentage="3.47">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Coordination and management of national disease control programs</narrative>
        </description>
      </budget-item>
      <budget-item code="e07bbbe4-54fa-4084-a6fe-7f1c9c3b77b6" percentage="24.4">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Grant management</narrative>
        </description>
      </budget-item>
      <budget-item code="ccf25cc9-a86c-4849-a5ee-61fcfbc7eb36" percentage="0.14">
        <description>
          <narrative>RSSH -&gt; RSSH: Community systems strengthening -&gt; Community-based monitoring</narrative>
        </description>
      </budget-item>
      <budget-item code="3e9642ae-693f-47d9-95b3-3cf2c3e2e170" percentage="0.04">
        <description>
          <narrative>RSSH -&gt; RSSH: Community systems strengthening -&gt; Other community responses and systems intervention(s)</narrative>
        </description>
      </budget-item>
      <budget-item code="043741b4-bd0a-492c-8759-b4cac0a50e64" percentage="0.05">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Other health information systems and M&amp;E intervention(s)</narrative>
        </description>
      </budget-item>
      <budget-item code="004842a6-d6eb-49a2-a763-882fd356689a" percentage="1.16">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Program and data quality</narrative>
        </description>
      </budget-item>
      <budget-item code="5221e091-6641-4eee-b68d-9b5879a96a78" percentage="3.97">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Routine reporting</narrative>
        </description>
      </budget-item>
      <budget-item code="a917e4f1-a1df-4b72-a335-1d4b3db2d854" percentage="0.87">
        <description>
          <narrative>RSSH -&gt; RSSH: Health products management systems -&gt; Supply chain infrastructure and development of tools</narrative>
        </description>
      </budget-item>
      <budget-item code="6cc769f6-bf9e-46dd-90d8-d293fa8bc359" percentage="2.01">
        <description>
          <narrative>RSSH -&gt; RSSH: Integrated service delivery and quality improvement -&gt; Laboratory systems for disease prevention, control, treatment and disease surveillance</narrative>
        </description>
      </budget-item>
      <budget-item code="8478da1e-4bf9-41c9-b50a-39121b1476eb" percentage="3.69">
        <description>
          <narrative>RSSH -&gt; RSSH: Integrated service delivery and quality improvement -&gt; Service organization and facility management</narrative>
        </description>
      </budget-item>
      <budget-item code="f7014493-22e9-4c03-96d0-144fbb3a254f" percentage="3.88">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Case detection and diagnosis (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="edbef7da-ca99-4741-8ce0-ea3ba6cd3d3b" percentage="3.95">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Treatment (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="03642497-8d31-43e6-9dc7-a1d83d6bad5e" percentage="0.04">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; Engaging all care providers (TB/HIV)</narrative>
        </description>
      </budget-item>
      <budget-item code="92e11022-488c-4948-abb3-b61f3d9ca4f6" percentage="2.83">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Collaborative interventions</narrative>
        </description>
      </budget-item>
    </country-budget-items>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <budget type="2" status="2">
      <period-start iso-date="2020-01-01" />
      <period-end iso-date="2020-12-31" />
      <value currency="USD" value-date="2020-01-01">16042440.87</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2021-01-01" />
      <period-end iso-date="2021-12-31" />
      <value currency="USD" value-date="2021-01-01">6534649.21</value>
    </budget>
    <capital-spend percentage="9.75" />
    <transaction ref="3e42b03a-a791-485c-a018-53f2118bc098">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-09-24" />
      <value currency="USD" value-date="2020-09-24">22577090.00</value>
      <description>
        <narrative>Global Fund commitment to AGO-Z-UNDPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="0a832e14-95df-4b62-902d-cbf33ec95d33">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-10-02" />
      <value currency="USD" value-date="2020-10-02">14210334.14</value>
      <description>
        <narrative>Global Fund disbursement to AGO-Z-UNDPP01 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="afe6e347-418e-417e-8aaf-c99f113e6b39">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-10-21" />
      <value currency="USD" value-date="2020-10-21">172980.00</value>
      <description>
        <narrative>Global Fund disbursement to AGO-Z-UNDPP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="9b336795-97fc-4486-82b4-ea76730ab9f6">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-11-04" />
      <value currency="USD" value-date="2020-11-04">22628.75</value>
      <description>
        <narrative>Global Fund disbursement to AGO-Z-UNDPP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="91107619-dd26-4526-b1d9-062184eab91b">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-11-25" />
      <value currency="USD" value-date="2020-11-25">95360.00</value>
      <description>
        <narrative>Global Fund disbursement to AGO-Z-UNDPP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="aa9f1f39-d665-481a-b783-96234e317119">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-12-16" />
      <value currency="USD" value-date="2020-12-16">20837.25</value>
      <description>
        <narrative>Global Fund disbursement to AGO-Z-UNDPP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="f6852de2-b6ea-4b89-9a1c-ef3266c989f9">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-04-09" />
      <value currency="USD" value-date="2021-04-09">87500.00</value>
      <description>
        <narrative>Global Fund disbursement to AGO-Z-UNDPP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="672ec954-0401-47c1-9bba-0adc1d72f1ea">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-05-21" />
      <value currency="USD" value-date="2021-05-21">3486812.00</value>
      <description>
        <narrative>Global Fund disbursement to AGO-Z-UNDPP01 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="cedc7306-0513-40b9-b272-80c33fb9be4d">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-07-01" />
      <value currency="USD" value-date="2021-07-01">54340.00</value>
      <description>
        <narrative>Global Fund disbursement to AGO-Z-UNDPP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="5b6fd09f-2097-48f4-ae16-7202f05e401d">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-07-01" />
      <value currency="USD" value-date="2021-07-01">51539.74</value>
      <description>
        <narrative>Global Fund disbursement to AGO-Z-UNDPP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="7947d6d1-926b-4d50-9e3a-e7f14af3e8f4">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-12-16" />
      <value currency="USD" value-date="2022-12-16">-4374758.12</value>
      <description>
        <narrative>Global Fund commitment to AGO-Z-UNDPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="AGO-Z-UNDPP01-EXP-20210630">
      <transaction-type code="4" />
      <transaction-date iso-date="2021-06-30" />
      <value currency="USD" value-date="2021-06-30">13289319.94</value>
      <description>
        <narrative>Expenditure reported by United Nations Development Programme for AGO-Z-UNDPP01, Jul 2020 to Jun 2021.</narrative>
      </description>
      <provider-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </provider-org>
    </transaction>
    <transaction ref="AGO-Z-UNDPP01-EXP-20211230">
      <transaction-type code="4" />
      <transaction-date iso-date="2021-12-30" />
      <value currency="USD" value-date="2021-12-30">2241134.19</value>
      <description>
        <narrative>Expenditure reported by United Nations Development Programme for AGO-Z-UNDPP01, Jul 2021 to Dec 2021.</narrative>
      </description>
      <provider-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </provider-org>
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/AGO-Z-UNDP" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-11" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>CM- Other 1: Proportion of health facilities without stock-out of key commodities (ACTs) during the reporting period</narrative>
      </title>
      <description>
        <narrative>Module: Case management.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>CM- Other 1: Proportion of health facilities without stock-out of key commodities (ACTs) during the reporting period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31" value="62.99">
          <comment>
            <narrative>Numerator: 1748; Denominator: 2775.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target value="94.99">
            <comment>
              <narrative>Numerator: 2636; Denominator: 2775.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="94.99">
            <comment>
              <narrative>Numerator: 2636; Denominator: 2775.</narrative>
            </comment>
          </target>
          <actual value="18.5">
            <comment>
              <narrative>Numerator: 128; Denominator: 691.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Proportion of confirmed malaria cases that received first-line antimalarial treatment at public sector health facilities</narrative>
      </title>
      <description>
        <narrative>Module: Case management.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Proportion of confirmed malaria cases that received first-line antimalarial treatment at public sector health facilities</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31" value="77.86">
          <comment>
            <narrative>Numerator: 2874247; Denominator: 3691394.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target value="95">
            <comment>
              <narrative>Numerator: 2863171; Denominator: 3013864.</narrative>
            </comment>
          </target>
          <actual value="75.9">
            <comment>
              <narrative>Numerator: 2127002; Denominator: 2803157.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="95">
            <comment>
              <narrative>Numerator: 2342594; Denominator: 2465889.</narrative>
            </comment>
          </target>
          <actual value="80.4">
            <comment>
              <narrative>Numerator: 3372590; Denominator: 4194657.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Proportion of health facilities without stock-outs of key commodities during the reporting period</narrative>
      </title>
      <description>
        <narrative>Module: Case management.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Proportion of health facilities without stock-outs of key commodities during the reporting period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31" value="52.76">
          <comment>
            <narrative>Numerator: 1464; Denominator: 2775.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target value="94.99">
            <comment>
              <narrative>Numerator: 2636; Denominator: 2775.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="94.99">
            <comment>
              <narrative>Numerator: 2636; Denominator: 2775.</narrative>
            </comment>
          </target>
          <actual value="84.8">
            <comment>
              <narrative>Numerator: 586; Denominator: 691.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Proportion of suspected malaria cases that receive a parasitological test at public sector health facilities</narrative>
      </title>
      <description>
        <narrative>Module: Case management.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Proportion of suspected malaria cases that receive a parasitological test at public sector health facilities</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31" value="92.77">
          <comment>
            <narrative>Numerator: 7139430; Denominator: 7695594.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target value="95">
            <comment>
              <narrative>Numerator: 5255766; Denominator: 5532385.</narrative>
            </comment>
          </target>
          <actual value="96.3">
            <comment>
              <narrative>Numerator: 5518522; Denominator: 5727769.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="95">
            <comment>
              <narrative>Numerator: 4300172; Denominator: 4526497.</narrative>
            </comment>
          </target>
          <actual value="92.2">
            <comment>
              <narrative>Numerator: 7300249; Denominator: 7914815.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of sex workers reached with HIV prevention programs - defined package of services</narrative>
      </title>
      <description>
        <narrative>Module: Comprehensive prevention programs for sex workers and their clients.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of sex workers reached with HIV prevention programs - defined package of services</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31" value="10">
          <comment>
            <narrative>Numerator: 2499; Denominator: 25000.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target value="9.5">
            <comment>
              <narrative>Numerator: 3296; Denominator: 34691.</narrative>
            </comment>
          </target>
          <actual value="7.7">
            <comment>
              <narrative>Numerator: 2678; Denominator: 34691.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="9.5">
            <comment>
              <narrative>Numerator: 3296; Denominator: 34691.</narrative>
            </comment>
          </target>
          <actual value="28.9">
            <comment>
              <narrative>Numerator: 10010; Denominator: 34691.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31" value="534" />
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target value="832.7" />
          <actual value="427" />
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="952" />
          <actual value="501" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31" value="534" />
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target value="757" />
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="828" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of HIV-positive women who received ART during pregnancy and/or labour and delivery</narrative>
      </title>
      <description>
        <narrative>Module: PMTCT.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of HIV-positive women who received ART during pregnancy and/or labour and delivery</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31" value="36.28">
          <comment>
            <narrative>Numerator: 7008; Denominator: 19315.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target value="51">
            <comment>
              <narrative>Numerator: 5780; Denominator: 11334.</narrative>
            </comment>
          </target>
          <actual value="61">
            <comment>
              <narrative>Numerator: 7337; Denominator: 12025.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="55">
            <comment>
              <narrative>Numerator: 6114; Denominator: 11116.</narrative>
            </comment>
          </target>
          <actual value="67.1">
            <comment>
              <narrative>Numerator: 9396; Denominator: 14000.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of adolescent girls and young women (AGYW) reached with HIV prevention programs- defined package of services</narrative>
      </title>
      <description>
        <narrative>Module: Prevention programs for adolescents and youth, in and out of school.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of adolescent girls and young women (AGYW) reached with HIV prevention programs- defined package of services</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31" value="18.6">
          <comment>
            <narrative>Numerator: 27859; Denominator: 150000.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target value="1.95">
            <comment>
              <narrative>Numerator: 17500; Denominator: 897772.</narrative>
            </comment>
          </target>
          <actual value="2.9">
            <comment>
              <narrative>Numerator: 25947; Denominator: 897772.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="1.95">
            <comment>
              <narrative>Numerator: 17500; Denominator: 897772.</narrative>
            </comment>
          </target>
          <actual value="4.7">
            <comment>
              <narrative>Numerator: 41823; Denominator: 897772.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of HMIS or other routine reporting units submitting timely reports according to national guidelines</narrative>
      </title>
      <description>
        <narrative>Module: RSSH: Health management information systems and M&amp;E.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of HMIS or other routine reporting units submitting timely reports according to national guidelines</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2016" iso-date="2016-12-31" value="69.15">
          <comment>
            <narrative>Numerator: 1919; Denominator: 2775.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target value="90.09">
            <comment>
              <narrative>Numerator: 2500; Denominator: 2775.</narrative>
            </comment>
          </target>
          <actual value="86.8">
            <comment>
              <narrative>Numerator: 2304; Denominator: 2653.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="90.09">
            <comment>
              <narrative>Numerator: 2500; Denominator: 2775.</narrative>
            </comment>
          </target>
          <actual value="73.6">
            <comment>
              <narrative>Numerator: 12439; Denominator: 16902.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Proportion of pregnant women attending antenatal clinics who received three or more doses of intermittent preventive treatment for malaria</narrative>
      </title>
      <description>
        <narrative>Module: Specific prevention interventions (SPI).</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Proportion of pregnant women attending antenatal clinics who received three or more doses of intermittent preventive treatment for malaria</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2016" iso-date="2016-12-31" value="19" />
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target value="82">
            <comment>
              <narrative>Numerator: 546842; Denominator: 666880.</narrative>
            </comment>
          </target>
          <actual value="21.5">
            <comment>
              <narrative>Numerator: 108479; Denominator: 505239.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="82">
            <comment>
              <narrative>Numerator: 546842; Denominator: 666880.</narrative>
            </comment>
          </target>
          <actual value="20.4">
            <comment>
              <narrative>Numerator: 113820; Denominator: 558657.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2016" iso-date="2016-12-31" value="51093">
          <dimension name="Age" value="15+" />
        </baseline>
        <baseline year="2016" iso-date="2016-12-31" value="6784">
          <dimension name="Age" value="&lt;15" />
        </baseline>
        <baseline year="2017" iso-date="2017-12-31" value="57877" />
        <baseline year="2017" iso-date="2017-12-31" value="28579">
          <dimension name="HIV test status" value="Negative" />
        </baseline>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target value="40739" />
          <actual value="29352" />
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="43524" />
          <actual value="29827" />
          <actual value="26248">
            <dimension name="Age" value="15+" />
          </actual>
          <actual value="3486">
            <dimension name="Age" value="&lt;15" />
          </actual>
          <actual value="19122">
            <dimension name="HIV test status" value="Negative" />
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of reporting units reporting no stock-outs of anti-TB drugs on the last day of the quarter</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of reporting units reporting no stock-outs of anti-TB drugs on the last day of the quarter</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31" value="0">
          <comment>
            <narrative>Numerator: 0; Denominator: 111.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target value="65" />
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="70" />
          <actual value="50">
            <comment>
              <narrative>Numerator: 36; Denominator: 72.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31" value="66.4" />
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target value="77" />
          <actual value="67.8">
            <comment>
              <narrative>Numerator: 25952; Denominator: 38256.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="79" />
          <actual value="63.8">
            <comment>
              <narrative>Numerator: 19500; Denominator: 30580.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31" value="38.78">
          <comment>
            <narrative>Numerator: 1401; Denominator: 3613.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target value="66" />
          <actual value="32.7">
            <comment>
              <narrative>Numerator: 503; Denominator: 1536.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="80" />
          <actual value="34.4">
            <comment>
              <narrative>Numerator: 611; Denominator: 1777.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of registered new and relapse TB patients with documented HIV status</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of registered new and relapse TB patients with documented HIV status</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31" value="55.62">
          <comment>
            <narrative>Numerator: 32192; Denominator: 57877.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target value="70">
            <comment>
              <narrative>Numerator: 28517; Denominator: 40739.</narrative>
            </comment>
          </target>
          <actual value="67.6">
            <comment>
              <narrative>Numerator: 19637; Denominator: 29038.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="80">
            <comment>
              <narrative>Numerator: 34819; Denominator: 43524.</narrative>
            </comment>
          </target>
          <actual value="70.1">
            <comment>
              <narrative>Numerator: 20899; Denominator: 29827.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people living with HIV currently receiving antiretroviral therapy</narrative>
      </title>
      <description>
        <narrative>Module: Treatment, care and support.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of people living with HIV currently receiving antiretroviral therapy</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31" value="26.25">
          <comment>
            <narrative>Numerator: 77559; Denominator: 295452.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target value="34.78">
            <comment>
              <narrative>Numerator: 110381; Denominator: 317409.</narrative>
            </comment>
          </target>
          <actual value="31">
            <comment>
              <narrative>Numerator: 108897; Denominator: 351182.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="38.12">
            <comment>
              <narrative>Numerator: 122193; Denominator: 320575.</narrative>
            </comment>
          </target>
          <actual value="38.2">
            <comment>
              <narrative>Numerator: 130005; Denominator: 340000.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of long-lasting insecticidal nets distributed to targeted risk groups through continuous distribution</narrative>
      </title>
      <description>
        <narrative>Module: Vector control.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of long-lasting insecticidal nets distributed to targeted risk groups through continuous distribution</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31" value="175329" />
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target value="1235768" />
          <actual value="220226" />
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="1235768" />
          <actual value="335422" />
        </period>
      </indicator>
    </result>
  </iati-activity>
  <iati-activity last-updated-datetime="2026-11-10T13:42:47+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-AGO-Z-UNDP-2</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>Supporting the National Response to HIV/AIDS, Tuberculosis and Malaria in Angola - Angola (01-Jul-2021-30-Jun-2024)</narrative>
    </title>
    <description type="1">
      <narrative>Angola, Multicomponent, United Nations Development Programme</narrative>
    </description>
    <description type="2">
      <narrative>Goals: Reduce new infections, morbidity and mortality from HIV/AIDS  by 2024; Decrease TB incidence from 355 to 325 per 100.000 inhabitants by 2023 (355 per 100,000 is the incidence estimated by WHO in 2018); Decrease TB mortality from 7% in 2019 to less than 5% by 2023; Reduce by 40% the morbidity and mortality of malaria in the 4 provinces by 2025 compared to baseline in 2019. Objectives: Reduce new HIV infections by at least 20%  among the general population by 2024; Reduce new HIV infections among children born to HIV infected mothers by 60% by 2024; Increasing the coverage of PLHIV on ART from 24 % and 15 % in 2019 to 63% and 60% in adults and children, respectively,  by 2024; Develop a favorable ethical and legal enviroment for reduction of stigma and discrimation against people living and affected by HIV, key and vulnerable population; Increase the number of notified TB cases from 70.362 in 2018 to 101.530 in 2024; Increase the  treatment success rate of sensitive TB (all forms) from 25% in 2017 to 85%  in  2024; Increase the number of notified MDRTB cases from 1,523 in 2019 to 2,848 in 2024; By 2024, at least 90% of the  population in  target provinces uses LLINs as method of malaria prevention; By 2024, 100% of suspected malaria cases at health facility, and community levels are tested before receiving treatment; By  2024, 100% of malaria cases testing positive are treated according to the national guidelines, at all levels of the national health pyramid, including at community level;; By the end of 2024, 90% of health facilities are reporting their monthly reports; By the 2024, 90% of health facilities  monthly reports are  submitted timely.</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="40" role="2" crs-channel-code="41000">
      <narrative>United Nations Development Programme</narrative>
    </participating-org>
    <participating-org type="40" role="4" crs-channel-code="41000">
      <narrative>United Nations Development Programme</narrative>
    </participating-org>
    <other-identifier ref="AGO-Z-UNDPP02" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="3" />
    <activity-date type="1" iso-date="2021-07-01" />
    <activity-date type="2" iso-date="2021-07-01" />
    <activity-date type="3" iso-date="2024-06-30" />
    <activity-date type="4" iso-date="2024-06-30" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>Quentin De Hemptinne</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>quentin.dehemptinne@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="4" />
    <recipient-country code="AO" percentage="100">
      <narrative>Angola</narrative>
    </recipient-country>
    <sector vocabulary="1" code="12110" percentage="30.14">
      <narrative>Multicomponent, RSSH</narrative>
    </sector>
    <sector vocabulary="1" code="13040" percentage="29.99">
      <narrative>HIV</narrative>
    </sector>
    <sector vocabulary="1" code="12262" percentage="25.11">
      <narrative>Malaria</narrative>
    </sector>
    <sector vocabulary="1" code="12263" percentage="14.76">
      <narrative>Tuberculosis</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <tag vocabulary="3" code="3.8">
      <narrative>Achieve universal health coverage</narrative>
    </tag>
    <country-budget-items vocabulary="4">
      <budget-item code="2f83940f-3956-46e3-aeb4-0a2b2ee56af3" percentage="0.67">
        <description>
          <narrative>HIV -&gt; Differentiated HIV Testing Services -&gt; Community-based testing</narrative>
        </description>
      </budget-item>
      <budget-item code="f83bbdd0-a94f-473b-9cc3-ae8a59141348" percentage="1.39">
        <description>
          <narrative>HIV -&gt; Differentiated HIV Testing Services -&gt; Facility-based testing</narrative>
        </description>
      </budget-item>
      <budget-item code="67b7abf2-42e5-4cc4-b75d-4eb6ea4f22b4" percentage="0.01">
        <description>
          <narrative>HIV -&gt; Differentiated HIV Testing Services -&gt; Self-testing</narrative>
        </description>
      </budget-item>
      <budget-item code="1e10e245-2f3d-48cc-8d98-b02bf369e956" percentage="1.5">
        <description>
          <narrative>HIV -&gt; PMTCT -&gt; Prong 1: Primary prevention of HIV infection among women of childbearing age</narrative>
        </description>
      </budget-item>
      <budget-item code="3c4ea764-548b-44a2-9605-603566cfcdf9" percentage="0.21">
        <description>
          <narrative>HIV -&gt; PMTCT -&gt; Prong 2: Preventing unintended pregnancies among women living with HIV</narrative>
        </description>
      </budget-item>
      <budget-item code="8cc23209-2129-4c18-b058-a4c3a63b6ae4" percentage="4.21">
        <description>
          <narrative>HIV -&gt; PMTCT -&gt; Prong 3: Preventing vertical HIV transmission</narrative>
        </description>
      </budget-item>
      <budget-item code="88657fe2-2942-4159-860a-af9e84e64238" percentage="1.32">
        <description>
          <narrative>HIV -&gt; Prevention -&gt; Behavior change interventions</narrative>
        </description>
      </budget-item>
      <budget-item code="e60fdd71-5159-45b8-b0e5-887e3c84eba3" percentage="0.38">
        <description>
          <narrative>HIV -&gt; Prevention -&gt; Community empowerment</narrative>
        </description>
      </budget-item>
      <budget-item code="b0f7e056-b292-405c-81ee-0e3d059dde00" percentage="1.71">
        <description>
          <narrative>HIV -&gt; Prevention -&gt; Condom and lubricant programming</narrative>
        </description>
      </budget-item>
      <budget-item code="61bfa00d-5158-4201-9e12-b91bee129c91" percentage="0.1">
        <description>
          <narrative>HIV -&gt; Prevention -&gt; Pre-exposure prophylaxis</narrative>
        </description>
      </budget-item>
      <budget-item code="7eb04704-e70b-48cf-94f5-ca1a78006662" percentage="0.35">
        <description>
          <narrative>HIV -&gt; Prevention -&gt; Prevention and management of co-infections and co-morbidities (Prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="e2860998-43fe-4145-aabf-08302069b9f1" percentage="0.21">
        <description>
          <narrative>HIV -&gt; Prevention -&gt; Sexual and reproductive health services, including STIs</narrative>
        </description>
      </budget-item>
      <budget-item code="9476a49e-917c-4607-b0d3-5ccee13653a6" percentage="0.2">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Stigma and discrimination reduction (HIV/TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="336e2f1a-7395-4d59-b42e-5e9916975074" percentage="0.21">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; Counseling and psycho-social support</narrative>
        </description>
      </budget-item>
      <budget-item code="b0eb178f-7923-4f1d-a0dc-04aed075b79a" percentage="17.11">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; Differentiated ART service delivery and HIV care</narrative>
        </description>
      </budget-item>
      <budget-item code="582a5bc6-226b-4ea9-9391-54880da66119" percentage="0.3">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; Prevention and management of co-infections and co-morbidities (Treatment, care and support)</narrative>
        </description>
      </budget-item>
      <budget-item code="62adfb99-3345-4b03-ad9f-89b544624a5b" percentage="0.12">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; Treatment monitoring - Viral load</narrative>
        </description>
      </budget-item>
      <budget-item code="c57a87ac-a92d-42c4-a1c4-71e7b1488c68" percentage="6.66">
        <description>
          <narrative>Malaria -&gt; Case management -&gt; Facility-based treatment</narrative>
        </description>
      </budget-item>
      <budget-item code="6c67c2c1-0738-43b2-b25c-253bcaa30395" percentage="2.88">
        <description>
          <narrative>Malaria -&gt; Case management -&gt; Integrated community case management (iCCM)</narrative>
        </description>
      </budget-item>
      <budget-item code="7dc2c140-895c-4865-b68b-cb22d24bcd27" percentage="0.64">
        <description>
          <narrative>Malaria -&gt; Specific prevention interventions (SPI) -&gt; Intermittent preventive treatment (IPT) - In pregnancy</narrative>
        </description>
      </budget-item>
      <budget-item code="75fb98a9-9f2d-4148-af97-5b067ab6d941" percentage="0.84">
        <description>
          <narrative>Malaria -&gt; Vector control -&gt; Entomological monitoring</narrative>
        </description>
      </budget-item>
      <budget-item code="7d79e040-039c-40ed-a6be-410f717edf17" percentage="0.08">
        <description>
          <narrative>Malaria -&gt; Vector control -&gt; Long-lasting insecticidal nets (LLIN) - Continuous distribution - ANC</narrative>
        </description>
      </budget-item>
      <budget-item code="425c71d1-ebf2-496b-ab92-9c0a941421e3" percentage="2.63">
        <description>
          <narrative>Malaria -&gt; Vector control -&gt; Long-lasting insecticidal nets (LLIN) - Continuous distribution - EPI</narrative>
        </description>
      </budget-item>
      <budget-item code="1c7a6c73-2778-4b7c-ac64-5fc1d74dd939" percentage="11.37">
        <description>
          <narrative>Malaria -&gt; Vector control -&gt; Long-lasting insecticidal nets (LLIN) - Mass campaign - Universal</narrative>
        </description>
      </budget-item>
      <budget-item code="6a7cb452-4c5d-49b6-aa43-8437d24fa1c5" percentage="1.13">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Coordination and management of national disease control programs</narrative>
        </description>
      </budget-item>
      <budget-item code="31a8e187-9648-42f5-a520-92e7e53d4ac6" percentage="23.26">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Grant management</narrative>
        </description>
      </budget-item>
      <budget-item code="a459608e-6d6a-4392-8e91-a6ce763883ca" percentage="0.19">
        <description>
          <narrative>RSSH -&gt; RSSH: Community systems strengthening -&gt; Community-based monitoring</narrative>
        </description>
      </budget-item>
      <budget-item code="792f3049-9f2b-41ae-a2df-af58779797ea" percentage="0.02">
        <description>
          <narrative>RSSH -&gt; RSSH: Community systems strengthening -&gt; Community-led research and advocacy</narrative>
        </description>
      </budget-item>
      <budget-item code="25710664-d25f-448a-9b94-5e4b210a97c6" percentage="0.66">
        <description>
          <narrative>RSSH -&gt; RSSH: Community systems strengthening -&gt; Institutional capacity building, planning and leadership development</narrative>
        </description>
      </budget-item>
      <budget-item code="e61e1ae8-85c6-488f-8a92-215981bf93a2" percentage="0.26">
        <description>
          <narrative>RSSH -&gt; RSSH: Community systems strengthening -&gt; Social mobilization, building community linkages and coordination</narrative>
        </description>
      </budget-item>
      <budget-item code="c9e8bc4a-398e-4c4b-afbb-cf98965f552e" percentage="0.11">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Analysis, evaluations, reviews and transparency</narrative>
        </description>
      </budget-item>
      <budget-item code="d110361a-331b-4f72-bd32-016450445cc3" percentage="1.04">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Program and data quality</narrative>
        </description>
      </budget-item>
      <budget-item code="7d2483ee-e340-40e2-8f81-88b761c385aa" percentage="1.13">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Routine reporting</narrative>
        </description>
      </budget-item>
      <budget-item code="b235c58e-3a80-49b8-aeb9-ddaad2b16768" percentage="1.04">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Surveys</narrative>
        </description>
      </budget-item>
      <budget-item code="afeceaba-4839-4dc1-b17d-02d01f956207" percentage="0.22">
        <description>
          <narrative>RSSH -&gt; RSSH: Health products management systems -&gt; Avoidance, reduction and management of health care waste</narrative>
        </description>
      </budget-item>
      <budget-item code="cc2a3288-298b-4e87-9cd4-3b8c1601d54c" percentage="0.05">
        <description>
          <narrative>RSSH -&gt; RSSH: Health products management systems -&gt; Policy, strategy, governance</narrative>
        </description>
      </budget-item>
      <budget-item code="5c6d2150-43bf-412f-a249-05dbaa402867" percentage="0.05">
        <description>
          <narrative>RSSH -&gt; RSSH: Health products management systems -&gt; Procurement capacity</narrative>
        </description>
      </budget-item>
      <budget-item code="45f58950-e70b-425c-a83d-28115a57a936" percentage="0.15">
        <description>
          <narrative>RSSH -&gt; RSSH: Health products management systems -&gt; Regulatory/quality assurance support</narrative>
        </description>
      </budget-item>
      <budget-item code="73afa0ce-d818-4bb2-adeb-c13f28c03a1f" percentage="0.33">
        <description>
          <narrative>RSSH -&gt; RSSH: Health products management systems -&gt; Storage and distribution capacity</narrative>
        </description>
      </budget-item>
      <budget-item code="0fa82570-990a-4ca3-98f1-4952587f8be1" percentage="0.01">
        <description>
          <narrative>RSSH -&gt; RSSH: Integrated service delivery and quality improvement -&gt; Service delivery infrastructure</narrative>
        </description>
      </budget-item>
      <budget-item code="0651e028-d13e-4937-8777-a97183a5b108" percentage="0.37">
        <description>
          <narrative>RSSH -&gt; RSSH: Laboratory systems -&gt; Laboratory supply chain systems</narrative>
        </description>
      </budget-item>
      <budget-item code="951569a8-a591-40fc-9492-c7eb2322279f" percentage="0.01">
        <description>
          <narrative>RSSH -&gt; RSSH: Laboratory systems -&gt; National laboratory governance and management structures</narrative>
        </description>
      </budget-item>
      <budget-item code="23a802a3-2312-4589-bbe9-62a7cf2c91d2" percentage="0.11">
        <description>
          <narrative>RSSH -&gt; RSSH: Laboratory systems -&gt; Quality management systems and accreditation</narrative>
        </description>
      </budget-item>
      <budget-item code="30f85a5d-1110-4276-932f-a742fc65c90f" percentage="0.11">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Case detection and diagnosis (MDR-TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="22851d66-f7e4-4cc5-950a-ad9cac3568a2" percentage="0.48">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Community MDR-TB care delivery</narrative>
        </description>
      </budget-item>
      <budget-item code="8194063f-1bf8-4be2-9ebd-2823d5ac44a3" percentage="5.78">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Treatment (MDR-TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="a93b0a8f-4b2d-4b43-806e-06b2f2240144" percentage="2.28">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Case detection and diagnosis (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="2695e028-456c-4ded-83a4-ded520ff9d79" percentage="0.58">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Community TB care delivery</narrative>
        </description>
      </budget-item>
      <budget-item code="e5d69248-af9e-44de-a99d-c2557c675f55" percentage="0.19">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Engaging all care providers (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="87435fc1-d92b-4039-b203-96061e6e85be" percentage="0.54">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Key populations (TB care and prevention) - Prisoners</narrative>
        </description>
      </budget-item>
      <budget-item code="3ec9daf3-963a-4853-8e5f-65867d3e7630" percentage="0.34">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Prevention (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="2b47e4dd-6430-4bc5-829c-127bb93a72a8" percentage="3.93">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Treatment (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="2146ce4f-9254-4a2a-8be8-e14734ab53dc" percentage="0.53">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Collaborative interventions</narrative>
        </description>
      </budget-item>
    </country-budget-items>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <budget type="2" status="2">
      <period-start iso-date="2021-01-01" />
      <period-end iso-date="2021-12-31" />
      <value currency="USD" value-date="2021-01-01">7320611.68</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2022-01-01" />
      <period-end iso-date="2022-12-31" />
      <value currency="USD" value-date="2022-01-01">42213695.37</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2023-01-01" />
      <period-end iso-date="2023-12-31" />
      <value currency="USD" value-date="2023-01-01">37718085.09</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2024-01-01" />
      <period-end iso-date="2024-12-31" />
      <value currency="USD" value-date="2024-01-01">14150954.33</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2025-01-01" />
      <period-end iso-date="2025-12-31" />
      <value currency="USD" value-date="2025-01-01">4483236.29</value>
    </budget>
    <capital-spend percentage="7.72" />
    <transaction ref="9f600e01-2726-4b22-8293-f3d35f56ed24">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-06-15" />
      <value currency="USD" value-date="2021-06-15">54351000.07</value>
      <description>
        <narrative>Global Fund commitment to AGO-Z-UNDPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="676da477-dc16-4d88-9cc8-25677d3d5b60">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-06-16" />
      <value currency="USD" value-date="2021-06-16">22261909.55</value>
      <description>
        <narrative>Global Fund disbursement to AGO-Z-UNDPP02 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="59ad667a-71f5-4537-930b-0fad373c1d5b">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-10-01" />
      <value currency="USD" value-date="2021-10-01">52253596.52</value>
      <description>
        <narrative>Global Fund commitment to AGO-Z-UNDPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="93493e20-1f1f-4474-ba69-1199a2fbd0e7">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-10-01" />
      <value currency="USD" value-date="2021-10-01">-32089090.52</value>
      <description>
        <narrative>Global Fund commitment to AGO-Z-UNDPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="6fad8d76-8231-4e4e-8fd6-471d1e863a16">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-10-07" />
      <value currency="USD" value-date="2021-10-07">12738082.61</value>
      <description>
        <narrative>Global Fund disbursement to AGO-Z-UNDPP02 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="a2f66b96-b594-4a54-827c-909dd93e3af0">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-10-21" />
      <value currency="USD" value-date="2021-10-21">544724.00</value>
      <description>
        <narrative>Global Fund disbursement to AGO-Z-UNDPP02 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="26088a93-0ec4-416c-abe7-4cfac4a9857a">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-10-21" />
      <value currency="USD" value-date="2021-10-21">9414982.00</value>
      <description>
        <narrative>Global Fund disbursement to AGO-Z-UNDPP02 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="1c38a2be-5fd1-436e-9df9-63eb2df9e2ce">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-02-24" />
      <value currency="USD" value-date="2022-02-24">50000.00</value>
      <description>
        <narrative>Global Fund commitment to AGO-Z-UNDPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="f42e71cf-734c-4648-8a1d-3e7dc2d03a36">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-07-21" />
      <value currency="USD" value-date="2022-07-21">20024548.51</value>
      <description>
        <narrative>Global Fund disbursement to AGO-Z-UNDPP02 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="fed63c78-2115-402f-8631-2528712918bc">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-03-21" />
      <value currency="USD" value-date="2023-03-21">50000.00</value>
      <description>
        <narrative>Global Fund disbursement to AGO-Z-UNDPP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="abb3571d-6361-442c-ac93-d5fe89a60913">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-07-23" />
      <value currency="USD" value-date="2023-07-23">50000.00</value>
      <description>
        <narrative>Global Fund commitment to AGO-Z-UNDPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="dc53e6e5-c3fc-4c39-b9b3-a92936d34f11">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-10-10" />
      <value currency="USD" value-date="2023-10-10">-9531259.40</value>
      <description>
        <narrative>Global Fund commitment to AGO-Z-UNDPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="fbbce355-623f-4258-a71c-013eb9321275">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-10-10" />
      <value currency="USD" value-date="2023-10-10">19345441.33</value>
      <description>
        <narrative>Global Fund commitment to AGO-Z-UNDPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="c3635dec-ae43-40df-8456-f6f5cf23c005">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-10-12" />
      <value currency="USD" value-date="2023-10-12">14087114.20</value>
      <description>
        <narrative>Global Fund disbursement to AGO-Z-UNDPP02 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="5ce8641d-e979-47f3-8a74-c5f00cd00248">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-10-12" />
      <value currency="USD" value-date="2023-10-12">5258327.13</value>
      <description>
        <narrative>Global Fund disbursement to AGO-Z-UNDPP02 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="9325bd52-2e8a-48c4-8713-ebeb5bc2a861">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-01-10" />
      <value currency="USD" value-date="2024-01-10">14342384.02</value>
      <description>
        <narrative>Global Fund commitment to AGO-Z-UNDPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="55fa9c79-ba35-4d10-bc70-e9514676da13">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-01-16" />
      <value currency="USD" value-date="2024-01-16">3963382.00</value>
      <description>
        <narrative>Global Fund disbursement to AGO-Z-UNDPP02 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="e4255a39-43f4-48de-a107-58b145bfc47f">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-04-11" />
      <value currency="USD" value-date="2024-04-11">50000.00</value>
      <description>
        <narrative>Global Fund disbursement to AGO-Z-UNDPP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="6106e316-ec05-4278-9837-7775ef118843">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-06-18" />
      <value currency="USD" value-date="2024-06-18">2106605.00</value>
      <description>
        <narrative>Global Fund disbursement to AGO-Z-UNDPP02 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="6070623e-014e-42f9-b263-a0555a921fec">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-09-30" />
      <value currency="USD" value-date="2024-09-30">-13230.08</value>
      <description>
        <narrative>Global Fund commitment to AGO-Z-UNDPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="41ede9d8-3b5b-4df1-9172-8250364f8e36">
      <transaction-type code="7" />
      <transaction-date iso-date="2024-10-01" />
      <value currency="USD" value-date="2024-10-01">13230.08</value>
      <description>
        <narrative>Funds returned to the Global Fund from AGO-Z-UNDPP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="602bce76-181e-4c5c-8b45-5be67ac72fb2">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-11-10" />
      <value currency="USD" value-date="2025-11-10">-1078202.00</value>
      <description>
        <narrative>Global Fund commitment to AGO-Z-UNDPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="1cccfa57-041c-4cad-95a4-d3a673c8ef6a">
      <transaction-type code="7" />
      <transaction-date iso-date="2025-11-11" />
      <value currency="USD" value-date="2025-11-11">1078202.00</value>
      <description>
        <narrative>Funds returned to the Global Fund from AGO-Z-UNDPP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="bb536b4a-fb78-473e-9c0a-6ee82e594f94">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-06-01" />
      <value currency="USD" value-date="2026-06-01">245434.00</value>
      <description>
        <narrative>Global Fund disbursement to AGO-Z-UNDPP02 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="904303d3-b4ed-4970-8bfa-34a312d63247">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-06-01" />
      <value currency="USD" value-date="2026-06-01">7969871.00</value>
      <description>
        <narrative>Global Fund disbursement to AGO-Z-UNDPP02 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="0be8b484-9195-4130-ab2c-9f5ff1fd7b24">
      <transaction-type code="7" />
      <transaction-date iso-date="2026-06-05" />
      <value currency="USD" value-date="2026-06-05">17913.61</value>
      <description>
        <narrative>Funds returned to the Global Fund from AGO-Z-UNDPP02 (Multilateral).</narrative>
      </description>
      <provider-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="2b2427b6-3bfb-4e39-85b0-0efb6aabf741">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-06-09" />
      <value currency="USD" value-date="2026-06-09">-17913.61</value>
      <description>
        <narrative>Global Fund commitment to AGO-Z-UNDPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="9ea1d10f-7075-4cbb-8b60-9620f18d9250">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-10-09" />
      <value currency="USD" value-date="2026-10-09">245434.00</value>
      <description>
        <narrative>Global Fund disbursement to AGO-Z-UNDPP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="f9eea59c-a7e1-4067-b74a-bd89f9781375">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-10-09" />
      <value currency="USD" value-date="2026-10-09">245434.00</value>
      <description>
        <narrative>Global Fund commitment to AGO-Z-UNDPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="AGO-Z-UNDPP02-EXP-20220630">
      <transaction-type code="4" />
      <transaction-date iso-date="2022-06-30" />
      <value currency="USD" value-date="2022-06-30">39838488.00</value>
      <description>
        <narrative>Expenditure reported by United Nations Development Programme for AGO-Z-UNDPP02, Jul 2021 to Jun 2022.</narrative>
      </description>
      <provider-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </provider-org>
    </transaction>
    <transaction ref="AGO-Z-UNDPP02-EXP-20230630">
      <transaction-type code="4" />
      <transaction-date iso-date="2023-06-30" />
      <value currency="USD" value-date="2023-06-30">24116519.13</value>
      <description>
        <narrative>Expenditure reported by United Nations Development Programme for AGO-Z-UNDPP02, Jul 2022 to Jun 2023.</narrative>
      </description>
      <provider-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </provider-org>
    </transaction>
    <transaction ref="AGO-Z-UNDPP02-EXP-20240630">
      <transaction-type code="4" />
      <transaction-date iso-date="2024-06-30" />
      <value currency="USD" value-date="2024-06-30">25994323.74</value>
      <description>
        <narrative>Expenditure reported by United Nations Development Programme for AGO-Z-UNDPP02, Jul 2023 to Jun 2024.</narrative>
      </description>
      <provider-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </provider-org>
    </transaction>
    <transaction ref="AGO-Z-UNDPP02-EXP-20241231">
      <transaction-type code="4" />
      <transaction-date iso-date="2024-12-31" />
      <value currency="USD" value-date="2024-12-31">2097006.86</value>
      <description>
        <narrative>Expenditure reported by United Nations Development Programme for AGO-Z-UNDPP02, Jul 2024 to Dec 2024.</narrative>
      </description>
      <provider-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </provider-org>
    </transaction>
    <transaction ref="AGO-Z-UNDPP02-EXP-20250630">
      <transaction-type code="4" />
      <transaction-date iso-date="2025-06-30" />
      <value currency="USD" value-date="2025-06-30">1070717.00</value>
      <description>
        <narrative>Expenditure reported by United Nations Development Programme for AGO-Z-UNDPP02, Jan 2025 to Jun 2025.</narrative>
      </description>
      <provider-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </provider-org>
    </transaction>
    <transaction ref="AGO-Z-UNDPP02-EXP-20251231">
      <transaction-type code="4" />
      <transaction-date iso-date="2025-12-31" />
      <value currency="USD" value-date="2025-12-31">3998155.00</value>
      <description>
        <narrative>Expenditure reported by United Nations Development Programme for AGO-Z-UNDPP02, Jan 2025 to Dec 2025.</narrative>
      </description>
      <provider-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </provider-org>
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/AGO-Z-UNDP" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-11" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
    <document-link url="https://docs.theglobalfund.org/files/Applications/Funding Requests/AGO/2021/Multicomponent/en/AGO-Z_FundingRequest_1_en.zip" format="application/zip">
      <title>
        <narrative>2021 - Funding Request - Window 4 - Multicomponent - Angola - English</narrative>
      </title>
      <description>
        <narrative>Funding Request of funding request FR977-AGO-Z.</narrative>
      </description>
      <category code="A01" />
      <category code="A02" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2021-02-08" />
    </document-link>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Proportion of confirmed malaria cases that received first-line antimalarial treatment at public sector health facilities</narrative>
      </title>
      <description>
        <narrative>Module: Case management.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Proportion of confirmed malaria cases that received first-line antimalarial treatment at public sector health facilities</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="88.33">
          <comment>
            <narrative>Numerator: 965543; Denominator: 1093124.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2022-06-30" />
          <target value="95" />
          <actual value="58.6">
            <comment>
              <narrative>Numerator: 694858; Denominator: 1185213.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="95" />
          <actual value="56.3">
            <comment>
              <narrative>Numerator: 318741; Denominator: 566525.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="95" />
          <actual value="60.8">
            <comment>
              <narrative>Numerator: 376117; Denominator: 618688.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="96" />
          <actual value="82.6">
            <comment>
              <narrative>Numerator: 434867; Denominator: 526775.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2023-06-30" />
          <target value="96" />
          <actual value="86.3">
            <comment>
              <narrative>Numerator: 1042543; Denominator: 1207939.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="96" />
          <actual value="89.2">
            <comment>
              <narrative>Numerator: 607676; Denominator: 681164.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2024-06-30" />
          <target value="96" />
          <actual value="87.1">
            <comment>
              <narrative>Numerator: 1351798; Denominator: 1551622.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="96" />
          <actual value="86.4">
            <comment>
              <narrative>Numerator: 523378; Denominator: 606073.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="96" />
          <actual value="87.6">
            <comment>
              <narrative>Numerator: 828420; Denominator: 945549.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Proportion of suspected malaria cases that receive a parasitological test at public sector health facilities</narrative>
      </title>
      <description>
        <narrative>Module: Case management.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Proportion of suspected malaria cases that receive a parasitological test at public sector health facilities</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31">
          <comment>
            <narrative>Numerator: 2124803; Denominator: 2257131; Percentage: 94.14%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="5+" />
          <comment>
            <narrative>Numerator: 1428721; Denominator: 2124803; Percentage: 67.24%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="5+" />
          <comment>
            <narrative>Numerator: 1428721; Denominator: 2124803; Percentage: 67.24%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="5+" />
          <comment>
            <narrative>Numerator: 1428721; Denominator: 2124803; Percentage: 67.24%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="5+" />
          <comment>
            <narrative>Numerator: 1428721; Denominator: 2124803; Percentage: 67.24%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="5+" />
          <comment>
            <narrative>Numerator: 1428721; Denominator: 2124803; Percentage: 67.24%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="5+" />
          <comment>
            <narrative>Numerator: 1428721; Denominator: 2124803; Percentage: 67.24%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;5" />
          <comment>
            <narrative>Numerator: 696082; Denominator: 2124803; Percentage: 32.76%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;5" />
          <comment>
            <narrative>Numerator: 696082; Denominator: 2124803; Percentage: 32.76%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;5" />
          <comment>
            <narrative>Numerator: 696082; Denominator: 2124803; Percentage: 32.76%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;5" />
          <comment>
            <narrative>Numerator: 696082; Denominator: 2124803; Percentage: 32.76%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;5" />
          <comment>
            <narrative>Numerator: 696082; Denominator: 2124803; Percentage: 32.76%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;5" />
          <comment>
            <narrative>Numerator: 696082; Denominator: 2124803; Percentage: 32.76%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Testing type" value="Microscopy" />
          <comment>
            <narrative>Numerator: 1064421; Denominator: 2124803; Percentage: 50.1%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Testing type" value="Microscopy" />
          <comment>
            <narrative>Numerator: 1064421; Denominator: 2124803; Percentage: 50.1%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Testing type" value="Microscopy" />
          <comment>
            <narrative>Numerator: 1064421; Denominator: 2124803; Percentage: 50.1%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Testing type" value="Microscopy" />
          <comment>
            <narrative>Numerator: 1064421; Denominator: 2124803; Percentage: 50.1%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Testing type" value="Microscopy" />
          <comment>
            <narrative>Numerator: 1064421; Denominator: 2124803; Percentage: 50.1%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Testing type" value="Microscopy" />
          <comment>
            <narrative>Numerator: 1064421; Denominator: 2124803; Percentage: 50.1%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Testing type" value="Rapid diagnostic test" />
          <comment>
            <narrative>Numerator: 1060382; Denominator: 2124803; Percentage: 49.9%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Testing type" value="Rapid diagnostic test" />
          <comment>
            <narrative>Numerator: 1060382; Denominator: 2124803; Percentage: 49.9%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Testing type" value="Rapid diagnostic test" />
          <comment>
            <narrative>Numerator: 1060382; Denominator: 2124803; Percentage: 49.9%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Testing type" value="Rapid diagnostic test" />
          <comment>
            <narrative>Numerator: 1060382; Denominator: 2124803; Percentage: 49.9%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Testing type" value="Rapid diagnostic test" />
          <comment>
            <narrative>Numerator: 1060382; Denominator: 2124803; Percentage: 49.9%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Testing type" value="Rapid diagnostic test" />
          <comment>
            <narrative>Numerator: 1060382; Denominator: 2124803; Percentage: 49.9%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 100%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1049380; Denominator: 1132386; Percentage: 92.7%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="5+" />
            <comment>
              <narrative>Numerator: 713175.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;5" />
            <comment>
              <narrative>Numerator: 336205.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Testing type" value="Microscopy" />
            <comment>
              <narrative>Numerator: 542974.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Testing type" value="Rapid diagnostic test" />
            <comment>
              <narrative>Numerator: 506406.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2022-06-30" />
          <target>
            <comment>
              <narrative>Percentage: 100%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2159536; Denominator: 2444919; Percentage: 88.3%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target>
            <comment>
              <narrative>Percentage: 100%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1110156; Denominator: 1312533; Percentage: 84.6%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="5+" />
            <comment>
              <narrative>Numerator: 754054; Denominator: 1110156; Percentage: 67.92%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;5" />
            <comment>
              <narrative>Numerator: 356102; Denominator: 1110156; Percentage: 32.08%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Testing type" value="Microscopy" />
            <comment>
              <narrative>Numerator: 686812.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Testing type" value="Rapid diagnostic test" />
            <comment>
              <narrative>Numerator: 423344.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 100%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1138410; Denominator: 1197923; Percentage: 95%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="5+" />
            <comment>
              <narrative>Numerator: 770551; Denominator: 1138410; Percentage: 67.69%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;5" />
            <comment>
              <narrative>Numerator: 367859; Denominator: 1138410; Percentage: 32.31%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Testing type" value="Microscopy" />
            <comment>
              <narrative>Numerator: 589539; Denominator: 1138410; Percentage: 51.79%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Testing type" value="Rapid diagnostic test" />
            <comment>
              <narrative>Numerator: 548871; Denominator: 1138410; Percentage: 48.21%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2023-06-30" />
          <target>
            <comment>
              <narrative>Percentage: 100%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2584888; Denominator: 2744092; Percentage: 94.2%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target>
            <comment>
              <narrative>Percentage: 100%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1446478; Denominator: 1546169; Percentage: 93.6%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="5+" />
            <comment>
              <narrative>Numerator: 985712; Denominator: 1446478; Percentage: 68.15%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;5" />
            <comment>
              <narrative>Numerator: 460766; Denominator: 1446478; Percentage: 31.85%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Testing type" value="Microscopy" />
            <comment>
              <narrative>Numerator: 703303; Denominator: 1446478; Percentage: 48.62%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Testing type" value="Rapid diagnostic test" />
            <comment>
              <narrative>Numerator: 743175; Denominator: 1446478; Percentage: 51.38%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Percentage: 100%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 3068156; Denominator: 3337878; Percentage: 91.9%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 100%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1324759; Denominator: 1395581; Percentage: 94.9%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="5+" />
            <comment>
              <narrative>Numerator: 904534; Denominator: 1324759; Percentage: 68.28%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;5" />
            <comment>
              <narrative>Numerator: 420225; Denominator: 1324759; Percentage: 31.72%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Testing type" value="Microscopy" />
            <comment>
              <narrative>Numerator: 679895; Denominator: 1324759; Percentage: 51.32%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Testing type" value="Rapid diagnostic test" />
            <comment>
              <narrative>Numerator: 644864; Denominator: 1324759; Percentage: 48.68%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Percentage: 100%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1743397; Denominator: 1942297; Percentage: 89.8%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="5+" />
            <comment>
              <narrative>Numerator: 1211882; Denominator: 1743397; Percentage: 69.51%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;5" />
            <comment>
              <narrative>Numerator: 531515; Denominator: 1743397; Percentage: 30.49%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Testing type" value="Microscopy" />
            <comment>
              <narrative>Numerator: 862305; Denominator: 1743397; Percentage: 49.46%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Testing type" value="Rapid diagnostic test" />
            <comment>
              <narrative>Numerator: 881092; Denominator: 1743397; Percentage: 50.54%.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="266" />
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2022-06-30" />
          <target value="556" />
          <actual value="296" />
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="278" />
          <actual value="104" />
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="278" />
          <actual value="192" />
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2023-06-30" />
          <target value="611" />
          <actual value="613" />
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="305.5" />
          <actual value="302" />
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="305.5" />
          <actual value="311" />
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2024-06-30" />
          <target value="670" />
          <actual value="535" />
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="335" />
          <actual value="240" />
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="335" />
          <actual value="295" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="266" />
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="278" />
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2022-06-30" />
          <target value="556" />
          <actual value="192" />
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="278" />
          <actual value="192" />
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2023-06-30" />
          <target value="612" />
          <actual value="564" />
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="306" />
          <actual value="264" />
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="306" />
          <actual value="300" />
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2024-06-30" />
          <target value="670" />
          <actual value="476" />
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="335" />
          <actual value="218" />
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="335" />
          <actual value="258" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of HIV-positive women who received ART during pregnancy and/or labour and delivery</narrative>
      </title>
      <description>
        <narrative>Module: PMTCT.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of HIV-positive women who received ART during pregnancy and/or labour and delivery</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - special.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="36.71">
          <comment>
            <narrative>Numerator: 1507; Denominator: 4105.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2022-06-30" />
          <target value="57">
            <comment>
              <narrative>Numerator: 2478; Denominator: 4346.</narrative>
            </comment>
          </target>
          <actual value="44.3">
            <comment>
              <narrative>Numerator: 1927; Denominator: 4346.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="28.5">
            <comment>
              <narrative>Numerator: 1239; Denominator: 4346.</narrative>
            </comment>
          </target>
          <actual value="16.2">
            <comment>
              <narrative>Numerator: 703; Denominator: 4346.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="28.5">
            <comment>
              <narrative>Numerator: 1239; Denominator: 4346.</narrative>
            </comment>
          </target>
          <actual value="28.2">
            <comment>
              <narrative>Numerator: 1224; Denominator: 4346.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2023-06-30" />
          <target value="68">
            <comment>
              <narrative>Numerator: 3020; Denominator: 4442.</narrative>
            </comment>
          </target>
          <actual value="59.5">
            <comment>
              <narrative>Numerator: 2641; Denominator: 4442.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="34">
            <comment>
              <narrative>Numerator: 1510; Denominator: 4442.</narrative>
            </comment>
          </target>
          <actual value="28.8">
            <comment>
              <narrative>Numerator: 1279; Denominator: 4442.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="34">
            <comment>
              <narrative>Numerator: 1510; Denominator: 4442.</narrative>
            </comment>
          </target>
          <actual value="30.7">
            <comment>
              <narrative>Numerator: 1362; Denominator: 4442.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="39.5">
            <comment>
              <narrative>Numerator: 1795; Denominator: 4543.</narrative>
            </comment>
          </target>
          <actual value="28.8">
            <comment>
              <narrative>Numerator: 1264; Denominator: 4392.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2024-06-30" />
          <target value="79">
            <comment>
              <narrative>Numerator: 3590; Denominator: 4543.</narrative>
            </comment>
          </target>
          <actual value="52">
            <comment>
              <narrative>Numerator: 2282; Denominator: 4392.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="39.5">
            <comment>
              <narrative>Numerator: 1795; Denominator: 4543.</narrative>
            </comment>
          </target>
          <actual value="23.2">
            <comment>
              <narrative>Numerator: 1018; Denominator: 4392.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of pregnant women who know their HIV status</narrative>
      </title>
      <description>
        <narrative>Module: PMTCT.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of pregnant women who know their HIV status</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - special.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31">
          <comment>
            <narrative>Percentage: 69%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Percentage: 98.4%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Percentage: 98.4%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Percentage: 98.4%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Percentage: 98.4%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Percentage: 98.4%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Percentage: 98.4%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Percentage: 1.6%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Percentage: 1.6%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Percentage: 1.6%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Percentage: 1.6%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Percentage: 1.6%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Percentage: 1.6%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2022-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 151014; Denominator: 185603; Percentage: 81.4%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 138501; Denominator: 185603; Percentage: 74.6%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 75507; Denominator: 185603; Percentage: 40.7%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 70082; Denominator: 185603; Percentage: 37.8%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 68750.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 1332.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 75507; Denominator: 185603; Percentage: 40.7%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 68419; Denominator: 185603; Percentage: 36.9%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 639; Denominator: 68419; Percentage: 0.93%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 81665; Denominator: 189553; Percentage: 43.1%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 84211; Denominator: 189553; Percentage: 44.4%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 83456; Denominator: 84211; Percentage: 99.1%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 522; Denominator: 84211; Percentage: 0.62%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2023-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 163330; Denominator: 189553; Percentage: 86.2%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 186772; Denominator: 189554; Percentage: 98.5%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 81665; Denominator: 189553; Percentage: 43.1%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 102561; Denominator: 189554; Percentage: 54.1%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 101853; Denominator: 102561; Percentage: 99.31%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 702; Denominator: 102561; Percentage: 0.68%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 176386; Denominator: 193784; Percentage: 91%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 209150; Denominator: 193784; Percentage: 107.9%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 88193; Denominator: 193784; Percentage: 45.5%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 99163; Denominator: 193784; Percentage: 51.2%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 98456; Denominator: 99163; Percentage: 99.29%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 707; Denominator: 99163; Percentage: 0.71%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 88193; Denominator: 193784; Percentage: 45.5%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 109987; Denominator: 193784; Percentage: 56.8%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 109489; Denominator: 109987; Percentage: 99.55%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 498; Denominator: 109987; Percentage: 0.45%.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of men who have sex with men reached with HIV prevention programs</narrative>
      </title>
      <description>
        <narrative>Module: Prevention.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of men who have sex with men reached with HIV prevention programs</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - special.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="10.69">
          <comment>
            <narrative>Numerator: 686; Denominator: 6420.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="15">
            <comment>
              <narrative>Numerator: 1081.52; Denominator: 7210.11.</narrative>
            </comment>
          </target>
          <actual value="16.5">
            <comment>
              <narrative>Numerator: 1188; Denominator: 7210.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2022-06-30" />
          <target value="30">
            <comment>
              <narrative>Numerator: 2163; Denominator: 7210.1.</narrative>
            </comment>
          </target>
          <actual value="34.1">
            <comment>
              <narrative>Numerator: 2459; Denominator: 7210.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="15">
            <comment>
              <narrative>Numerator: 1081.52; Denominator: 7210.11.</narrative>
            </comment>
          </target>
          <actual value="17.6">
            <comment>
              <narrative>Numerator: 1271; Denominator: 7210.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="20">
            <comment>
              <narrative>Numerator: 1488.41; Denominator: 7442.06.</narrative>
            </comment>
          </target>
          <actual value="18.1">
            <comment>
              <narrative>Numerator: 1347; Denominator: 7442.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2023-06-30" />
          <target value="40">
            <comment>
              <narrative>Numerator: 2976.8; Denominator: 7442.1.</narrative>
            </comment>
          </target>
          <actual value="44.5">
            <comment>
              <narrative>Numerator: 3309; Denominator: 7442.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="20">
            <comment>
              <narrative>Numerator: 1488.41; Denominator: 7442.06.</narrative>
            </comment>
          </target>
          <actual value="26.4">
            <comment>
              <narrative>Numerator: 1962; Denominator: 7442.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2024-06-30" />
          <target value="50">
            <comment>
              <narrative>Numerator: 3841; Denominator: 7682.1.</narrative>
            </comment>
          </target>
          <actual value="75.4">
            <comment>
              <narrative>Numerator: 5794; Denominator: 7682.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="25">
            <comment>
              <narrative>Numerator: 1920.52; Denominator: 7682.09.</narrative>
            </comment>
          </target>
          <actual value="25.4">
            <comment>
              <narrative>Numerator: 1951; Denominator: 7682.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="25">
            <comment>
              <narrative>Numerator: 1920.52; Denominator: 7682.09.</narrative>
            </comment>
          </target>
          <actual value="50">
            <comment>
              <narrative>Numerator: 3843; Denominator: 7682.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of sex workers reached with HIV prevention programs</narrative>
      </title>
      <description>
        <narrative>Module: Prevention.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of sex workers reached with HIV prevention programs</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - special.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="8.1">
          <comment>
            <narrative>Numerator: 1225; Denominator: 15126.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="20">
            <comment>
              <narrative>Numerator: 3628.53; Denominator: 18142.66.</narrative>
            </comment>
          </target>
          <actual value="32.3">
            <comment>
              <narrative>Numerator: 5864; Denominator: 18143.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2022-06-30" />
          <target value="40">
            <comment>
              <narrative>Numerator: 7257; Denominator: 18142.7.</narrative>
            </comment>
          </target>
          <actual value="57.9">
            <comment>
              <narrative>Numerator: 10505; Denominator: 18143.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="20">
            <comment>
              <narrative>Numerator: 3628.53; Denominator: 18142.66.</narrative>
            </comment>
          </target>
          <actual value="25.6">
            <comment>
              <narrative>Numerator: 4641; Denominator: 18143.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2023-06-30" />
          <target value="50">
            <comment>
              <narrative>Numerator: 9353.2; Denominator: 18706.4.</narrative>
            </comment>
          </target>
          <actual value="62.9">
            <comment>
              <narrative>Numerator: 11772; Denominator: 18706.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="25">
            <comment>
              <narrative>Numerator: 4676.6; Denominator: 18706.38.</narrative>
            </comment>
          </target>
          <actual value="26.6">
            <comment>
              <narrative>Numerator: 4975; Denominator: 18706.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="25">
            <comment>
              <narrative>Numerator: 4676.6; Denominator: 18706.38.</narrative>
            </comment>
          </target>
          <actual value="36.3">
            <comment>
              <narrative>Numerator: 6797; Denominator: 18706.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="30">
            <comment>
              <narrative>Numerator: 5788.22; Denominator: 19294.07.</narrative>
            </comment>
          </target>
          <actual value="30.3">
            <comment>
              <narrative>Numerator: 5855; Denominator: 19294.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2024-06-30" />
          <target value="60">
            <comment>
              <narrative>Numerator: 11576.4; Denominator: 19294.1.</narrative>
            </comment>
          </target>
          <actual value="90">
            <comment>
              <narrative>Numerator: 17357; Denominator: 19294.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="30">
            <comment>
              <narrative>Numerator: 5788.22; Denominator: 19294.07.</narrative>
            </comment>
          </target>
          <actual value="59.6">
            <comment>
              <narrative>Numerator: 11502; Denominator: 19294.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of young people aged 10-24 years reached by comprehensive sexuality education and/or life skills-based HIV education out of schools</narrative>
      </title>
      <description>
        <narrative>Module: Prevention.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of young people aged 10-24 years reached by comprehensive sexuality education and/or life skills-based HIV education out of schools</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="2.94">
          <comment>
            <narrative>Numerator: 25263; Denominator: 859243.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2022-06-30" />
          <target value="7">
            <comment>
              <narrative>Numerator: 24509.8; Denominator: 350140.</narrative>
            </comment>
          </target>
          <actual value="11">
            <comment>
              <narrative>Numerator: 38565; Denominator: 350140.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="6">
            <comment>
              <narrative>Numerator: 21008.4; Denominator: 350140.</narrative>
            </comment>
          </target>
          <actual value="2.9">
            <comment>
              <narrative>Numerator: 10053; Denominator: 350140.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="7">
            <comment>
              <narrative>Numerator: 24509.8; Denominator: 350140.</narrative>
            </comment>
          </target>
          <actual value="11">
            <comment>
              <narrative>Numerator: 38565; Denominator: 350140.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="8">
            <comment>
              <narrative>Numerator: 28759.68; Denominator: 359496.</narrative>
            </comment>
          </target>
          <actual value="6.8">
            <comment>
              <narrative>Numerator: 24424; Denominator: 359496.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2023-06-30" />
          <target value="10">
            <comment>
              <narrative>Numerator: 35949.6; Denominator: 359496.</narrative>
            </comment>
          </target>
          <actual value="13.2">
            <comment>
              <narrative>Numerator: 47291; Denominator: 359496.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="10">
            <comment>
              <narrative>Numerator: 35949.6; Denominator: 359496.</narrative>
            </comment>
          </target>
          <actual value="13.2">
            <comment>
              <narrative>Numerator: 47291; Denominator: 359496.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="12">
            <comment>
              <narrative>Numerator: 44289; Denominator: 369075.</narrative>
            </comment>
          </target>
          <actual value="11">
            <comment>
              <narrative>Numerator: 40456; Denominator: 369075.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2024-06-30" />
          <target value="15">
            <comment>
              <narrative>Numerator: 55361.3; Denominator: 369075.</narrative>
            </comment>
          </target>
          <actual value="13.2">
            <comment>
              <narrative>Numerator: 48621; Denominator: 369075.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="15">
            <comment>
              <narrative>Numerator: 55361.25; Denominator: 369075.</narrative>
            </comment>
          </target>
          <actual value="13.2">
            <comment>
              <narrative>Numerator: 48621; Denominator: 369075.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Completeness of facility reporting: Percentage of expected facility monthly reports (for the reporting period) that are actually received</narrative>
      </title>
      <description>
        <narrative>Module: RSSH: Health management information systems and M&amp;E.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Completeness of facility reporting: Percentage of expected facility monthly reports (for the reporting period) that are actually received</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="86.58">
          <comment>
            <narrative>Numerator: 3193; Denominator: 3688.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="79.63">
          <dimension name="Report type" value="HIV reports" />
          <comment>
            <narrative>Numerator: 258; Denominator: 324.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="79.63">
          <dimension name="Report type" value="HIV reports" />
          <comment>
            <narrative>Numerator: 258; Denominator: 324.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="79.63">
          <dimension name="Report type" value="HIV reports" />
          <comment>
            <narrative>Numerator: 258; Denominator: 324.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="79.63">
          <dimension name="Report type" value="HIV reports" />
          <comment>
            <narrative>Numerator: 258; Denominator: 324.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="79.63">
          <dimension name="Report type" value="HIV reports" />
          <comment>
            <narrative>Numerator: 258; Denominator: 324.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="79.63">
          <dimension name="Report type" value="HIV reports" />
          <comment>
            <narrative>Numerator: 258; Denominator: 324.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="87.39">
          <dimension name="Report type" value="Malaria reports" />
          <comment>
            <narrative>Numerator: 2905; Denominator: 3324.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="87.39">
          <dimension name="Report type" value="Malaria reports" />
          <comment>
            <narrative>Numerator: 2905; Denominator: 3324.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="87.39">
          <dimension name="Report type" value="Malaria reports" />
          <comment>
            <narrative>Numerator: 2905; Denominator: 3324.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="87.39">
          <dimension name="Report type" value="Malaria reports" />
          <comment>
            <narrative>Numerator: 2905; Denominator: 3324.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="87.39">
          <dimension name="Report type" value="Malaria reports" />
          <comment>
            <narrative>Numerator: 2905; Denominator: 3324.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="87.39">
          <dimension name="Report type" value="Malaria reports" />
          <comment>
            <narrative>Numerator: 2905; Denominator: 3324.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="75">
          <dimension name="Report type" value="TB reports" />
          <comment>
            <narrative>Numerator: 30; Denominator: 40.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="75">
          <dimension name="Report type" value="TB reports" />
          <comment>
            <narrative>Numerator: 30; Denominator: 40.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="75">
          <dimension name="Report type" value="TB reports" />
          <comment>
            <narrative>Numerator: 30; Denominator: 40.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="75">
          <dimension name="Report type" value="TB reports" />
          <comment>
            <narrative>Numerator: 30; Denominator: 40.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="75">
          <dimension name="Report type" value="TB reports" />
          <comment>
            <narrative>Numerator: 30; Denominator: 40.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="75">
          <dimension name="Report type" value="TB reports" />
          <comment>
            <narrative>Numerator: 30; Denominator: 40.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 3346; Denominator: 3718.</narrative>
            </comment>
          </target>
          <actual value="77.2">
            <comment>
              <narrative>Numerator: 4022; Denominator: 5210.</narrative>
            </comment>
          </actual>
          <actual value="46.5">
            <dimension name="Report type" value="HIV reports" />
            <comment>
              <narrative>Numerator: 798; Denominator: 1716.</narrative>
            </comment>
          </actual>
          <actual value="93.67">
            <dimension name="Report type" value="Malaria reports" />
            <comment>
              <narrative>Numerator: 3020; Denominator: 3224.</narrative>
            </comment>
          </actual>
          <actual value="75.56">
            <dimension name="Report type" value="TB reports" />
            <comment>
              <narrative>Numerator: 204; Denominator: 270.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2022-06-30" />
          <target value="90">
            <comment>
              <narrative>Numerator: 6692; Denominator: 7436.</narrative>
            </comment>
          </target>
          <actual value="77.2">
            <comment>
              <narrative>Numerator: 8145; Denominator: 10557.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="90">
            <comment>
              <narrative>Numerator: 3346; Denominator: 3718.</narrative>
            </comment>
          </target>
          <actual value="77.1">
            <comment>
              <narrative>Numerator: 4123; Denominator: 5347.</narrative>
            </comment>
          </actual>
          <actual value="46.18">
            <dimension name="Report type" value="HIV reports" />
            <comment>
              <narrative>Numerator: 852; Denominator: 1845.</narrative>
            </comment>
          </actual>
          <actual value="93.22">
            <dimension name="Report type" value="Malaria reports" />
            <comment>
              <narrative>Numerator: 3040; Denominator: 3261.</narrative>
            </comment>
          </actual>
          <actual value="95.85">
            <dimension name="Report type" value="TB reports" />
            <comment>
              <narrative>Numerator: 231; Denominator: 241.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 3346; Denominator: 3718.</narrative>
            </comment>
          </target>
          <actual value="75.4">
            <comment>
              <narrative>Numerator: 4137; Denominator: 5488.</narrative>
            </comment>
          </actual>
          <actual value="48.3">
            <dimension name="Report type" value="HIV reports" />
            <comment>
              <narrative>Numerator: 939; Denominator: 1944.</narrative>
            </comment>
          </actual>
          <actual value="91.11">
            <dimension name="Report type" value="Malaria reports" />
            <comment>
              <narrative>Numerator: 2972; Denominator: 3262.</narrative>
            </comment>
          </actual>
          <actual value="80.14">
            <dimension name="Report type" value="TB reports" />
            <comment>
              <narrative>Numerator: 226; Denominator: 282.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2023-06-30" />
          <target value="90">
            <comment>
              <narrative>Numerator: 6692; Denominator: 7436.</narrative>
            </comment>
          </target>
          <actual value="79.5">
            <comment>
              <narrative>Numerator: 8880; Denominator: 11175.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="90">
            <comment>
              <narrative>Numerator: 3346; Denominator: 3718.</narrative>
            </comment>
          </target>
          <actual value="83.4">
            <comment>
              <narrative>Numerator: 4743; Denominator: 5687.</narrative>
            </comment>
          </actual>
          <actual value="62.36">
            <dimension name="Report type" value="HIV reports" />
            <comment>
              <narrative>Numerator: 1345; Denominator: 2157.</narrative>
            </comment>
          </actual>
          <actual value="96.23">
            <dimension name="Report type" value="Malaria reports" />
            <comment>
              <narrative>Numerator: 3143; Denominator: 3266.</narrative>
            </comment>
          </actual>
          <actual value="96.59">
            <dimension name="Report type" value="TB reports" />
            <comment>
              <narrative>Numerator: 255; Denominator: 264.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2024-06-30" />
          <target value="90">
            <comment>
              <narrative>Numerator: 6692; Denominator: 7436.</narrative>
            </comment>
          </target>
          <actual value="76.2">
            <comment>
              <narrative>Numerator: 10287; Denominator: 13493.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 3346; Denominator: 3718.</narrative>
            </comment>
          </target>
          <actual value="79.5">
            <comment>
              <narrative>Numerator: 5372; Denominator: 6761.</narrative>
            </comment>
          </actual>
          <actual value="60.75">
            <dimension name="Report type" value="HIV reports" />
            <comment>
              <narrative>Numerator: 1910; Denominator: 3144.</narrative>
            </comment>
          </actual>
          <actual value="97.28">
            <dimension name="Report type" value="Malaria reports" />
            <comment>
              <narrative>Numerator: 3221; Denominator: 3311.</narrative>
            </comment>
          </actual>
          <actual value="78.76">
            <dimension name="Report type" value="TB reports" />
            <comment>
              <narrative>Numerator: 241; Denominator: 306.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="90">
            <comment>
              <narrative>Numerator: 3346; Denominator: 3718.</narrative>
            </comment>
          </target>
          <actual value="73">
            <comment>
              <narrative>Numerator: 4915; Denominator: 6732.</narrative>
            </comment>
          </actual>
          <actual value="46.21">
            <dimension name="Report type" value="HIV reports" />
            <comment>
              <narrative>Numerator: 1421; Denominator: 3075.</narrative>
            </comment>
          </actual>
          <actual value="96.55">
            <dimension name="Report type" value="Malaria reports" />
            <comment>
              <narrative>Numerator: 3218; Denominator: 3333.</narrative>
            </comment>
          </actual>
          <actual value="85.19">
            <dimension name="Report type" value="TB reports" />
            <comment>
              <narrative>Numerator: 276; Denominator: 324.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Timeliness of facility reporting: Percentage of submitted facility monthly reports (for the reporting period) that are received on time per the national guidelines</narrative>
      </title>
      <description>
        <narrative>Module: RSSH: Health management information systems and M&amp;E.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Timeliness of facility reporting: Percentage of submitted facility monthly reports (for the reporting period) that are received on time per the national guidelines</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="79.24">
          <comment>
            <narrative>Numerator: 2530; Denominator: 3193.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="72.09">
          <dimension name="Report type" value="HIV reports" />
          <comment>
            <narrative>Numerator: 186; Denominator: 258.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="72.09">
          <dimension name="Report type" value="HIV reports" />
          <comment>
            <narrative>Numerator: 186; Denominator: 258.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="72.09">
          <dimension name="Report type" value="HIV reports" />
          <comment>
            <narrative>Numerator: 186; Denominator: 258.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="72.09">
          <dimension name="Report type" value="HIV reports" />
          <comment>
            <narrative>Numerator: 186; Denominator: 258.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="72.09">
          <dimension name="Report type" value="HIV reports" />
          <comment>
            <narrative>Numerator: 186; Denominator: 258.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="72.09">
          <dimension name="Report type" value="HIV reports" />
          <comment>
            <narrative>Numerator: 186; Denominator: 258.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="80">
          <dimension name="Report type" value="Malaria reports" />
          <comment>
            <narrative>Numerator: 2324; Denominator: 2905.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="80">
          <dimension name="Report type" value="Malaria reports" />
          <comment>
            <narrative>Numerator: 2324; Denominator: 2905.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="80">
          <dimension name="Report type" value="Malaria reports" />
          <comment>
            <narrative>Numerator: 2324; Denominator: 2905.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="80">
          <dimension name="Report type" value="Malaria reports" />
          <comment>
            <narrative>Numerator: 2324; Denominator: 2905.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="80">
          <dimension name="Report type" value="Malaria reports" />
          <comment>
            <narrative>Numerator: 2324; Denominator: 2905.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="80">
          <dimension name="Report type" value="Malaria reports" />
          <comment>
            <narrative>Numerator: 2324; Denominator: 2905.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="66.67">
          <dimension name="Report type" value="TB reports" />
          <comment>
            <narrative>Numerator: 20; Denominator: 30.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="66.67">
          <dimension name="Report type" value="TB reports" />
          <comment>
            <narrative>Numerator: 20; Denominator: 30.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="66.67">
          <dimension name="Report type" value="TB reports" />
          <comment>
            <narrative>Numerator: 20; Denominator: 30.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="66.67">
          <dimension name="Report type" value="TB reports" />
          <comment>
            <narrative>Numerator: 20; Denominator: 30.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="66.67">
          <dimension name="Report type" value="TB reports" />
          <comment>
            <narrative>Numerator: 20; Denominator: 30.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="66.67">
          <dimension name="Report type" value="TB reports" />
          <comment>
            <narrative>Numerator: 20; Denominator: 30.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2022-06-30" />
          <target value="90">
            <comment>
              <narrative>Numerator: 6024; Denominator: 6692.</narrative>
            </comment>
          </target>
          <actual value="91.4">
            <comment>
              <narrative>Numerator: 7444; Denominator: 8145.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 3012; Denominator: 3346.</narrative>
            </comment>
          </target>
          <actual value="91.4">
            <comment>
              <narrative>Numerator: 3676; Denominator: 4022.</narrative>
            </comment>
          </actual>
          <actual value="90.6">
            <dimension name="Report type" value="HIV reports" />
            <comment>
              <narrative>Numerator: 723; Denominator: 798.</narrative>
            </comment>
          </actual>
          <actual value="95.96">
            <dimension name="Report type" value="Malaria reports" />
            <comment>
              <narrative>Numerator: 2898; Denominator: 3020.</narrative>
            </comment>
          </actual>
          <actual value="26.96">
            <dimension name="Report type" value="TB reports" />
            <comment>
              <narrative>Numerator: 55; Denominator: 204.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="90">
            <comment>
              <narrative>Numerator: 3012; Denominator: 3346.</narrative>
            </comment>
          </target>
          <actual value="91.4">
            <comment>
              <narrative>Numerator: 3768; Denominator: 4123.</narrative>
            </comment>
          </actual>
          <actual value="93.31">
            <dimension name="Report type" value="HIV reports" />
            <comment>
              <narrative>Numerator: 795; Denominator: 852.</narrative>
            </comment>
          </actual>
          <actual value="97.73">
            <dimension name="Report type" value="Malaria reports" />
            <comment>
              <narrative>Numerator: 2971; Denominator: 3040.</narrative>
            </comment>
          </actual>
          <actual value="0.87">
            <dimension name="Report type" value="TB reports" />
            <comment>
              <narrative>Numerator: 2; Denominator: 231.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 3012; Denominator: 3346.</narrative>
            </comment>
          </target>
          <actual value="86.4">
            <comment>
              <narrative>Numerator: 3574; Denominator: 4137.</narrative>
            </comment>
          </actual>
          <actual value="79.34">
            <dimension name="Report type" value="HIV reports" />
            <comment>
              <narrative>Numerator: 745; Denominator: 939.</narrative>
            </comment>
          </actual>
          <actual value="93.3">
            <dimension name="Report type" value="Malaria reports" />
            <comment>
              <narrative>Numerator: 2773; Denominator: 2972.</narrative>
            </comment>
          </actual>
          <actual value="24.78">
            <dimension name="Report type" value="TB reports" />
            <comment>
              <narrative>Numerator: 56; Denominator: 226.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2023-06-30" />
          <target value="90">
            <comment>
              <narrative>Numerator: 6024; Denominator: 6692.</narrative>
            </comment>
          </target>
          <actual value="88.2">
            <comment>
              <narrative>Numerator: 7832; Denominator: 8880.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="90">
            <comment>
              <narrative>Numerator: 3012; Denominator: 3346.</narrative>
            </comment>
          </target>
          <actual value="89.8">
            <comment>
              <narrative>Numerator: 4258; Denominator: 4743.</narrative>
            </comment>
          </actual>
          <actual value="88.33">
            <dimension name="Report type" value="HIV reports" />
            <comment>
              <narrative>Numerator: 1188; Denominator: 1345.</narrative>
            </comment>
          </actual>
          <actual value="95.32">
            <dimension name="Report type" value="Malaria reports" />
            <comment>
              <narrative>Numerator: 2996; Denominator: 3143.</narrative>
            </comment>
          </actual>
          <actual value="29.02">
            <dimension name="Report type" value="TB reports" />
            <comment>
              <narrative>Numerator: 74; Denominator: 255.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 3012; Denominator: 3346.</narrative>
            </comment>
          </target>
          <actual value="84.3">
            <comment>
              <narrative>Numerator: 4529; Denominator: 5372.</narrative>
            </comment>
          </actual>
          <actual value="82.41">
            <dimension name="Report type" value="HIV reports" />
            <comment>
              <narrative>Numerator: 1574; Denominator: 1910.</narrative>
            </comment>
          </actual>
          <actual value="91.74">
            <dimension name="Report type" value="Malaria reports" />
            <comment>
              <narrative>Numerator: 2955; Denominator: 3221.</narrative>
            </comment>
          </actual>
          <actual value="0">
            <dimension name="Report type" value="TB reports" />
            <comment>
              <narrative>Numerator: 0; Denominator: 241.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2024-06-30" />
          <target value="90">
            <comment>
              <narrative>Numerator: 6024; Denominator: 6692.</narrative>
            </comment>
          </target>
          <actual value="86.2">
            <comment>
              <narrative>Numerator: 8866; Denominator: 10287.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="90">
            <comment>
              <narrative>Numerator: 3012; Denominator: 3346.</narrative>
            </comment>
          </target>
          <actual value="88.2">
            <comment>
              <narrative>Numerator: 4337; Denominator: 4915.</narrative>
            </comment>
          </actual>
          <actual value="89.51">
            <dimension name="Report type" value="HIV reports" />
            <comment>
              <narrative>Numerator: 1272; Denominator: 1421.</narrative>
            </comment>
          </actual>
          <actual value="95.25">
            <dimension name="Report type" value="Malaria reports" />
            <comment>
              <narrative>Numerator: 3065; Denominator: 3218.</narrative>
            </comment>
          </actual>
          <actual value="0">
            <dimension name="Report type" value="TB reports" />
            <comment>
              <narrative>Numerator: 0; Denominator: 276.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Proportion of pregnant women attending antenatal clinics who received three or more doses of intermittent preventive treatment for malaria</narrative>
      </title>
      <description>
        <narrative>Module: Specific prevention interventions (SPI).</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Proportion of pregnant women attending antenatal clinics who received three or more doses of intermittent preventive treatment for malaria</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="21.8">
          <comment>
            <narrative>Numerator: 221954; Denominator: 1018055.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="40">
            <comment>
              <narrative>Numerator: 283743.4; Denominator: 709358.5.</narrative>
            </comment>
          </target>
          <actual value="31.2">
            <comment>
              <narrative>Numerator: 148172; Denominator: 475478.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2022-06-30" />
          <target value="40">
            <comment>
              <narrative>Numerator: 567486.8; Denominator: 1418717.</narrative>
            </comment>
          </target>
          <actual value="30.4">
            <comment>
              <narrative>Numerator: 302337; Denominator: 994281.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="40">
            <comment>
              <narrative>Numerator: 283743.4; Denominator: 709358.5.</narrative>
            </comment>
          </target>
          <actual value="29.7">
            <comment>
              <narrative>Numerator: 154165; Denominator: 518803.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2023-06-30" />
          <target value="55">
            <comment>
              <narrative>Numerator: 804327.2; Denominator: 1462413.</narrative>
            </comment>
          </target>
          <actual value="30.1">
            <comment>
              <narrative>Numerator: 341575; Denominator: 1133293.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="55">
            <comment>
              <narrative>Numerator: 402163.58; Denominator: 731206.5.</narrative>
            </comment>
          </target>
          <actual value="30.4">
            <comment>
              <narrative>Numerator: 159172; Denominator: 522824.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="55">
            <comment>
              <narrative>Numerator: 402163.58; Denominator: 731206.5.</narrative>
            </comment>
          </target>
          <actual value="29.9">
            <comment>
              <narrative>Numerator: 182403; Denominator: 610469.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="65">
            <comment>
              <narrative>Numerator: 489761.35; Denominator: 753479.</narrative>
            </comment>
          </target>
          <actual value="28.5">
            <comment>
              <narrative>Numerator: 158620; Denominator: 556904.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2024-06-30" />
          <target value="65">
            <comment>
              <narrative>Numerator: 979522.8; Denominator: 1506958.</narrative>
            </comment>
          </target>
          <actual value="27.2">
            <comment>
              <narrative>Numerator: 310613; Denominator: 1142012.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="65">
            <comment>
              <narrative>Numerator: 489761.35; Denominator: 753479.</narrative>
            </comment>
          </target>
          <actual value="26">
            <comment>
              <narrative>Numerator: 151993; Denominator: 585108.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Proportion of pregnant women attending antenatal clinics who received three or more doses of intermittent preventive treatment for malaria</narrative>
      </title>
      <description>
        <narrative>Module: Specific prevention interventions (SPI).</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Proportion of pregnant women attending antenatal clinics who received three or more doses of intermittent preventive treatment for malaria</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="31.63">
          <comment>
            <narrative>Numerator: 52773; Denominator: 166828.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="40">
            <comment>
              <narrative>Numerator: 41089.4; Denominator: 102723.56.</narrative>
            </comment>
          </target>
          <actual value="33.6">
            <comment>
              <narrative>Numerator: 26901; Denominator: 80164.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2022-06-30" />
          <target value="40">
            <comment>
              <narrative>Numerator: 93385; Denominator: 233462.7.</narrative>
            </comment>
          </target>
          <actual value="32.4">
            <comment>
              <narrative>Numerator: 57046; Denominator: 175817.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="40">
            <comment>
              <narrative>Numerator: 52295.6; Denominator: 130739.08.</narrative>
            </comment>
          </target>
          <actual value="31.5">
            <comment>
              <narrative>Numerator: 30145; Denominator: 95653.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="55">
            <comment>
              <narrative>Numerator: 58060.64; Denominator: 105564.7.</narrative>
            </comment>
          </target>
          <actual value="33.1">
            <comment>
              <narrative>Numerator: 30911; Denominator: 93338.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2023-06-30" />
          <target value="55">
            <comment>
              <narrative>Numerator: 131956; Denominator: 239919.8.</narrative>
            </comment>
          </target>
          <actual value="34.6">
            <comment>
              <narrative>Numerator: 69121; Denominator: 199686.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="55">
            <comment>
              <narrative>Numerator: 73895.36; Denominator: 134355.08.</narrative>
            </comment>
          </target>
          <actual value="35.9">
            <comment>
              <narrative>Numerator: 38210; Denominator: 106348.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="65">
            <comment>
              <narrative>Numerator: 70507.36; Denominator: 108473.05.</narrative>
            </comment>
          </target>
          <actual value="35.7">
            <comment>
              <narrative>Numerator: 35117; Denominator: 98300.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2024-06-30" />
          <target value="65">
            <comment>
              <narrative>Numerator: 160244; Denominator: 246529.7.</narrative>
            </comment>
          </target>
          <actual value="35.9">
            <comment>
              <narrative>Numerator: 71081; Denominator: 197790.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="65">
            <comment>
              <narrative>Numerator: 89736.64; Denominator: 138056.62.</narrative>
            </comment>
          </target>
          <actual value="36.1">
            <comment>
              <narrative>Numerator: 35964; Denominator: 99490.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31">
          <comment>
            <narrative>Numerator: 78303.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 65287.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 65287.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 65287.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 65287.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 65287.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 65287.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 8818.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 8818.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 8818.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 8818.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 8818.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 8818.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
          <comment>
            <narrative>Numerator: 34887.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
          <comment>
            <narrative>Numerator: 34887.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
          <comment>
            <narrative>Numerator: 34887.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
          <comment>
            <narrative>Numerator: 34887.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
          <comment>
            <narrative>Numerator: 34887.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
          <comment>
            <narrative>Numerator: 34887.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 31840.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 31840.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 31840.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 31840.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 31840.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 31840.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 42265.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 42265.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 42265.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 42265.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 42265.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 42265.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 57195.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 57195.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 57195.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 57195.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 57195.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 57195.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Not documented" />
          <comment>
            <narrative>Numerator: 16408.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Not documented" />
          <comment>
            <narrative>Numerator: 16408.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Not documented" />
          <comment>
            <narrative>Numerator: 16408.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Not documented" />
          <comment>
            <narrative>Numerator: 16408.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Not documented" />
          <comment>
            <narrative>Numerator: 16408.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Not documented" />
          <comment>
            <narrative>Numerator: 16408.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 4700.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 4700.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 4700.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 4700.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 4700.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 4700.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 44753.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 26462.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 23701.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 2761.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
            <comment>
              <narrative>Numerator: 13784.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 11687.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 14687.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2022-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 89505.5.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 57259.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 44752.5.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 30797.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
            <comment>
              <narrative>Numerator: 16029.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 13365.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 17245.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 18713; Denominator: 20332; Percentage: 92.04%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Not documented" />
            <comment>
              <narrative>Numerator: 10465.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 1579; Denominator: 20332; Percentage: 7.77%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 48758.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 34938.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 31295; Denominator: 34938; Percentage: 89.57%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 3643; Denominator: 34938; Percentage: 10.43%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
            <comment>
              <narrative>Numerator: 18157; Denominator: 34938; Percentage: 51.97%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 15301; Denominator: 34938; Percentage: 43.79%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 19637; Denominator: 34938; Percentage: 56.21%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 21092; Denominator: 34938; Percentage: 60.37%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Not documented" />
            <comment>
              <narrative>Numerator: 12086; Denominator: 34938; Percentage: 34.59%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 1778; Denominator: 34938; Percentage: 5.09%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2023-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 97516.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 66924.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 48758.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 31986.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 27730; Denominator: 31641; Percentage: 87.64%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 3911; Denominator: 31641; Percentage: 12.36%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
            <comment>
              <narrative>Numerator: 16378; Denominator: 31986; Percentage: 51.2%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 13927; Denominator: 31641; Percentage: 44.02%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 17714; Denominator: 31641; Percentage: 55.98%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 22412; Denominator: 31986; Percentage: 70.07%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Not documented" />
            <comment>
              <narrative>Numerator: 7604; Denominator: 31986; Percentage: 23.77%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 1970; Denominator: 31986; Percentage: 6.16%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 52796.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 31909.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 28319.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 3587.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
            <comment>
              <narrative>Numerator: 15831.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 14051.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 17855.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 21940.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Not documented" />
            <comment>
              <narrative>Numerator: 8130.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 1839.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 105592.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 73670.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 52796.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 41761.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 37498; Denominator: 41761; Percentage: 89.79%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 4186; Denominator: 41761; Percentage: 10.02%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
            <comment>
              <narrative>Numerator: 20157; Denominator: 41761; Percentage: 48.27%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 17974; Denominator: 41761; Percentage: 43.04%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 23710; Denominator: 41761; Percentage: 56.78%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 31224; Denominator: 41761; Percentage: 74.77%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Not documented" />
            <comment>
              <narrative>Numerator: 8179; Denominator: 41761; Percentage: 19.59%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 2358; Denominator: 41761; Percentage: 5.65%.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="13613" />
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2022-06-30" />
          <target value="15616" />
          <actual value="14842" />
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="7808" />
          <actual value="6497" />
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="7808" />
          <actual value="8345" />
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="8516" />
          <actual value="7731" />
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2023-06-30" />
          <target value="17032" />
          <actual value="15922" />
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="8516" />
          <actual value="8191" />
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="8771.5" />
          <actual value="7256" />
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2024-06-30" />
          <target value="17543" />
          <actual value="15623" />
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="8771.5" />
          <actual value="8367" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="60" />
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="75">
            <comment>
              <narrative>Numerator: 5105; Denominator: 6806.5.</narrative>
            </comment>
          </target>
          <actual value="56.8">
            <comment>
              <narrative>Numerator: 6142; Denominator: 10806.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2022-06-30" />
          <target value="75">
            <comment>
              <narrative>Numerator: 10210; Denominator: 13613.</narrative>
            </comment>
          </target>
          <actual value="60.3">
            <comment>
              <narrative>Numerator: 10440; Denominator: 17303.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="75">
            <comment>
              <narrative>Numerator: 5105; Denominator: 6806.5.</narrative>
            </comment>
          </target>
          <actual value="66.2">
            <comment>
              <narrative>Numerator: 4298; Denominator: 6497.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="82.5">
            <comment>
              <narrative>Numerator: 6441.5; Denominator: 7808.</narrative>
            </comment>
          </target>
          <actual value="65.9">
            <comment>
              <narrative>Numerator: 5464; Denominator: 8289.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2023-06-30" />
          <target value="82.5">
            <comment>
              <narrative>Numerator: 12883; Denominator: 15616.</narrative>
            </comment>
          </target>
          <actual value="72">
            <comment>
              <narrative>Numerator: 11353; Denominator: 15779.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="82.5">
            <comment>
              <narrative>Numerator: 6441.5; Denominator: 7808.</narrative>
            </comment>
          </target>
          <actual value="78.6">
            <comment>
              <narrative>Numerator: 5889; Denominator: 7490.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2024-06-30" />
          <target value="85">
            <comment>
              <narrative>Numerator: 14478; Denominator: 17032.</narrative>
            </comment>
          </target>
          <actual value="68">
            <comment>
              <narrative>Numerator: 10261; Denominator: 15096.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="85">
            <comment>
              <narrative>Numerator: 7239; Denominator: 8516.</narrative>
            </comment>
          </target>
          <actual value="65.8">
            <comment>
              <narrative>Numerator: 5253; Denominator: 7985.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="85">
            <comment>
              <narrative>Numerator: 7239; Denominator: 8516.</narrative>
            </comment>
          </target>
          <actual value="70.4">
            <comment>
              <narrative>Numerator: 5008; Denominator: 7111.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of registered new and relapse TB patients with documented HIV status</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of registered new and relapse TB patients with documented HIV status</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="80" />
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2022-06-30" />
          <target value="85">
            <comment>
              <narrative>Numerator: 13273; Denominator: 15616.</narrative>
            </comment>
          </target>
          <actual value="66.6">
            <comment>
              <narrative>Numerator: 9890; Denominator: 14842.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="85">
            <comment>
              <narrative>Numerator: 6636.5; Denominator: 7808.</narrative>
            </comment>
          </target>
          <actual value="80.3">
            <comment>
              <narrative>Numerator: 5215; Denominator: 6497.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="85">
            <comment>
              <narrative>Numerator: 6636.5; Denominator: 7808.</narrative>
            </comment>
          </target>
          <actual value="56">
            <comment>
              <narrative>Numerator: 4675; Denominator: 8345.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="92">
            <comment>
              <narrative>Numerator: 7835; Denominator: 8516.</narrative>
            </comment>
          </target>
          <actual value="79.7">
            <comment>
              <narrative>Numerator: 6160; Denominator: 7731.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2023-06-30" />
          <target value="92">
            <comment>
              <narrative>Numerator: 15670; Denominator: 17032.</narrative>
            </comment>
          </target>
          <actual value="85.4">
            <comment>
              <narrative>Numerator: 13593; Denominator: 15922.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="92">
            <comment>
              <narrative>Numerator: 7835; Denominator: 8516.</narrative>
            </comment>
          </target>
          <actual value="90.7">
            <comment>
              <narrative>Numerator: 7433; Denominator: 8191.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2024-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 17543; Denominator: 17543.</narrative>
            </comment>
          </target>
          <actual value="90.9">
            <comment>
              <narrative>Numerator: 14198; Denominator: 15623.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 8771.5; Denominator: 8771.5.</narrative>
            </comment>
          </target>
          <actual value="88.8">
            <comment>
              <narrative>Numerator: 6446; Denominator: 7256.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 8771.5; Denominator: 8771.5.</narrative>
            </comment>
          </target>
          <actual value="92.6">
            <comment>
              <narrative>Numerator: 7752; Denominator: 8367.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of adults (15 and above) on ART among all adults living with HIV at the end of the reporting period</narrative>
      </title>
      <description>
        <narrative>Module: Treatment, care and support.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of adults (15 and above) on ART among all adults living with HIV at the end of the reporting period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="25.22">
          <comment>
            <narrative>Numerator: 10365; Denominator: 41103.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="35">
            <comment>
              <narrative>Numerator: 15685.25; Denominator: 44815.</narrative>
            </comment>
          </target>
          <actual value="22">
            <comment>
              <narrative>Numerator: 9874; Denominator: 44815.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2022-06-30" />
          <target value="39">
            <comment>
              <narrative>Numerator: 17453; Denominator: 44815.</narrative>
            </comment>
          </target>
          <actual value="26.3">
            <comment>
              <narrative>Numerator: 11781; Denominator: 44815.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="39">
            <comment>
              <narrative>Numerator: 17453; Denominator: 44815.</narrative>
            </comment>
          </target>
          <actual value="26.3">
            <comment>
              <narrative>Numerator: 11781; Denominator: 44815.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="45">
            <comment>
              <narrative>Numerator: 20853; Denominator: 46340.</narrative>
            </comment>
          </target>
          <actual value="29">
            <comment>
              <narrative>Numerator: 13424; Denominator: 46340.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2023-06-30" />
          <target value="50">
            <comment>
              <narrative>Numerator: 23340; Denominator: 46340.</narrative>
            </comment>
          </target>
          <actual value="54.2">
            <comment>
              <narrative>Numerator: 16504; Denominator: 30463.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="50">
            <comment>
              <narrative>Numerator: 23340; Denominator: 46340.</narrative>
            </comment>
          </target>
          <actual value="54.2">
            <comment>
              <narrative>Numerator: 16504; Denominator: 30463.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="55">
            <comment>
              <narrative>Numerator: 26289.45; Denominator: 47799.</narrative>
            </comment>
          </target>
          <actual value="59.5">
            <comment>
              <narrative>Numerator: 18125; Denominator: 30463.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2024-06-30" />
          <target value="63.6">
            <comment>
              <narrative>Numerator: 30419; Denominator: 47799.</narrative>
            </comment>
          </target>
          <actual value="56.7">
            <comment>
              <narrative>Numerator: 19759; Denominator: 34842.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="63.6">
            <comment>
              <narrative>Numerator: 30419; Denominator: 47799.</narrative>
            </comment>
          </target>
          <actual value="56.7">
            <comment>
              <narrative>Numerator: 19759; Denominator: 34842.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of children (under 15) on ART among all children living with HIV at the end of the reporting period</narrative>
      </title>
      <description>
        <narrative>Module: Treatment, care and support.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of children (under 15) on ART among all children living with HIV at the end of the reporting period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="15.32">
          <comment>
            <narrative>Numerator: 630; Denominator: 4111.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="35">
            <comment>
              <narrative>Numerator: 1322.65; Denominator: 3779.</narrative>
            </comment>
          </target>
          <actual value="11.2">
            <comment>
              <narrative>Numerator: 425; Denominator: 3799.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2022-06-30" />
          <target value="39">
            <comment>
              <narrative>Numerator: 1475; Denominator: 3779.</narrative>
            </comment>
          </target>
          <actual value="17.7">
            <comment>
              <narrative>Numerator: 671; Denominator: 3799.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="39">
            <comment>
              <narrative>Numerator: 1475; Denominator: 3779.</narrative>
            </comment>
          </target>
          <actual value="17.7">
            <comment>
              <narrative>Numerator: 671; Denominator: 3799.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2023-06-30" />
          <target value="50.8">
            <comment>
              <narrative>Numerator: 1851; Denominator: 3647.</narrative>
            </comment>
          </target>
          <actual value="23.4">
            <comment>
              <narrative>Numerator: 893; Denominator: 3816.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="45">
            <comment>
              <narrative>Numerator: 1641.15; Denominator: 3647.</narrative>
            </comment>
          </target>
          <actual value="22.2">
            <comment>
              <narrative>Numerator: 809; Denominator: 3647.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="50.8">
            <comment>
              <narrative>Numerator: 1851; Denominator: 3647.</narrative>
            </comment>
          </target>
          <actual value="23.4">
            <comment>
              <narrative>Numerator: 893; Denominator: 3816.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2024-06-30" />
          <target value="60.8">
            <comment>
              <narrative>Numerator: 2135; Denominator: 3514.</narrative>
            </comment>
          </target>
          <actual value="30.7">
            <comment>
              <narrative>Numerator: 1141; Denominator: 3716.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="55">
            <comment>
              <narrative>Numerator: 1932.7; Denominator: 3514.</narrative>
            </comment>
          </target>
          <actual value="26.7">
            <comment>
              <narrative>Numerator: 1019; Denominator: 3816.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="60.8">
            <comment>
              <narrative>Numerator: 2135; Denominator: 3514.</narrative>
            </comment>
          </target>
          <actual value="30.7">
            <comment>
              <narrative>Numerator: 1141; Denominator: 3716.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people on ART among all people living with HIV at the end of the reporting period</narrative>
      </title>
      <description>
        <narrative>Module: Treatment, care and support.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of people on ART among all people living with HIV at the end of the reporting period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2018" iso-date="2018-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 5100; Denominator: 31000; Percentage: 16.45%.</narrative>
          </comment>
        </baseline>
        <baseline year="2018" iso-date="2018-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 5100; Denominator: 31000; Percentage: 16.45%.</narrative>
          </comment>
        </baseline>
        <baseline year="2018" iso-date="2018-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 5100; Denominator: 31000; Percentage: 16.45%.</narrative>
          </comment>
        </baseline>
        <baseline year="2018" iso-date="2018-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 5100; Denominator: 31000; Percentage: 16.45%.</narrative>
          </comment>
        </baseline>
        <baseline year="2018" iso-date="2018-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 5100; Denominator: 31000; Percentage: 16.45%.</narrative>
          </comment>
        </baseline>
        <baseline year="2018" iso-date="2018-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 5100; Denominator: 31000; Percentage: 16.45%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <comment>
            <narrative>Numerator: 93300; Denominator: 340000; Percentage: 27.44%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 88200; Denominator: 310000; Percentage: 28.45%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 88200; Denominator: 310000; Percentage: 28.45%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 88200; Denominator: 310000; Percentage: 28.45%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 88200; Denominator: 310000; Percentage: 28.45%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 88200; Denominator: 310000; Percentage: 28.45%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 88200; Denominator: 310000; Percentage: 28.45%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender | Age" value="Female | 15+" />
          <comment>
            <narrative>Numerator: 62800; Denominator: 220000; Percentage: 28.55%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender | Age" value="Female | 15+" />
          <comment>
            <narrative>Numerator: 62800; Denominator: 220000; Percentage: 28.55%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender | Age" value="Female | 15+" />
          <comment>
            <narrative>Numerator: 62800; Denominator: 220000; Percentage: 28.55%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender | Age" value="Female | 15+" />
          <comment>
            <narrative>Numerator: 62800; Denominator: 220000; Percentage: 28.55%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender | Age" value="Female | 15+" />
          <comment>
            <narrative>Numerator: 62800; Denominator: 220000; Percentage: 28.55%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender | Age" value="Female | 15+" />
          <comment>
            <narrative>Numerator: 62800; Denominator: 220000; Percentage: 28.55%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender | Age" value="Male | 15+" />
          <comment>
            <narrative>Numerator: 25400; Denominator: 90000; Percentage: 28.22%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender | Age" value="Male | 15+" />
          <comment>
            <narrative>Numerator: 25400; Denominator: 90000; Percentage: 28.22%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender | Age" value="Male | 15+" />
          <comment>
            <narrative>Numerator: 25400; Denominator: 90000; Percentage: 28.22%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender | Age" value="Male | 15+" />
          <comment>
            <narrative>Numerator: 25400; Denominator: 90000; Percentage: 28.22%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender | Age" value="Male | 15+" />
          <comment>
            <narrative>Numerator: 25400; Denominator: 90000; Percentage: 28.22%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender | Age" value="Male | 15+" />
          <comment>
            <narrative>Numerator: 25400; Denominator: 90000; Percentage: 28.22%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Duration of treatment" value="Newly initiating ART" />
          <comment>
            <narrative>Numerator: 4600; Denominator: 340000; Percentage: 1.35%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Duration of treatment" value="Newly initiating ART" />
          <comment>
            <narrative>Numerator: 4600; Denominator: 340000; Percentage: 1.35%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Duration of treatment" value="Newly initiating ART" />
          <comment>
            <narrative>Numerator: 4600; Denominator: 340000; Percentage: 1.35%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Duration of treatment" value="Newly initiating ART" />
          <comment>
            <narrative>Numerator: 4600; Denominator: 340000; Percentage: 1.35%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Duration of treatment" value="Newly initiating ART" />
          <comment>
            <narrative>Numerator: 4600; Denominator: 340000; Percentage: 1.35%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Duration of treatment" value="Newly initiating ART" />
          <comment>
            <narrative>Numerator: 4600; Denominator: 340000; Percentage: 1.35%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 126350; Denominator: 361000; Percentage: 35%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 127763; Denominator: 361000; Percentage: 35.4%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 120880.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 6883.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender | Age" value="Female | 15+" />
            <comment>
              <narrative>Numerator: 87961.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender | Age" value="Male | 15+" />
            <comment>
              <narrative>Numerator: 32919.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Duration of treatment" value="Newly initiating ART" />
            <comment>
              <narrative>Numerator: 20745.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2022-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 144400; Denominator: 361000; Percentage: 40%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 146298; Denominator: 361000; Percentage: 40.5%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 144400; Denominator: 361000; Percentage: 40%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 146298; Denominator: 361000; Percentage: 40.5%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender | Age" value="Female | 15+" />
            <comment>
              <narrative>Numerator: 101110.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender | Age" value="Male | 15+" />
            <comment>
              <narrative>Numerator: 37448.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Duration of treatment" value="Newly initiating ART" />
            <comment>
              <narrative>Numerator: 17380.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2023-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 186000; Denominator: 372000; Percentage: 50%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 134794; Denominator: 313656; Percentage: 43%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 167400; Denominator: 372000; Percentage: 45%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 151887; Denominator: 372000; Percentage: 40.8%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Duration of treatment" value="Newly initiating ART" />
            <comment>
              <narrative>Numerator: 8161; Denominator: 151887; Percentage: 5.37%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 186000; Denominator: 372000; Percentage: 50%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 134794; Denominator: 313656; Percentage: 43%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 127509; Denominator: 278549; Percentage: 45.78%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 7285; Denominator: 35108; Percentage: 20.75%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender | Age" value="Female | 15+" />
            <comment>
              <narrative>Numerator: 92801; Denominator: 185092; Percentage: 50.14%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender | Age" value="Male | 15+" />
            <comment>
              <narrative>Numerator: 34708; Denominator: 93457; Percentage: 37.14%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Duration of treatment" value="Newly initiating ART" />
            <comment>
              <narrative>Numerator: 19332; Denominator: 134794; Percentage: 14.34%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 210100; Denominator: 382000; Percentage: 55%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 126397; Denominator: 315000; Percentage: 40.1%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 119541.1; Denominator: 280000; Percentage: 42.69%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 6855.9; Denominator: 35000; Percentage: 19.59%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender | Age" value="Female | 15+" />
            <comment>
              <narrative>Numerator: 87088.9; Denominator: 190000; Percentage: 45.84%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender | Age" value="Male | 15+" />
            <comment>
              <narrative>Numerator: 32452.2; Denominator: 90000; Percentage: 36.06%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Duration of treatment" value="Newly initiating ART" />
            <comment>
              <narrative>Numerator: 22481.2; Denominator: 126397; Percentage: 17.79%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 229200; Denominator: 382000; Percentage: 60%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 181795; Denominator: 323423; Percentage: 56.2%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 229200; Denominator: 382000; Percentage: 60%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 181795; Denominator: 323423; Percentage: 56.2%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 171937; Denominator: 291562; Percentage: 58.97%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 9858; Denominator: 31861; Percentage: 30.94%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender | Age" value="Female | 15+" />
            <comment>
              <narrative>Numerator: 124860; Denominator: 195079; Percentage: 64%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender | Age" value="Male | 15+" />
            <comment>
              <narrative>Numerator: 47077; Denominator: 96483; Percentage: 48.79%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Duration of treatment" value="Newly initiating ART" />
            <comment>
              <narrative>Numerator: 21402; Denominator: 181795; Percentage: 11.77%.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of long-lasting insecticidal nets distributed to at-risk populations through mass campaigns</narrative>
      </title>
      <description>
        <narrative>Module: Vector control.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of long-lasting insecticidal nets distributed to at-risk populations through mass campaigns</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="0" />
        <baseline year="2019" iso-date="2019-12-31" value="0">
          <dimension name="Target / Risk population group" value="Migrants/ refugees/ IDPs" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="0">
          <dimension name="Target / Risk population group" value="Migrants/ refugees/ IDPs" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="0">
          <dimension name="Target / Risk population group" value="Others" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="0">
          <dimension name="Target / Risk population group" value="Others" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="0">
          <dimension name="Target / Risk population group" value="Prisoners" />
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="0">
          <dimension name="Target / Risk population group" value="Prisoners" />
        </baseline>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="1422288" />
          <actual value="2837430" />
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2023-06-30" />
          <target value="2844576" />
          <actual value="2837430" />
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="1422288" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of long-lasting insecticidal nets distributed to targeted risk groups through continuous distribution</narrative>
      </title>
      <description>
        <narrative>Module: Vector control.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of long-lasting insecticidal nets distributed to targeted risk groups through continuous distribution</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31">
          <comment>
            <narrative>Numerator: 186289.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Target / Risk population group" value="Children 0-5" />
          <comment>
            <narrative>Numerator: 92409.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Target / Risk population group" value="Children 0-5" />
          <comment>
            <narrative>Numerator: 92409.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Target / Risk population group" value="Children 0-5" />
          <comment>
            <narrative>Numerator: 92409.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Target / Risk population group" value="Children 0-5" />
          <comment>
            <narrative>Numerator: 92409.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Target / Risk population group" value="Pregnant women" />
          <comment>
            <narrative>Numerator: 93880.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Target / Risk population group" value="Pregnant women" />
          <comment>
            <narrative>Numerator: 93880.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Target / Risk population group" value="Pregnant women" />
          <comment>
            <narrative>Numerator: 93880.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Target / Risk population group" value="Pregnant women" />
          <comment>
            <narrative>Numerator: 93880.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 516762.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 12915.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Target / Risk population group" value="Children 0-5" />
            <comment>
              <narrative>Numerator: 4932.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Target / Risk population group" value="Pregnant women" />
            <comment>
              <narrative>Numerator: 7983.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2022-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 1033524.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 88290.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 516762.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 75375.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Target / Risk population group" value="Children 0-5" />
            <comment>
              <narrative>Numerator: 36814.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Target / Risk population group" value="Pregnant women" />
            <comment>
              <narrative>Numerator: 38561.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 542180.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 101433.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Target / Risk population group" value="Children 0-5" />
            <comment>
              <narrative>Numerator: 30621; Denominator: 101433; Percentage: 30.19%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Target / Risk population group" value="Pregnant women" />
            <comment>
              <narrative>Numerator: 70812; Denominator: 101433; Percentage: 69.81%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 1084360.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 222482.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 542180.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 121049.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Target / Risk population group" value="Children 0-5" />
            <comment>
              <narrative>Numerator: 46526; Denominator: 121049; Percentage: 38.44%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Target / Risk population group" value="Pregnant women" />
            <comment>
              <narrative>Numerator: 74523; Denominator: 121049; Percentage: 61.56%.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
  </iati-activity>
  <iati-activity last-updated-datetime="2026-11-11T11:05:58+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-AGO-Z-UNDP-3</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>Supporting the National Response to HIV/AIDS, Tuberculosis and Malaria in Angola - Angola (01-Jul-2024-30-Jun-2027)</narrative>
    </title>
    <description type="1">
      <narrative>Angola, Multicomponent, United Nations Development Programme</narrative>
    </description>
    <description type="2">
      <narrative>Goals: Reduce by 50% new infections from HIV/AIDS, among people of all ages, by 2026; Treat 75% of the persons diagnosed with HIV; Reduce the mother-to-child transmission rate from 15% in 2022 to 6% in 2026; Decrease TB incidence from 325 to 261 per 100.000 inhabitants by 2027 (325 per 100,000 is the incidence estimated by WHO in 2021); By 2025, reduce by 40% malaria morbidity in the country, in relation to the baseline of 2020 (positivity rate in 2020: 52%); By 2025, reduce by 50% malaria mortality in the country, in relation to the baseline of 2020 (mortality rate by 100,000 in 2020: 38). Objectives: By 2026, offer HIV combination prevention packages in at least 60% of the municipalities containing the highest HIV incidence rates among the priority population; By 2026, identify 75% of the persons estimated to be living with HIV and who do not know their status; By 2026, increase Viral Load Coverage among PLHIV to 75% and to 80% among pregnant women; Increase the case detection rate of TB by 5% per year (2024-2027); By 2027, increase the treatment success rate for TB-S from 68% to 78% among adults (5% increase per year during 4 years); By 2027, all the 82 municipalities with installed mWRD have medical doctors trained in MDR/RR-TB treatment; By 2027, promote one standard model of C-DOT in all municipalities; By 2025, provide malaria preventative services to at least 80% of the population at risk; By 2025, provide early diagnosis and treatment to 100% of malaria suspected cases; By 2025, strengthen the epidemiological and entomological surveillance systems, and monitoring and evaluation so that 100% of municipalities can achieve their malaria prevention and control targets; By the end of 2027, 90% of health facilities are reporting their monthly reports; By the 2027, 90% of health facilities  monthly reports are  submitted timely.</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="40" role="2" crs-channel-code="41000">
      <narrative>United Nations Development Programme</narrative>
    </participating-org>
    <participating-org type="40" role="4" crs-channel-code="41000">
      <narrative>United Nations Development Programme</narrative>
    </participating-org>
    <other-identifier ref="AGO-Z-UNDPP03" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="2" />
    <activity-date type="1" iso-date="2024-07-01" />
    <activity-date type="2" iso-date="2024-07-01" />
    <activity-date type="3" iso-date="2027-06-30" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>Quentin De Hemptinne</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>quentin.dehemptinne@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="4" />
    <recipient-country code="AO" percentage="100">
      <narrative>Angola</narrative>
    </recipient-country>
    <sector vocabulary="1" code="12262" percentage="34.96">
      <narrative>Malaria</narrative>
    </sector>
    <sector vocabulary="1" code="13040" percentage="27.87">
      <narrative>HIV</narrative>
    </sector>
    <sector vocabulary="1" code="12110" percentage="23.42">
      <narrative>Multicomponent, RSSH</narrative>
    </sector>
    <sector vocabulary="1" code="12263" percentage="13.75">
      <narrative>Tuberculosis</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <tag vocabulary="3" code="3.8">
      <narrative>Achieve universal health coverage</narrative>
    </tag>
    <country-budget-items vocabulary="4">
      <budget-item code="f8950f0e-59db-4839-9e56-5ad9689ca68d" percentage="0.57">
        <description>
          <narrative>HIV -&gt; Differentiated HIV Testing Services -&gt; Community-based testing for AGYW and their male sexual partners programs</narrative>
        </description>
      </budget-item>
      <budget-item code="aecf0171-ec0b-4298-be44-3c2a390d7a69" percentage="0.78">
        <description>
          <narrative>HIV -&gt; Differentiated HIV Testing Services -&gt; Community-based testing for KP programs</narrative>
        </description>
      </budget-item>
      <budget-item code="891c6028-9f9a-427f-8e25-55b502d52054" percentage="0.22">
        <description>
          <narrative>HIV -&gt; Differentiated HIV Testing Services -&gt; Community-based testing outside of KP and AGYW programs</narrative>
        </description>
      </budget-item>
      <budget-item code="d0aef99a-6d26-4e24-9937-7363cf44e158" percentage="0.33">
        <description>
          <narrative>HIV -&gt; Differentiated HIV Testing Services -&gt; Facility-based testing for adolescent girls and young women (AGYW) and their male sexual partners programs</narrative>
        </description>
      </budget-item>
      <budget-item code="e41c9e1f-dfcd-4d62-9a3d-2c6d760bb3af" percentage="0.22">
        <description>
          <narrative>HIV -&gt; Differentiated HIV Testing Services -&gt; Facility-based testing for key population (KP) programs</narrative>
        </description>
      </budget-item>
      <budget-item code="26ab57aa-470b-4e99-bff9-92e1452cf6cd" percentage="2.62">
        <description>
          <narrative>HIV -&gt; Differentiated HIV Testing Services -&gt; Facility-based testing outside of key population (KP) and adolescent girls and young women (AGYW) programs</narrative>
        </description>
      </budget-item>
      <budget-item code="48867067-7709-4cef-94a9-7dcc66211686" percentage="0.25">
        <description>
          <narrative>HIV -&gt; Differentiated HIV Testing Services -&gt; Self-testing for KP programs</narrative>
        </description>
      </budget-item>
      <budget-item code="fa74be82-0e67-471f-99cd-c36d38ba6843" percentage="0.08">
        <description>
          <narrative>HIV -&gt; Elimination of vertical transmission of HIV, syphilis and hepatitis B -&gt; Early infant diagnosis and follow-up HIV testing for exposed infants</narrative>
        </description>
      </budget-item>
      <budget-item code="54f285ef-8db0-40b2-8052-f00a00522b8d" percentage="4.38">
        <description>
          <narrative>HIV -&gt; Elimination of vertical transmission of HIV, syphilis and hepatitis B -&gt; Integrated testing of pregnant women for HIV, syphilis and hepatitis B</narrative>
        </description>
      </budget-item>
      <budget-item code="3eb32c17-6380-4aa6-8a3b-73b4cb922dee" percentage="0.1">
        <description>
          <narrative>HIV -&gt; Elimination of vertical transmission of HIV, syphilis and hepatitis B -&gt; Post-natal infant prophylaxis</narrative>
        </description>
      </budget-item>
      <budget-item code="698ea3f4-346f-4df8-ab2e-c01a47bbccd9" percentage="0.1">
        <description>
          <narrative>HIV -&gt; Elimination of vertical transmission of HIV, syphilis and hepatitis B -&gt; Prevention of incident HIV among pregnant and breastfeeding women</narrative>
        </description>
      </budget-item>
      <budget-item code="1ef60004-7321-4f53-93cf-6bdfa56924ef" percentage="1.35">
        <description>
          <narrative>HIV -&gt; Elimination of vertical transmission of HIV, syphilis and hepatitis B -&gt; Retention support for pregnant and breastfeeding women (facility and community)</narrative>
        </description>
      </budget-item>
      <budget-item code="8549b926-d8fb-4fa0-b3b8-79fc250303b6" percentage="0.34">
        <description>
          <narrative>HIV -&gt; Prevention package for adolescent girls and young women (AGYW) and male sexual partners in high HIV incidence settings -&gt; Comprehensive sexuality education for adolescent girls and young women (AGYW) and adolescent boys and young men (ABYM)</narrative>
        </description>
      </budget-item>
      <budget-item code="9d329dd4-6e6b-430c-80f6-afb56fbbbacd" percentage="0.95">
        <description>
          <narrative>HIV -&gt; Prevention package for adolescent girls and young women (AGYW) and male sexual partners in high HIV incidence settings -&gt; Condom and lubricant programming for AGYW in high HIV incidence settings</narrative>
        </description>
      </budget-item>
      <budget-item code="0a745960-07a1-46b7-add6-90d0e9ec5fd4" percentage="0.74">
        <description>
          <narrative>HIV -&gt; Prevention package for adolescent girls and young women (AGYW) and male sexual partners in high HIV incidence settings -&gt; HIV prevention communication, information and demand creation for AGYW in high HIV incidence settings</narrative>
        </description>
      </budget-item>
      <budget-item code="5c4d112f-f0f4-4a20-8ac8-5c566f7aa322" percentage="0.27">
        <description>
          <narrative>HIV -&gt; Prevention package for adolescent girls and young women (AGYW) and male sexual partners in high HIV incidence settings -&gt; Removing human rights-related barriers to prevention for AGYW in high HIV incidence settings</narrative>
        </description>
      </budget-item>
      <budget-item code="e71b58f8-6d5d-4f73-93c5-cea93aefb0c3" percentage="0.15">
        <description>
          <narrative>HIV -&gt; Prevention package for adolescent girls and young women (AGYW) and male sexual partners in high HIV incidence settings -&gt; Sexual and reproductive health services, including STIs, hepatitis, post-violence care for AGYW and male sexual partners in high HIV incidence settings</narrative>
        </description>
      </budget-item>
      <budget-item code="7a803e07-8560-47f6-9b59-72193d6812db" percentage="0.11">
        <description>
          <narrative>HIV -&gt; Prevention package for men who have sex with men (MSM) and their sexual partners -&gt; Condom and lubricant programming for MSM</narrative>
        </description>
      </budget-item>
      <budget-item code="7300b0bf-fc7f-49ac-b933-534346c226a5" percentage="0.06">
        <description>
          <narrative>HIV -&gt; Prevention package for men who have sex with men (MSM) and their sexual partners -&gt; Pre-exposure prophylaxis (PrEP) programming for MSM</narrative>
        </description>
      </budget-item>
      <budget-item code="b7a2ebc7-33dc-42f2-b664-e760a5d99b0a" percentage="0.14">
        <description>
          <narrative>HIV -&gt; Prevention package for men who have sex with men (MSM) and their sexual partners -&gt; Removing human rights-related barriers to prevention for MSM</narrative>
        </description>
      </budget-item>
      <budget-item code="e14e7a7d-49ce-4bb6-8454-ae4224e7a32e" percentage="0.11">
        <description>
          <narrative>HIV -&gt; Prevention package for men who have sex with men (MSM) and their sexual partners -&gt; Sexual and reproductive health services, including STIs, hepatitis, post-violence care for MSM</narrative>
        </description>
      </budget-item>
      <budget-item code="52020c8d-d3b6-42f6-9137-038784523b8a" percentage="0.09">
        <description>
          <narrative>HIV -&gt; Prevention package for other vulnerable populations (OVP) -&gt; Condom and lubricant programming for OVP</narrative>
        </description>
      </budget-item>
      <budget-item code="97e87d65-a4de-4357-81ae-2aae27b112a2" percentage="0.22">
        <description>
          <narrative>HIV -&gt; Prevention package for other vulnerable populations (OVP) -&gt; HIV prevention communication, information and demand creation for OVP</narrative>
        </description>
      </budget-item>
      <budget-item code="8a68b0fa-0674-4039-b5d0-396ae5bcf3d3" percentage="0.08">
        <description>
          <narrative>HIV -&gt; Prevention package for other vulnerable populations (OVP) -&gt; Removing human rights-related barriers to prevention for OVP</narrative>
        </description>
      </budget-item>
      <budget-item code="d01264fd-1485-4b1a-b85c-fbaa2fa20933" percentage="0.05">
        <description>
          <narrative>HIV -&gt; Prevention package for other vulnerable populations (OVP) -&gt; Sexual and reproductive health services, including STIs, hepatitis, post-violence care for OVP</narrative>
        </description>
      </budget-item>
      <budget-item code="94dbd87e-0cec-46fb-83f5-7c805de185cb" percentage="0.78">
        <description>
          <narrative>HIV -&gt; Prevention package for sex workers, their clients and other sexual partners -&gt; Condom and lubricant programming for sex workers</narrative>
        </description>
      </budget-item>
      <budget-item code="394d6538-8808-4811-b96b-d6bf71843cb6" percentage="0">
        <description>
          <narrative>HIV -&gt; Prevention package for sex workers, their clients and other sexual partners -&gt; HIV prevention communication, information and demand creation for sex workers</narrative>
        </description>
      </budget-item>
      <budget-item code="4ad468bf-4376-466e-944a-b25f3e1b00ee" percentage="0.47">
        <description>
          <narrative>HIV -&gt; Prevention package for sex workers, their clients and other sexual partners -&gt; Pre-exposure prophylaxis (PrEP) programming for sex workers</narrative>
        </description>
      </budget-item>
      <budget-item code="0d89e3fa-e33d-4d2a-a9a8-48ae7bd8ad56" percentage="0.04">
        <description>
          <narrative>HIV -&gt; Prevention package for sex workers, their clients and other sexual partners -&gt; Removing human rights-related barriers to prevention for sex workers</narrative>
        </description>
      </budget-item>
      <budget-item code="3f39233d-f679-42ce-8532-a7949f0d93ef" percentage="0.43">
        <description>
          <narrative>HIV -&gt; Prevention package for sex workers, their clients and other sexual partners -&gt; Sexual and reproductive health services, including STIs, hepatitis, post-violence care for sex workers</narrative>
        </description>
      </budget-item>
      <budget-item code="daac344e-ec8e-4193-9c8a-266fdd2e69ac" percentage="0.01">
        <description>
          <narrative>HIV -&gt; Prevention package for transgender people and their sexual partners -&gt; Condom and lubricant programming for transgender people</narrative>
        </description>
      </budget-item>
      <budget-item code="55ece96e-d30c-46d2-8db0-27306b249434" percentage="0.08">
        <description>
          <narrative>HIV -&gt; Prevention package for transgender people and their sexual partners -&gt; HIV prevention communication, information and demand creation for transgender people</narrative>
        </description>
      </budget-item>
      <budget-item code="6853dd18-909c-4836-8981-2e434afc456c" percentage="0">
        <description>
          <narrative>HIV -&gt; Prevention package for transgender people and their sexual partners -&gt; Pre-exposure prophylaxis (PrEP) programming for transgender people</narrative>
        </description>
      </budget-item>
      <budget-item code="58b982df-6d9f-4cf8-8a29-3e452601002f" percentage="0.02">
        <description>
          <narrative>HIV -&gt; Prevention package for transgender people and their sexual partners -&gt; Removing human rights-related barriers to prevention for transgender people</narrative>
        </description>
      </budget-item>
      <budget-item code="ec84ef8b-ad12-46a3-9175-4f68245fa984" percentage="0">
        <description>
          <narrative>HIV -&gt; Prevention package for transgender people and their sexual partners -&gt; Sexual and reproductive health services, including STIs, hepatitis, post-violence care for transgender people</narrative>
        </description>
      </budget-item>
      <budget-item code="9bcc0e33-1356-4897-a1b3-d9171e326a60" percentage="0.01">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Eliminating stigma and discrimination in all settings</narrative>
        </description>
      </budget-item>
      <budget-item code="10e03ea0-16be-40e1-9fba-682edec921d0" percentage="0.07">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Ensuring rights-based law enforcement practices</narrative>
        </description>
      </budget-item>
      <budget-item code="b745fdfb-055f-428b-9634-646cf15f5904" percentage="0.04">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Improving laws, regulations and policies relating to HIV and HIV/TB</narrative>
        </description>
      </budget-item>
      <budget-item code="ecc245de-32bf-41ff-8eb1-f5fae2eb1557" percentage="0.03">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Legal literacy ("Know Your Rights") (HIV/TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="530c3ad4-ec67-412e-9dc9-b83b6de6bf61" percentage="0.89">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; Diagnosis and management of advanced HIV disease (adults and children)</narrative>
        </description>
      </budget-item>
      <budget-item code="d49b353e-9087-48e0-9c3b-f8ed91d6fd53" percentage="2.41">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; HIV treatment and differentiated service delivery - adults (15 and above)</narrative>
        </description>
      </budget-item>
      <budget-item code="6bb2376e-8c74-4cf1-98f0-f72ea58797fa" percentage="2.57">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; HIV treatment and differentiated service delivery - children (under 15)</narrative>
        </description>
      </budget-item>
      <budget-item code="423a40f4-4716-48a1-9c6c-7b78ede223af" percentage="1.85">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; Integrated management of common co-infections and co-morbidities (adults and children)</narrative>
        </description>
      </budget-item>
      <budget-item code="f4ee9261-d065-449a-8c27-d7a734d6ccae" percentage="0">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; Treatment monitoring - Drug resistance</narrative>
        </description>
      </budget-item>
      <budget-item code="75665eb3-7cb7-4083-b197-c97fcbe30044" percentage="3.83">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; Treatment monitoring - Viral load and antiretroviral (ARV) toxicity</narrative>
        </description>
      </budget-item>
      <budget-item code="738953d0-45d2-486f-957e-e3fee8de75cd" percentage="14.19">
        <description>
          <narrative>Malaria -&gt; Case management -&gt; Facility-based treatment</narrative>
        </description>
      </budget-item>
      <budget-item code="c0797acd-77a1-43ee-9c39-6bf17fd6f4ed" percentage="3.07">
        <description>
          <narrative>Malaria -&gt; Case management -&gt; Integrated community case management (iCCM)</narrative>
        </description>
      </budget-item>
      <budget-item code="09ec106d-6825-4ae2-a0ad-18a0f9f53a64" percentage="0.04">
        <description>
          <narrative>Malaria -&gt; Vector control -&gt; Entomological monitoring</narrative>
        </description>
      </budget-item>
      <budget-item code="479fb4f4-6792-4b4c-92a8-c428d9c4dddb" percentage="1.07">
        <description>
          <narrative>Malaria -&gt; Vector control -&gt; Insecticide treated nets (ITNs) - Continuous distribution: ANC</narrative>
        </description>
      </budget-item>
      <budget-item code="ec73574f-f014-44eb-a8c7-9791b58bc103" percentage="0.56">
        <description>
          <narrative>Malaria -&gt; Vector control -&gt; Insecticide treated nets (ITNs) - Continuous distribution: EPI</narrative>
        </description>
      </budget-item>
      <budget-item code="0904e74b-3fd7-4544-bb4e-8343228bdbe5" percentage="16">
        <description>
          <narrative>Malaria -&gt; Vector control -&gt; Insecticide treated nets (ITNs) - Mass campaign: universal</narrative>
        </description>
      </budget-item>
      <budget-item code="a58d3044-b095-4df4-b7b7-c7df42d56d3d" percentage="0.04">
        <description>
          <narrative>Malaria -&gt; Vector control -&gt; Social and behavior change (SBC) (Vector control)</narrative>
        </description>
      </budget-item>
      <budget-item code="cd09d6c8-13e6-412e-a54d-84c32d99a370" percentage="0.03">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Coordination and management of national disease control programs</narrative>
        </description>
      </budget-item>
      <budget-item code="43337786-bfab-487f-b388-9fbe8808948d" percentage="19.46">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Grant management</narrative>
        </description>
      </budget-item>
      <budget-item code="80d429dc-894d-4f0c-99cc-2403b8f1f5fe" percentage="0.29">
        <description>
          <narrative>RSSH -&gt; RSSH/PP: Human resources for health (HRH) and quality of care -&gt; RSSH/PP: HRH planning, management and governance including for community health workers (CHWs)</narrative>
        </description>
      </budget-item>
      <budget-item code="5a6fc5ba-08a3-455c-887d-00867a865303" percentage="0.24">
        <description>
          <narrative>RSSH -&gt; RSSH/PP: Human resources for health (HRH) and quality of care -&gt; RSSH/PP: Quality improvement and capacity building for quality of care</narrative>
        </description>
      </budget-item>
      <budget-item code="f9c0078b-d557-4047-b352-b4b2eba7e5b8" percentage="0.21">
        <description>
          <narrative>RSSH -&gt; RSSH/PP: Laboratory systems (including national and peripheral) -&gt; RSSH/PP: Laboratory Information systems</narrative>
        </description>
      </budget-item>
      <budget-item code="376b4c32-f875-4663-ba6e-759f6042be74" percentage="0.07">
        <description>
          <narrative>RSSH -&gt; RSSH/PP: Laboratory systems (including national and peripheral) -&gt; RSSH/PP: Laboratory supply chain systems</narrative>
        </description>
      </budget-item>
      <budget-item code="09d00f5e-f29a-445c-a7e5-4a1e21a3dce7" percentage="0.01">
        <description>
          <narrative>RSSH -&gt; RSSH/PP: Laboratory systems (including national and peripheral) -&gt; RSSH/PP: Laboratory-based surveillance</narrative>
        </description>
      </budget-item>
      <budget-item code="19ae85a9-12db-4fb8-9313-84f9feef29a0" percentage="0.24">
        <description>
          <narrative>RSSH -&gt; RSSH/PP: Laboratory systems (including national and peripheral) -&gt; RSSH/PP: National laboratory governance and management structures</narrative>
        </description>
      </budget-item>
      <budget-item code="dbf27095-3379-4518-8890-897d22a754ef" percentage="0.02">
        <description>
          <narrative>RSSH -&gt; RSSH/PP: Laboratory systems (including national and peripheral) -&gt; RSSH/PP: Network optimization and geospatial analysis</narrative>
        </description>
      </budget-item>
      <budget-item code="0aa54232-09ea-488b-86df-48a82af99ed4" percentage="0">
        <description>
          <narrative>RSSH -&gt; RSSH/PP: Laboratory systems (including national and peripheral) -&gt; RSSH/PP: Quality management systems and accreditation</narrative>
        </description>
      </budget-item>
      <budget-item code="a964bfef-7776-4f8c-bf11-c2f904336a18" percentage="0.17">
        <description>
          <narrative>RSSH -&gt; RSSH/PP: Laboratory systems (including national and peripheral) -&gt; RSSH/PP: Specimen referral and transport system</narrative>
        </description>
      </budget-item>
      <budget-item code="db62704e-5b08-4eb1-b5cb-39a697705c19" percentage="0.14">
        <description>
          <narrative>RSSH -&gt; RSSH: Community systems strengthening -&gt; Capacity building and leadership development</narrative>
        </description>
      </budget-item>
      <budget-item code="7dbf6454-4357-4937-89a1-9a1c7f0174fa" percentage="0.27">
        <description>
          <narrative>RSSH -&gt; RSSH: Community systems strengthening -&gt; Community engagement, linkages and coordination</narrative>
        </description>
      </budget-item>
      <budget-item code="8c042996-0cb7-4540-ad17-483cf18ec784" percentage="0.19">
        <description>
          <narrative>RSSH -&gt; RSSH: Community systems strengthening -&gt; Community-led monitoring</narrative>
        </description>
      </budget-item>
      <budget-item code="12d82614-1fc1-4696-b954-b899115b31d9" percentage="0.02">
        <description>
          <narrative>RSSH -&gt; RSSH: Community systems strengthening -&gt; Community-led research and advocacy</narrative>
        </description>
      </budget-item>
      <budget-item code="eacd0e9d-d48a-433b-8461-31679dc01dc1" percentage="0.02">
        <description>
          <narrative>RSSH -&gt; RSSH: Health financing systems -&gt; Public financial management (PFM) systems</narrative>
        </description>
      </budget-item>
      <budget-item code="ffe3ecaa-6068-456f-9036-38d34bacd266" percentage="0.05">
        <description>
          <narrative>RSSH -&gt; RSSH: Health products management systems -&gt; Avoidance, reduction and management of health care waste</narrative>
        </description>
      </budget-item>
      <budget-item code="48d7f7e3-61fc-4c8d-88f3-aefc44da79dc" percentage="0.07">
        <description>
          <narrative>RSSH -&gt; RSSH: Health products management systems -&gt; Planning and procurement capacity</narrative>
        </description>
      </budget-item>
      <budget-item code="78165abf-6e6d-46ad-b445-d380c1037123" percentage="0">
        <description>
          <narrative>RSSH -&gt; RSSH: Health products management systems -&gt; Policy, strategy, governance</narrative>
        </description>
      </budget-item>
      <budget-item code="1e7328c2-4fcd-47b0-8e3c-31a8a421d74c" percentage="0.03">
        <description>
          <narrative>RSSH -&gt; RSSH: Health products management systems -&gt; Regulatory/quality assurance support</narrative>
        </description>
      </budget-item>
      <budget-item code="31d3a0e8-e9f1-4c88-b1b7-ce75b4e952eb" percentage="0.05">
        <description>
          <narrative>RSSH -&gt; RSSH: Health products management systems -&gt; Storage and distribution capacity, design &amp; operations</narrative>
        </description>
      </budget-item>
      <budget-item code="38ed2119-0193-4f73-9333-90fbd5a8cc0b" percentage="0.02">
        <description>
          <narrative>RSSH -&gt; RSSH: Health products management systems -&gt; Supply chain information systems</narrative>
        </description>
      </budget-item>
      <budget-item code="0e90e07b-37cc-4294-9a44-c1afd707a824" percentage="0.04">
        <description>
          <narrative>RSSH -&gt; RSSH: Health sector planning and governance for integrated people-centered services -&gt; Integration/coordination across disease programs and at the service delivery level</narrative>
        </description>
      </budget-item>
      <budget-item code="2c341d5c-b46c-47a9-9aff-2700be47f75e" percentage="0.6">
        <description>
          <narrative>RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Analyses, evaluations, reviews and data use</narrative>
        </description>
      </budget-item>
      <budget-item code="f94cd008-2af3-49cf-9149-7be7cf0228e7" percentage="0.29">
        <description>
          <narrative>RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Data quality</narrative>
        </description>
      </budget-item>
      <budget-item code="42e7a4b3-fa75-4c16-8a4d-110492b156f4" percentage="0.84">
        <description>
          <narrative>RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Routine reporting</narrative>
        </description>
      </budget-item>
      <budget-item code="1a5ab4c7-9695-4567-adb4-0a3768fa01ee" percentage="0.08">
        <description>
          <narrative>RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Surveys</narrative>
        </description>
      </budget-item>
      <budget-item code="ea39b4f6-cd94-4310-b181-394f794f9144" percentage="1.97">
        <description>
          <narrative>Tuberculosis -&gt; Drug-resistant (DR)-TB diagnosis, treatment and care -&gt; DR-TB diagnosis/drug susceptibility testing (DST)</narrative>
        </description>
      </budget-item>
      <budget-item code="5b20da70-c625-405c-858b-6de52626ae46" percentage="1.66">
        <description>
          <narrative>Tuberculosis -&gt; Drug-resistant (DR)-TB diagnosis, treatment and care -&gt; DR-TB treatment, care and support</narrative>
        </description>
      </budget-item>
      <budget-item code="99700b2a-3a9a-4855-b789-986d7a150e52" percentage="1.48">
        <description>
          <narrative>Tuberculosis -&gt; Key and vulnerable populations (KVP) - TB/DR-TB -&gt; KVP - Children and adolescents</narrative>
        </description>
      </budget-item>
      <budget-item code="99e62de4-459a-4fc3-a5da-f5297d23736d" percentage="0.01">
        <description>
          <narrative>Tuberculosis -&gt; Key and vulnerable populations (KVP) - TB/DR-TB -&gt; KVP - People in prisons/jails/detention centers</narrative>
        </description>
      </budget-item>
      <budget-item code="f50f08b4-b9d9-4b4a-a8b2-065858f9ce31" percentage="0.57">
        <description>
          <narrative>Tuberculosis -&gt; TB diagnosis, treatment and care -&gt; TB screening and diagnosis</narrative>
        </description>
      </budget-item>
      <budget-item code="003bd5ec-d813-43cd-9bae-ec060870a2c4" percentage="7.66">
        <description>
          <narrative>Tuberculosis -&gt; TB diagnosis, treatment and care -&gt; TB treatment, care and support</narrative>
        </description>
      </budget-item>
      <budget-item code="7332ed72-b538-4ab5-b90e-f820e56c0c5b" percentage="0.14">
        <description>
          <narrative>Tuberculosis -&gt; TB/DR-TB Prevention -&gt; Infection prevention and control (IPC)</narrative>
        </description>
      </budget-item>
      <budget-item code="68262ac7-05ab-4aec-9c9e-320d5883c55c" percentage="0.01">
        <description>
          <narrative>Tuberculosis -&gt; TB/DR-TB Prevention -&gt; Screening/testing for TB infection</narrative>
        </description>
      </budget-item>
      <budget-item code="8f363382-1b81-4d2d-a396-2be1435016f2" percentage="0">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Collaborative interventions</narrative>
        </description>
      </budget-item>
      <budget-item code="602586f6-9a77-484c-bf39-acc8a3151170" percentage="0.02">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Prevention</narrative>
        </description>
      </budget-item>
      <budget-item code="7c7a7505-bdfe-4146-976c-78a03ca0d545" percentage="0.22">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Screening, testing and diagnosis</narrative>
        </description>
      </budget-item>
    </country-budget-items>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <budget type="2" status="2">
      <period-start iso-date="2024-01-01" />
      <period-end iso-date="2024-12-31" />
      <value currency="USD" value-date="2024-01-01">29522558.26</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2025-01-01" />
      <period-end iso-date="2025-12-31" />
      <value currency="USD" value-date="2025-01-01">35018029.99</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2026-01-01" />
      <period-end iso-date="2026-12-31" />
      <value currency="USD" value-date="2026-01-01">40553109.50</value>
    </budget>
    <capital-spend percentage="2.78" />
    <transaction ref="946de8ea-a769-456e-8710-8b3e1173af31">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-06-18" />
      <value currency="USD" value-date="2024-06-18">56720615.33</value>
      <description>
        <narrative>Global Fund commitment to AGO-Z-UNDPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="e984f1d5-658b-4e37-b5b1-74b35cdecfe6">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-06-20" />
      <value currency="USD" value-date="2024-06-20">20447172.07</value>
      <description>
        <narrative>Global Fund disbursement to AGO-Z-UNDPP03 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="aae6ede2-b4f3-4899-bdf3-5c485eb530cc">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-10-15" />
      <value currency="USD" value-date="2024-10-15">4104167.00</value>
      <description>
        <narrative>Global Fund disbursement to AGO-Z-UNDPP03 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="8c927e5d-a8cc-4d86-a50b-cbcdffcc6c59">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-12-03" />
      <value currency="USD" value-date="2024-12-03">9499301.00</value>
      <description>
        <narrative>Global Fund disbursement to AGO-Z-UNDPP03 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="e91e7d0a-c4a9-4dbf-8fca-2285e21bbbc9">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-06-11" />
      <value currency="USD" value-date="2025-06-11">3903616.00</value>
      <description>
        <narrative>Global Fund disbursement to AGO-Z-UNDPP03 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="50c70759-88b6-424b-8d37-a55574d2f54c">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-08-05" />
      <value currency="USD" value-date="2025-08-05">8395675.00</value>
      <description>
        <narrative>Global Fund disbursement to AGO-Z-UNDPP03 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="fafc181b-5b7b-479c-8a28-973a9cdf6062">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-11-10" />
      <value currency="USD" value-date="2025-11-10">1078202.00</value>
      <description>
        <narrative>Global Fund commitment to AGO-Z-UNDPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="3590a883-48cb-47e8-ac2a-9e7fbb49b1f1">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-11-11" />
      <value currency="USD" value-date="2025-11-11">1078202.00</value>
      <description>
        <narrative>Global Fund disbursement to AGO-Z-UNDPP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="65c49fed-2119-411b-a055-98e6e2adb602">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-12-15" />
      <value currency="USD" value-date="2025-12-15">39701158.00</value>
      <description>
        <narrative>Global Fund commitment to AGO-Z-UNDPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="969c6547-a0b8-4e8e-b62c-2f2ccf19cf9b">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-12-15" />
      <value currency="USD" value-date="2025-12-15">-10370684.26</value>
      <description>
        <narrative>Global Fund commitment to AGO-Z-UNDPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="fc3c66ad-56df-4491-bf51-1f16c13034b3">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-12-18" />
      <value currency="USD" value-date="2025-12-18">10227583.00</value>
      <description>
        <narrative>Global Fund disbursement to AGO-Z-UNDPP03 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="29ac5d8d-46dd-4c39-b818-c07c56044930">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-04-21" />
      <value currency="USD" value-date="2026-04-21">4831424.00</value>
      <description>
        <narrative>Global Fund disbursement to AGO-Z-UNDPP03 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="c34b66fa-c660-40d4-8f53-ccfe140c994b">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-07-21" />
      <value currency="USD" value-date="2026-07-21">3861546.00</value>
      <description>
        <narrative>Global Fund disbursement to AGO-Z-UNDPP03 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="bdd53742-bfc0-470d-803c-2054d8be449a">
      <transaction-type code="7" />
      <transaction-date iso-date="2026-10-09" />
      <value currency="USD" value-date="2026-10-09">245434.00</value>
      <description>
        <narrative>Funds returned to the Global Fund from AGO-Z-UNDPP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="3182d9e0-4ea7-4d32-9c5c-ed1f621debb7">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-10-09" />
      <value currency="USD" value-date="2026-10-09">-245434.00</value>
      <description>
        <narrative>Global Fund commitment to AGO-Z-UNDPP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="4024effc-76f2-48c1-b45b-94e24fc57375">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-10-13" />
      <value currency="USD" value-date="2026-10-13">16015558.00</value>
      <description>
        <narrative>Global Fund disbursement to AGO-Z-UNDPP03 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="AGO-Z-UNDPP03-EXP-20250630">
      <transaction-type code="4" />
      <transaction-date iso-date="2025-06-30" />
      <value currency="USD" value-date="2025-06-30">29488714.34</value>
      <description>
        <narrative>Expenditure reported by United Nations Development Programme for AGO-Z-UNDPP03, Jul 2024 to Jun 2025.</narrative>
      </description>
      <provider-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </provider-org>
    </transaction>
    <transaction ref="AGO-Z-UNDPP03-EXP-20251231">
      <transaction-type code="4" />
      <transaction-date iso-date="2025-12-31" />
      <value currency="USD" value-date="2025-12-31">13460372.00</value>
      <description>
        <narrative>Expenditure reported by United Nations Development Programme for AGO-Z-UNDPP03, Jul 2025 to Dec 2025.</narrative>
      </description>
      <provider-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </provider-org>
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/AGO-Z-UNDP" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-11" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
    <document-link url="https://docs.theglobalfund.org/files/Applications/Funding Requests/AGO/2023/Multicomponent/en/AGO-Z_FundingRequest_1_en.zip" format="application/zip">
      <title>
        <narrative>2023 - Funding Request - Window 3 - Multicomponent - Angola - English</narrative>
      </title>
      <description>
        <narrative>Funding Request of funding request FR1533-AGO-Z.</narrative>
      </description>
      <category code="A01" />
      <category code="A02" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2023-08-21" />
    </document-link>
    <conditions attached="1">
      <condition type="2">
        <narrative>1 - To the extent consistent with and without prejudice to the Framework Agreement and, in particular, Article 2 of the UNDP-Global Fund Grant Regulations, the Principal Recipient shall be guided by the Global Fund Guidelines for Grant Budgeting (2023, as amended from time to time, available at the Global Fund’s Internet site) in the budgeting of the Grant.</narrative>
      </condition>
      <condition type="1">
        <narrative>2 - Personal Data. (1) Principles. Program Activities are expected to respect the following principles and rights (“Data Protection Principles”): (a) Information that could be used to identify a natural person (“Personal Data”) will be: (i) processed lawfully, fairly and transparently; (ii) collected for specified, explicit and legitimate purposes and not further processed in a manner not compatible with those purposes;  (iii) adequate, relevant and limited to what is necessary for the purposes for which they are processed; (iv) accurate and, where necessary, kept up to date; (v) kept in a form which permits identification of the individuals for no longer than is necessary for the purposes for which the Personal Data is processed; and (vi) processed in a manner that ensures appropriate security of the Personal Data; and (b) Natural persons are afforded, where relevant, the right to information about Personal Data that is processed; the right to access and rectify or erase Personal Data; the right to data portability; the right to confidentiality of electronic communications; and the right to object to processing. (2) Limitations. Where collection and processing of Personal Data is required in order to implement Program Activities, whether by the Principal Recipient, a Sub-recipient, or Supplier, the Principal Recipient should respect the Data Protection Principles: (a) to the extent that doing so does not violate or conflict with any law and/or policy applicable to it; and (b) subject to the Principal Recipient balancing the Data Protection Principles with other fundamental rights in accordance with the principle of proportionality, taking into account the risks to the rights and freedoms of natural persons. (3) The Global Fund may collect or seek to collect data, and it is possible that such data may contain Personal Data. Prior to collection and at all times thereafter, the Principal Recipient shall take all necessary actions to ensure that the transfer of such information to the Global Fund does not violate any law or regulation applicable to the Principal Recipient.</narrative>
      </condition>
      <condition type="2">
        <narrative>3 - Under Article 3 of the UNDP-Global Fund Grant Regulations, the “Grant” consists of “funds as stated in the relevant Grant Confirmation together with any funds previously granted by the Global Fund to the Principal Recipient for the Program”. In this regard, please note that where the Global Fund has approved the use under the current Grant Confirmation of grant funds disbursed to the Principal Recipient under a previous Grant Agreement for the Program (“Previously Disbursed Grant Funds”), the Global Fund may reduce the amount of Grant Funds that remains uncommitted set forth in Section 3.6 of the Grant Confirmation by the amount of any Previously Disbursed Grant Funds, upon written notification to the Principal Recipient.</narrative>
      </condition>
      <condition type="1">
        <narrative>4 - (1) In accordance with the Global Fund’s Sustainability, Transition and Co-financing Policy (GF/B35/04) (the “STC Policy”), the commitment and disbursement of US$ 31,491,186 (the “Co-Financing Incentive”), is subject to the Global Fund’s satisfaction with the Host Country’s compliance with the requirements listed at 4.4(1)(a) and 4.4(1)(b) below (“Co-Financing Requirements”). The Grantee acknowledges and agrees that the Global Fund may reduce Grant Funds during the current or any subsequent Implementation Period in the event the Host Country fails to: (a) progressively increase government expenditure on health to meet national universal health coverage goals; and/or (b) maintain domestic funding of Global Fund-supported programs, with a focus on progressively absorbing the key costs of national disease plans, as identified in consultation with the Global Fund. (2) In order to satisfy the Co-Financing Requirements, the Grantee acknowledges and agrees that the Host Country shall, as set out in the co-financing commitment letter to be signed by the Government of Republic of Angola and submitted in form and substance satisfactory to the Global Fund within 6 months from the Implementation Period start date that: (a) fulfil the total minimum co-financing commitment required by the relevant policy of the Global Fund; and (b) provide to the Global Fund, by no later than the 30th of June of each year of the Implementation Period and the year following the end of the Implementation Period, evidence supporting achievement of the Co-Financing Requirements, including but not limited to: i. the General State Budget (Orçamento Geral de Estado - OGE) for the health sector approved for the current year; and ii. the co-financing monitoring report on the implementation of co-financing commitments for the previous year, compiled according to the methodology for monitoring co-financing commitments for HIV, TB and Malaria agreed between the Ministry of Health of Angola and the Secretariat (Standard Operating Procedure - SOP).</narrative>
      </condition>
      <condition type="2">
        <narrative>5 - Unless otherwise notified by the Global Fund in writing, prior to the use of Grant Funds to finance the procurement of second-line anti-tuberculosis drugs and for each disbursement request that includes funds for the procurement of multi-drug resistant tuberculosis medicines, the Principal Recipient shall submit to the Global Fund and obtain the Global Fund’s written approval of a written confirmation of the price estimate and quantities of the second-line anti-tuberculosis drugs that will be procured by the Principal Recipient from the Global Drug Facility’s procurement agent.</narrative>
      </condition>
      <condition type="2">
        <narrative>6 - The use of Grant Funds under the following Budget Lines is conditioned as follows: (1) The use of Grant Funds under Budget Lines 2, 495, 523, 763, 768, 772, 802, and 824 is conditioned on, for each Budget Line, the submission to the Global Fund for the Global Fund’s written approval, prior to 31 December 2024, of a costing plan and Terms of Reference. (2) The use of Grant Funds under Budget Lines 453 and 629 is conditioned on, for each Budget Line, the submission to the Global Fund for the Global Fund’s written approval, prior to 30 June 2025, of a costing plan and Terms of Reference. (3) The use of Grant Funds under Budget Lines 103 and 450 is conditioned on, for each Budget Line, the submission to the Global Fund for the Global Fund’s written approval, prior to 30 June 2024, of a comprehensive needs assessment including an assessment of all vehicles already procured with Global Fund Grant Funds (including Grant Funds from prior Global Fund Grants). (4) The use of Grant Funds under Budget Lines 663, 664, 665, 666, 667, 668, and 669 is conditioned on, for each Budget Line, the submission to the Global Fund for the Global Fund’s written approval, prior to 30 September 2024, of strategic and costing plans. (5) The use of Grant Funds under Budget Line 57 is conditioned on the submission to the Global Fund for the Global Fund’s written approval, prior to 30 June 2024, of written clarification of individual salary amounts.</narrative>
      </condition>
    </conditions>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Proportion of confirmed malaria cases that received first-line antimalarial treatment at public sector health facilities</narrative>
      </title>
      <description>
        <narrative>Module: Case management.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Proportion of confirmed malaria cases that received first-line antimalarial treatment at public sector health facilities</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="79.89">
          <comment>
            <narrative>Numerator: 1369835; Denominator: 1714670.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2025-06-30" />
          <target value="95">
            <comment>
              <narrative>Numerator: 2255580; Denominator: 2374295.</narrative>
            </comment>
          </target>
          <actual value="87.28">
            <comment>
              <narrative>Numerator: 2058307; Denominator: 2358315.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="95">
            <comment>
              <narrative>Numerator: 1127790; Denominator: 1187147.5.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="95">
            <comment>
              <narrative>Numerator: 1127790; Denominator: 1187147.5.</narrative>
            </comment>
          </target>
          <actual value="85.77">
            <comment>
              <narrative>Numerator: 1123928; Denominator: 1310460.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 1218111; Denominator: 1218111.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2026-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 2436222; Denominator: 2436222.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 1218111; Denominator: 1218111.</narrative>
            </comment>
          </target>
          <actual value="93.83">
            <comment>
              <narrative>Numerator: 990173; Denominator: 1055253.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 1209871; Denominator: 1209871.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-01-01" />
          <period-end iso-date="2027-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 1209871; Denominator: 1209871.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Proportion of confirmed malaria cases that received first-line antimalarial treatment in the community</narrative>
      </title>
      <description>
        <narrative>Module: Case management.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Proportion of confirmed malaria cases that received first-line antimalarial treatment in the community</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="96.48">
          <comment>
            <narrative>Numerator: 4931; Denominator: 5111.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="100">
          <dimension name="Age" value="&lt;5" />
          <comment>
            <narrative>Numerator: 2006; Denominator: 2006.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="100">
          <dimension name="Age" value="&lt;5" />
          <comment>
            <narrative>Numerator: 2006; Denominator: 2006.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 60825.5; Denominator: 60825.5.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2025-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 121651; Denominator: 121651.</narrative>
            </comment>
          </target>
          <actual value="100.63">
            <comment>
              <narrative>Numerator: 12648; Denominator: 12569.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 60825.5; Denominator: 60825.5.</narrative>
            </comment>
          </target>
          <actual value="100.7">
            <comment>
              <narrative>Numerator: 9760; Denominator: 9692.</narrative>
            </comment>
          </actual>
          <actual value="100.73">
            <dimension name="Age" value="&lt;5" />
            <comment>
              <narrative>Numerator: 3434; Denominator: 3409.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 91029; Denominator: 91029.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2026-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 182058; Denominator: 182058.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 91029; Denominator: 91029.</narrative>
            </comment>
          </target>
          <actual value="99.93">
            <comment>
              <narrative>Numerator: 44156; Denominator: 44189.</narrative>
            </comment>
          </actual>
          <actual value="99.82">
            <dimension name="Age" value="&lt;5" />
            <comment>
              <narrative>Numerator: 23509; Denominator: 23552.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 88283.5; Denominator: 88283.5.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-01-01" />
          <period-end iso-date="2027-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 88283.5; Denominator: 88283.5.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Proportion of suspected malaria cases that receive a parasitological test at public sector health facilities</narrative>
      </title>
      <description>
        <narrative>Module: Case management.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Proportion of suspected malaria cases that receive a parasitological test at public sector health facilities</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31">
          <comment>
            <narrative>Numerator: 3102402; Denominator: 3692228; Percentage: 84.03%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="5+" />
          <comment>
            <narrative>Numerator: 754054; Denominator: 1110156; Percentage: 67.92%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="5+" />
          <comment>
            <narrative>Numerator: 754054; Denominator: 1110156; Percentage: 67.92%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="&lt;5" />
          <comment>
            <narrative>Numerator: 356102; Denominator: 1110156; Percentage: 32.08%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="&lt;5" />
          <comment>
            <narrative>Numerator: 356102; Denominator: 1110156; Percentage: 32.08%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Testing type" value="Microscopy" />
          <comment>
            <narrative>Numerator: 686812; Denominator: 1110156; Percentage: 61.87%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Testing type" value="Microscopy" />
          <comment>
            <narrative>Numerator: 686812; Denominator: 1110156; Percentage: 61.87%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Testing type" value="Rapid diagnostic test" />
          <comment>
            <narrative>Numerator: 423344; Denominator: 1110156; Percentage: 38.13%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Testing type" value="Rapid diagnostic test" />
          <comment>
            <narrative>Numerator: 423344; Denominator: 1110156; Percentage: 38.13%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 2124463; Denominator: 2124463; Percentage: 100%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 4248926; Denominator: 4248926; Percentage: 100%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 4409187; Denominator: 5034863; Percentage: 87.57%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 2124463; Denominator: 2124463; Percentage: 100%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2372590; Denominator: 2836571; Percentage: 83.64%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="5+" />
            <comment>
              <narrative>Numerator: 3030927.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;5" />
            <comment>
              <narrative>Numerator: 1378260.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Testing type" value="Microscopy" />
            <comment>
              <narrative>Numerator: 1928626.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Testing type" value="Rapid diagnostic test" />
            <comment>
              <narrative>Numerator: 2480561.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 4512535; Denominator: 4512535; Percentage: 100%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 2256267.5; Denominator: 2256267.5; Percentage: 100%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 2256267.5; Denominator: 2256267.5; Percentage: 100%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2182662; Denominator: 2492198; Percentage: 87.58%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="5+" />
            <comment>
              <narrative>Numerator: 3045673; Denominator: 4332878; Percentage: 70.29%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;5" />
            <comment>
              <narrative>Numerator: 1287205; Denominator: 4332878; Percentage: 29.71%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Testing type" value="Microscopy" />
            <comment>
              <narrative>Numerator: 1966940.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Testing type" value="Rapid diagnostic test" />
            <comment>
              <narrative>Numerator: 2365938.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 2321475.5; Denominator: 2321475.5; Percentage: 100%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-01-01" />
          <period-end iso-date="2027-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 2321475.5; Denominator: 2321475.5; Percentage: 100%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Proportion of suspected malaria cases that receive a parasitological test in the community</narrative>
      </title>
      <description>
        <narrative>Module: Case management.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Proportion of suspected malaria cases that receive a parasitological test in the community</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31">
          <comment>
            <narrative>Numerator: 11378; Denominator: 15166; Percentage: 75.02%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="&lt;5" />
          <comment>
            <narrative>Numerator: 4469; Denominator: 4469; Percentage: 100%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="&lt;5" />
          <comment>
            <narrative>Numerator: 4469; Denominator: 4469; Percentage: 100%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Testing type" value="Rapid diagnostic test" />
          <comment>
            <narrative>Numerator: 4469; Denominator: 4469; Percentage: 100%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Testing type" value="Rapid diagnostic test" />
          <comment>
            <narrative>Numerator: 4469; Denominator: 4469; Percentage: 100%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 223731; Denominator: 223731; Percentage: 100%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 27093; Denominator: 29877; Percentage: 90.68%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 111865.5; Denominator: 111865.5; Percentage: 100%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 111865.5; Denominator: 111865.5; Percentage: 100%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 19785; Denominator: 21993; Percentage: 89.96%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;5" />
            <comment>
              <narrative>Numerator: 8308.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Testing type" value="Rapid diagnostic test" />
            <comment>
              <narrative>Numerator: 27093.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 315257; Denominator: 315257; Percentage: 100%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 157628.5; Denominator: 157628.5; Percentage: 100%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 157628.5; Denominator: 157628.5; Percentage: 100%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 75878; Denominator: 121262; Percentage: 62.57%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;5" />
            <comment>
              <narrative>Numerator: 39011; Denominator: 118377; Percentage: 32.95%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Testing type" value="Rapid diagnostic test" />
            <comment>
              <narrative>Numerator: 118377.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 157628.5; Denominator: 157628.5; Percentage: 100%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-01-01" />
          <period-end iso-date="2027-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 157628.5; Denominator: 157628.5; Percentage: 100%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of people with confirmed RR-TB and/or MDR-TB notified</narrative>
      </title>
      <description>
        <narrative>Module: Drug-resistant (DR)-TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of people with confirmed RR-TB and/or MDR-TB notified</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31">
          <comment>
            <narrative>Numerator: 500.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 185; Denominator: 192; Percentage: 96.35%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 185; Denominator: 192; Percentage: 96.35%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 7; Denominator: 192; Percentage: 3.65%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 7; Denominator: 192; Percentage: 3.65%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 69; Denominator: 192; Percentage: 35.94%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 69; Denominator: 192; Percentage: 35.94%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 123; Denominator: 192; Percentage: 64.06%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 123; Denominator: 192; Percentage: 64.06%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 549.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 748.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 274.5.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 274.5.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 422.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 578.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 27.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 258.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 347.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 607.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 303.5.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 303.5.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 448.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 762.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 22.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 313.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 471.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 333.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-01-01" />
          <period-end iso-date="2027-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 333.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people with confirmed RR-TB and/or MDR-TB that began second-line treatment</narrative>
      </title>
      <description>
        <narrative>Module: Drug-resistant (DR)-TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of people with confirmed RR-TB and/or MDR-TB that began second-line treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31">
          <comment>
            <narrative>Numerator: 462; Denominator: 500; Percentage: 92.4%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 185; Denominator: 192; Percentage: 96.35%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 123; Denominator: 192; Percentage: 64.06%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Treatment regimen" value="Shorter 6-9 month" />
          <comment>
            <narrative>Numerator: 93; Denominator: 192; Percentage: 48.44%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Treatment regimen" value="Shorter 6-9 month" />
          <comment>
            <narrative>Numerator: 93; Denominator: 192; Percentage: 48.44%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 531.4; Denominator: 549; Percentage: 96.8%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 605; Denominator: 748; Percentage: 80.88%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 265.74; Denominator: 274.5; Percentage: 96.81%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 265.74; Denominator: 274.5; Percentage: 96.81%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 280; Denominator: 422; Percentage: 66.35%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Treatment regimen" value="Shorter 6-9 month" />
            <comment>
              <narrative>Numerator: 590.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 294; Denominator: 303.5; Percentage: 96.87%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 588; Denominator: 607; Percentage: 96.9%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 294; Denominator: 303.5; Percentage: 96.87%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 420; Denominator: 448; Percentage: 93.75%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Treatment regimen" value="Shorter 6-9 month" />
            <comment>
              <narrative>Numerator: 777.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 322.58; Denominator: 333; Percentage: 96.87%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-01-01" />
          <period-end iso-date="2027-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 322.58; Denominator: 333; Percentage: 96.87%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of HIV-exposed infants receiving a virological test for HIV within 2 months of birth</narrative>
      </title>
      <description>
        <narrative>Module: Elimination of vertical transmission of HIV, syphilis and hepatitis B.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of HIV-exposed infants receiving a virological test for HIV within 2 months of birth</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - special.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31">
          <comment>
            <narrative>Numerator: 596; Denominator: 6048; Percentage: 9.85%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Negative" />
          <comment>
            <narrative>Numerator: 10388; Denominator: 30327; Percentage: 34.25%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Negative" />
          <comment>
            <narrative>Numerator: 10388; Denominator: 30327; Percentage: 34.25%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Positive" />
          <comment>
            <narrative>Numerator: 3064; Denominator: 30327; Percentage: 10.1%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Positive" />
          <comment>
            <narrative>Numerator: 3064; Denominator: 30327; Percentage: 10.1%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Unknown" />
          <comment>
            <narrative>Numerator: 27113; Denominator: 30327; Percentage: 89.4%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Unknown" />
          <comment>
            <narrative>Numerator: 27113; Denominator: 30327; Percentage: 89.4%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 708; Denominator: 6436; Percentage: 11%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 1416; Denominator: 6436; Percentage: 22%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 955; Denominator: 6436; Percentage: 14.84%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 708; Denominator: 6436; Percentage: 11%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 517; Denominator: 6436; Percentage: 8.03%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Negative" />
            <comment>
              <narrative>Numerator: 832.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Positive" />
            <comment>
              <narrative>Numerator: 17.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Unknown" />
            <comment>
              <narrative>Numerator: 106.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 1287; Denominator: 6605; Percentage: 19.49%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 2574; Denominator: 6605; Percentage: 39%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 1287; Denominator: 6605; Percentage: 19.49%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 650; Denominator: 6605; Percentage: 9.84%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Negative" />
            <comment>
              <narrative>Numerator: 1105.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Positive" />
            <comment>
              <narrative>Numerator: 18.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Unknown" />
            <comment>
              <narrative>Numerator: 190.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 1931; Denominator: 6780; Percentage: 28.48%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-01-01" />
          <period-end iso-date="2027-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 1931; Denominator: 6780; Percentage: 28.48%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of pregnant women who know their HIV status</narrative>
      </title>
      <description>
        <narrative>Module: Elimination of vertical transmission of HIV, syphilis and hepatitis B.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of pregnant women who know their HIV status</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - special.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31">
          <comment>
            <narrative>Numerator: 202805; Denominator: 262765; Percentage: 77.18%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Negative" />
          <comment>
            <narrative>Numerator: 165713; Denominator: 168941; Percentage: 98.09%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Negative" />
          <comment>
            <narrative>Numerator: 165713; Denominator: 168941; Percentage: 98.09%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Positive" />
          <comment>
            <narrative>Numerator: 3209; Denominator: 168941; Percentage: 1.9%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Positive" />
          <comment>
            <narrative>Numerator: 3209; Denominator: 168941; Percentage: 1.9%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Unknown" />
          <comment>
            <narrative>Numerator: 19; Denominator: 168941; Percentage: 0.01%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Unknown" />
          <comment>
            <narrative>Numerator: 19; Denominator: 168941; Percentage: 0.01%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 219018; Denominator: 279347; Percentage: 78.4%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 209425; Denominator: 279347; Percentage: 74.97%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 109509; Denominator: 279347; Percentage: 39.2%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 109509; Denominator: 279347; Percentage: 39.2%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 117400; Denominator: 279347; Percentage: 42.03%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Negative" />
            <comment>
              <narrative>Numerator: 206369.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Positive" />
            <comment>
              <narrative>Numerator: 3056.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Unknown" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 117486; Denominator: 286644; Percentage: 40.99%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 234972; Denominator: 286644; Percentage: 82%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 117486; Denominator: 286644; Percentage: 40.99%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 128416; Denominator: 286644; Percentage: 44.8%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Negative" />
            <comment>
              <narrative>Numerator: 227754.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Positive" />
            <comment>
              <narrative>Numerator: 3771.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Unknown" />
            <comment>
              <narrative>Numerator: 41193.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 126125; Denominator: 294179; Percentage: 42.87%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-01-01" />
          <period-end iso-date="2027-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 126125; Denominator: 294179; Percentage: 42.87%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of at-risk adolescent girls and young women reached with HIV prevention programs</narrative>
      </title>
      <description>
        <narrative>Module: Prevention package for adolescent girls and young women (AGYW) and male sexual partners in high HIV incidence settings.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of at-risk adolescent girls and young women reached with HIV prevention programs</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - special.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="16.46">
          <comment>
            <narrative>Numerator: 57642; Denominator: 350140.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="13.96">
            <comment>
              <narrative>Numerator: 38100; Denominator: 273017.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2025-06-30" />
          <target value="29.5">
            <comment>
              <narrative>Numerator: 80568; Denominator: 273017.</narrative>
            </comment>
          </target>
          <actual value="24.92">
            <comment>
              <narrative>Numerator: 68040; Denominator: 273017.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="15.56">
            <comment>
              <narrative>Numerator: 42468; Denominator: 273017.</narrative>
            </comment>
          </target>
          <actual value="16.12">
            <comment>
              <narrative>Numerator: 44000; Denominator: 273017.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2026-06-30" />
          <target value="31.8">
            <comment>
              <narrative>Numerator: 89536; Denominator: 281207.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="15.83">
            <comment>
              <narrative>Numerator: 44519; Denominator: 281207.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="16.01">
            <comment>
              <narrative>Numerator: 45017; Denominator: 281207.</narrative>
            </comment>
          </target>
          <actual value="12.93">
            <comment>
              <narrative>Numerator: 36361; Denominator: 281207.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="17.68">
            <comment>
              <narrative>Numerator: 51207; Denominator: 289643.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-01-01" />
          <period-end iso-date="2027-06-30" />
          <target value="18.21">
            <comment>
              <narrative>Numerator: 52733; Denominator: 289643.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of men who have sex with men reached with HIV prevention programs</narrative>
      </title>
      <description>
        <narrative>Module: Prevention package for men who have sex with men (MSM) and their sexual partners.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of men who have sex with men reached with HIV prevention programs</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - special.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31">
          <comment>
            <narrative>Numerator: 2618; Denominator: 7210; Percentage: 36.31%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="25+" />
          <comment>
            <narrative>Numerator: 555; Denominator: 1271; Percentage: 43.67%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="25+" />
          <comment>
            <narrative>Numerator: 555; Denominator: 1271; Percentage: 43.67%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 1477.5; Denominator: 8005; Percentage: 18.46%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 2955; Denominator: 8005; Percentage: 36.9%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 3841; Denominator: 8005; Percentage: 47.98%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 1477.5; Denominator: 8005; Percentage: 18.46%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2072; Denominator: 8005; Percentage: 25.88%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="25+" />
            <comment>
              <narrative>Numerator: 2066.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 4376.7; Denominator: 6916.9; Percentage: 63.3%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 2256; Denominator: 8228; Percentage: 27.42%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 2120.72; Denominator: 6916.9; Percentage: 30.66%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 3028; Denominator: 6917; Percentage: 43.78%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="25+" />
            <comment>
              <narrative>Numerator: 3281.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 2192.8; Denominator: 7159; Percentage: 30.63%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-01-01" />
          <period-end iso-date="2027-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 2192.8; Denominator: 7159; Percentage: 30.63%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of sex workers reached with HIV prevention programs</narrative>
      </title>
      <description>
        <narrative>Module: Prevention package for sex workers, their clients and other sexual partners.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of sex workers reached with HIV prevention programs</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - special.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31">
          <comment>
            <narrative>Numerator: 9616; Denominator: 18143; Percentage: 53%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="25+" />
          <comment>
            <narrative>Numerator: 1640; Denominator: 4641; Percentage: 35.34%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="25+" />
          <comment>
            <narrative>Numerator: 1640; Denominator: 4641; Percentage: 35.34%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 4638; Denominator: 4641; Percentage: 99.94%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 4638; Denominator: 4641; Percentage: 99.94%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 3; Denominator: 4641; Percentage: 0.06%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 3; Denominator: 4641; Percentage: 0.06%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 7169; Denominator: 27240; Percentage: 26.32%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 14338; Denominator: 27240; Percentage: 52.6%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 19124; Denominator: 27240; Percentage: 70.21%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 7169; Denominator: 27240; Percentage: 26.32%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 10624; Denominator: 27240; Percentage: 39%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="25+" />
            <comment>
              <narrative>Numerator: 6542.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 19124.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 11480; Denominator: 28023; Percentage: 40.97%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 22960; Denominator: 28023; Percentage: 81.9%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 11480; Denominator: 28023; Percentage: 40.97%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 15342; Denominator: 28023; Percentage: 54.75%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="25+" />
            <comment>
              <narrative>Numerator: 12157.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 29181.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 12777; Denominator: 28829; Percentage: 44.32%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-01-01" />
          <period-end iso-date="2027-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 12777; Denominator: 28829; Percentage: 44.32%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of transgender people reached with HIV prevention programs - defined package of services</narrative>
      </title>
      <description>
        <narrative>Module: Prevention package for transgender people and their sexual partners.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of transgender people reached with HIV prevention programs - defined package of services</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - special.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31">
          <comment>
            <narrative>Numerator: 2; Denominator: 150; Percentage: 1.33%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15-19" />
          <comment>
            <narrative>Numerator: 1.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15-19" />
          <comment>
            <narrative>Numerator: 1.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="20-24" />
          <comment>
            <narrative>Numerator: 1.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="20-24" />
          <comment>
            <narrative>Numerator: 1.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Transwomen" />
          <comment>
            <narrative>Numerator: 2.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Transwomen" />
          <comment>
            <narrative>Numerator: 2.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 81; Denominator: 301; Percentage: 26.9%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 53; Denominator: 301; Percentage: 17.61%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 40.5; Denominator: 301; Percentage: 13.46%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 40.5; Denominator: 301; Percentage: 13.46%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 32; Denominator: 301; Percentage: 10.63%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15-19" />
            <comment>
              <narrative>Numerator: 17.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="20-24" />
            <comment>
              <narrative>Numerator: 20.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Transwomen" />
            <comment>
              <narrative>Numerator: 53.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 46.5; Denominator: 310; Percentage: 15%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 82.5; Denominator: 239; Percentage: 34.5%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 36; Denominator: 239; Percentage: 15.06%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 38; Denominator: 239; Percentage: 15.9%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15-19" />
            <comment>
              <narrative>Numerator: 22.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="20-24" />
            <comment>
              <narrative>Numerator: 37.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Transwomen" />
            <comment>
              <narrative>Numerator: 72.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 40.5; Denominator: 246; Percentage: 16.46%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-01-01" />
          <period-end iso-date="2027-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 40.5; Denominator: 246; Percentage: 16.46%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of laboratories successfully participating in external quality assurance (EQA) or proficiency testing (PT) schemes</narrative>
      </title>
      <description>
        <narrative>Module: RSSH/PP: Laboratory systems (including national and peripheral).</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of laboratories successfully participating in external quality assurance (EQA) or proficiency testing (PT) schemes</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="12.5">
          <comment>
            <narrative>Numerator: 2; Denominator: 16.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2025-06-30" />
          <target value="40">
            <comment>
              <narrative>Numerator: 4; Denominator: 10.</narrative>
            </comment>
          </target>
          <actual value="37.5">
            <comment>
              <narrative>Numerator: 6; Denominator: 16.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="40">
            <comment>
              <narrative>Numerator: 4; Denominator: 10.</narrative>
            </comment>
          </target>
          <actual value="37.5">
            <comment>
              <narrative>Numerator: 6; Denominator: 16.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2026-06-30" />
          <target value="50">
            <comment>
              <narrative>Numerator: 5; Denominator: 10.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="50">
            <comment>
              <narrative>Numerator: 5; Denominator: 10.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 11; Denominator: 11.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2027-01-01" />
          <period-end iso-date="2027-06-30" />
          <target value="80">
            <comment>
              <narrative>Numerator: 8; Denominator: 10.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Completeness of reporting: Percentage of expected monthly reports (for the reporting period) that are actually received</narrative>
      </title>
      <description>
        <narrative>Module: RSSH: Monitoring and evaluation systems.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Completeness of reporting: Percentage of expected monthly reports (for the reporting period) that are actually received</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="76.52">
          <comment>
            <narrative>Numerator: 12383; Denominator: 16182.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="59.19">
          <dimension name="Report type" value="HIV reports" />
          <comment>
            <narrative>Numerator: 792; Denominator: 1338.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="59.19">
          <dimension name="Report type" value="HIV reports" />
          <comment>
            <narrative>Numerator: 792; Denominator: 1338.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="90.92">
          <dimension name="Report type" value="Malaria reports" />
          <comment>
            <narrative>Numerator: 7779; Denominator: 8556.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="90.92">
          <dimension name="Report type" value="Malaria reports" />
          <comment>
            <narrative>Numerator: 7779; Denominator: 8556.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="86.42">
          <dimension name="Provider type" value="Public" />
          <comment>
            <narrative>Numerator: 8714; Denominator: 10083.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="86.42">
          <dimension name="Provider type" value="Public" />
          <comment>
            <narrative>Numerator: 8714; Denominator: 10083.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="75.66">
          <dimension name="Report type" value="TB reports" />
          <comment>
            <narrative>Numerator: 143; Denominator: 189.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="75.66">
          <dimension name="Report type" value="TB reports" />
          <comment>
            <narrative>Numerator: 143; Denominator: 189.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2025-06-30" />
          <target value="87" />
          <actual value="90.41">
            <comment>
              <narrative>Numerator: 13289; Denominator: 14698.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="87" />
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="87" />
          <actual value="89.7">
            <comment>
              <narrative>Numerator: 6590; Denominator: 7347.</narrative>
            </comment>
          </actual>
          <actual value="84.16">
            <dimension name="Report type" value="HIV reports" />
            <comment>
              <narrative>Numerator: 4160; Denominator: 4943.</narrative>
            </comment>
          </actual>
          <actual value="93.38">
            <dimension name="Report type" value="Malaria reports" />
            <comment>
              <narrative>Numerator: 8392; Denominator: 8987.</narrative>
            </comment>
          </actual>
          <actual value="90.41">
            <dimension name="Provider type" value="Public" />
            <comment>
              <narrative>Numerator: 13289; Denominator: 14698.</narrative>
            </comment>
          </actual>
          <actual value="95.96">
            <dimension name="Report type" value="TB reports" />
            <comment>
              <narrative>Numerator: 737; Denominator: 768.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2026-06-30" />
          <target value="88" />
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="88" />
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="88" />
          <actual value="96.38">
            <comment>
              <narrative>Numerator: 7221; Denominator: 7492.</narrative>
            </comment>
          </actual>
          <actual value="90.8">
            <dimension name="Report type" value="HIV reports" />
            <comment>
              <narrative>Numerator: 4631; Denominator: 5100.</narrative>
            </comment>
          </actual>
          <actual value="95.98">
            <dimension name="Report type" value="Malaria reports" />
            <comment>
              <narrative>Numerator: 8684; Denominator: 9048.</narrative>
            </comment>
          </actual>
          <actual value="94.28">
            <dimension name="Provider type" value="Public" />
            <comment>
              <narrative>Numerator: 14074; Denominator: 14928.</narrative>
            </comment>
          </actual>
          <actual value="97.31">
            <dimension name="Report type" value="TB reports" />
            <comment>
              <narrative>Numerator: 759; Denominator: 780.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="90" />
        </period>
        <period>
          <period-start iso-date="2027-01-01" />
          <period-end iso-date="2027-06-30" />
          <target value="90" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Timeliness of reporting: Percentage of submitted monthly reports (for the reporting period) that are received on time per the national guidelines</narrative>
      </title>
      <description>
        <narrative>Module: RSSH: Monitoring and evaluation systems.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Timeliness of reporting: Percentage of submitted monthly reports (for the reporting period) that are received on time per the national guidelines</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="89.72">
          <comment>
            <narrative>Numerator: 11110; Denominator: 12383.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="69.44">
          <dimension name="Report type" value="HIV reports" />
          <comment>
            <narrative>Numerator: 550; Denominator: 792.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="69.44">
          <dimension name="Report type" value="HIV reports" />
          <comment>
            <narrative>Numerator: 550; Denominator: 792.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="87.88">
          <dimension name="Report type" value="Malaria reports" />
          <comment>
            <narrative>Numerator: 6836; Denominator: 7779.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="87.88">
          <dimension name="Report type" value="Malaria reports" />
          <comment>
            <narrative>Numerator: 6836; Denominator: 7779.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="84.76">
          <dimension name="Provider type" value="Public" />
          <comment>
            <narrative>Numerator: 7386; Denominator: 8714.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="84.76">
          <dimension name="Provider type" value="Public" />
          <comment>
            <narrative>Numerator: 7386; Denominator: 8714.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="0">
          <dimension name="Report type" value="TB reports" />
          <comment>
            <narrative>Numerator: 0; Denominator: 143.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="0">
          <dimension name="Report type" value="TB reports" />
          <comment>
            <narrative>Numerator: 0; Denominator: 143.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2025-06-30" />
          <target value="89" />
          <actual value="93.01">
            <comment>
              <narrative>Numerator: 12360; Denominator: 13289.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="89" />
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="89" />
          <actual value="93.79">
            <comment>
              <narrative>Numerator: 6181; Denominator: 6590.</narrative>
            </comment>
          </actual>
          <actual value="82.09">
            <dimension name="Report type" value="HIV reports" />
            <comment>
              <narrative>Numerator: 3415; Denominator: 4160.</narrative>
            </comment>
          </actual>
          <actual value="99.93">
            <dimension name="Report type" value="Malaria reports" />
            <comment>
              <narrative>Numerator: 8386; Denominator: 8392.</narrative>
            </comment>
          </actual>
          <actual value="93.01">
            <dimension name="Provider type" value="Public" />
            <comment>
              <narrative>Numerator: 12360; Denominator: 13289.</narrative>
            </comment>
          </actual>
          <actual value="75.85">
            <dimension name="Report type" value="TB reports" />
            <comment>
              <narrative>Numerator: 559; Denominator: 737.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2026-06-30" />
          <target value="90" />
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="90" />
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="90" />
          <actual value="95.53">
            <comment>
              <narrative>Numerator: 6898; Denominator: 7221.</narrative>
            </comment>
          </actual>
          <actual value="85.06">
            <dimension name="Report type" value="HIV reports" />
            <comment>
              <narrative>Numerator: 3939; Denominator: 4631.</narrative>
            </comment>
          </actual>
          <actual value="99.94">
            <dimension name="Report type" value="Malaria reports" />
            <comment>
              <narrative>Numerator: 8679; Denominator: 8684.</narrative>
            </comment>
          </actual>
          <actual value="94.29">
            <dimension name="Provider type" value="Public" />
            <comment>
              <narrative>Numerator: 13270; Denominator: 14074.</narrative>
            </comment>
          </actual>
          <actual value="85.9">
            <dimension name="Report type" value="TB reports" />
            <comment>
              <narrative>Numerator: 652; Denominator: 759.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="90" />
        </period>
        <period>
          <period-start iso-date="2027-01-01" />
          <period-end iso-date="2027-06-30" />
          <target value="90" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Proportion of pregnant women attending antenatal clinics who received three or more doses of intermittent preventive treatment for malaria</narrative>
      </title>
      <description>
        <narrative>Module: Specific prevention interventions (SPI).</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Proportion of pregnant women attending antenatal clinics who received three or more doses of intermittent preventive treatment for malaria</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="29.93">
          <comment>
            <narrative>Numerator: 79576; Denominator: 265907.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2025-06-30" />
          <target value="32.4">
            <comment>
              <narrative>Numerator: 103961; Denominator: 320948.</narrative>
            </comment>
          </target>
          <actual value="32.96">
            <comment>
              <narrative>Numerator: 98668; Denominator: 299337.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="32.39">
            <comment>
              <narrative>Numerator: 51980.5; Denominator: 160474.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="32.39">
            <comment>
              <narrative>Numerator: 51980.5; Denominator: 160474.</narrative>
            </comment>
          </target>
          <actual value="33.46">
            <comment>
              <narrative>Numerator: 53222; Denominator: 159047.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2026-06-30" />
          <target value="37.5">
            <comment>
              <narrative>Numerator: 134597; Denominator: 359256.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="37.47">
            <comment>
              <narrative>Numerator: 67298.5; Denominator: 179628.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="37.47">
            <comment>
              <narrative>Numerator: 67298.5; Denominator: 179628.</narrative>
            </comment>
          </target>
          <actual value="31.69">
            <comment>
              <narrative>Numerator: 53563; Denominator: 169047.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="45.49">
            <comment>
              <narrative>Numerator: 86631; Denominator: 190431.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-01-01" />
          <period-end iso-date="2027-06-30" />
          <target value="45.49">
            <comment>
              <narrative>Numerator: 86631; Denominator: 190431.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of patients with of all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB</narrative>
      </title>
      <description>
        <narrative>Module: TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of patients with of all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="19128" />
        <baseline year="2022" iso-date="2022-12-31" value="206">
          <dimension name="HIV status" value="Positive" />
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="206">
          <dimension name="HIV status" value="Positive" />
        </baseline>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2025-06-30" />
          <target value="19750" />
          <actual value="19469" />
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="9875" />
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="9875" />
          <actual value="9638" />
          <actual value="1184">
            <dimension name="HIV status" value="Positive" />
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="10200.88" />
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2026-06-30" />
          <target value="20401.8" />
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="10200.88" />
          <actual value="8806" />
          <actual value="1153">
            <dimension name="HIV status" value="Positive" />
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="10537.5" />
        </period>
        <period>
          <period-start iso-date="2027-01-01" />
          <period-end iso-date="2027-06-30" />
          <target value="10537.5" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of new and relapse TB patients tested using WHO recommended rapid diagnostic tests at the time of diagnosis</narrative>
      </title>
      <description>
        <narrative>Module: TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of new and relapse TB patients tested using WHO recommended rapid diagnostic tests at the time of diagnosis</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="29.2">
          <comment>
            <narrative>Numerator: 4582; Denominator: 15693.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="35.89">
            <comment>
              <narrative>Numerator: 3544.14; Denominator: 9875.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2025-06-30" />
          <target value="35.9">
            <comment>
              <narrative>Numerator: 7088.2; Denominator: 19750.</narrative>
            </comment>
          </target>
          <actual value="29.4">
            <comment>
              <narrative>Numerator: 5723; Denominator: 19469.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="35.89">
            <comment>
              <narrative>Numerator: 3544.14; Denominator: 9875.</narrative>
            </comment>
          </target>
          <actual value="34.61">
            <comment>
              <narrative>Numerator: 3336; Denominator: 9638.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2026-06-30" />
          <target value="53.4">
            <comment>
              <narrative>Numerator: 10884.4; Denominator: 20401.8.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="53.35">
            <comment>
              <narrative>Numerator: 5442.17; Denominator: 10200.88.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="53.35">
            <comment>
              <narrative>Numerator: 5442.17; Denominator: 10200.88.</narrative>
            </comment>
          </target>
          <actual value="0">
            <comment>
              <narrative>Numerator: 0; Denominator: -455.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="67.96">
            <comment>
              <narrative>Numerator: 7161.29; Denominator: 10537.5.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-01-01" />
          <period-end iso-date="2027-06-30" />
          <target value="67.96">
            <comment>
              <narrative>Numerator: 7161.29; Denominator: 10537.5.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Treatment success rate- all forms: Percentage of patients with all forms of TB, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB patients notified during a specified period; *includes only those with new and relapse TB</narrative>
      </title>
      <description>
        <narrative>Module: TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Treatment success rate- all forms: Percentage of patients with all forms of TB, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB patients notified during a specified period; *includes only those with new and relapse TB</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="65.9">
          <comment>
            <narrative>Numerator: 12405; Denominator: 18825.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2025-06-30" />
          <target value="66.4">
            <comment>
              <narrative>Numerator: 12735; Denominator: 19193.</narrative>
            </comment>
          </target>
          <actual value="69.91">
            <comment>
              <narrative>Numerator: 13874; Denominator: 19846.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="66.35">
            <comment>
              <narrative>Numerator: 6367.5; Denominator: 9596.5.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="66.35">
            <comment>
              <narrative>Numerator: 6367.5; Denominator: 9596.5.</narrative>
            </comment>
          </target>
          <actual value="64.61">
            <comment>
              <narrative>Numerator: 7443; Denominator: 11519.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="72.55">
            <comment>
              <narrative>Numerator: 7192.5; Denominator: 9913.18.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2026-06-30" />
          <target value="72.6">
            <comment>
              <narrative>Numerator: 14385; Denominator: 19826.4.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="72.55">
            <comment>
              <narrative>Numerator: 7192.5; Denominator: 9913.18.</narrative>
            </comment>
          </target>
          <actual value="72.47">
            <comment>
              <narrative>Numerator: 6336; Denominator: 8743.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="83.22">
            <comment>
              <narrative>Numerator: 8521.5; Denominator: 10240.32.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-01-01" />
          <period-end iso-date="2027-06-30" />
          <target value="83.22">
            <comment>
              <narrative>Numerator: 8521.5; Denominator: 10240.32.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31" value="73.31">
          <comment>
            <narrative>Numerator: 684; Denominator: 933.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="74.82">
            <comment>
              <narrative>Numerator: 380.73; Denominator: 508.88.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2025-06-30" />
          <target value="74.8">
            <comment>
              <narrative>Numerator: 761.4; Denominator: 1017.8.</narrative>
            </comment>
          </target>
          <actual value="38.25">
            <comment>
              <narrative>Numerator: 454; Denominator: 1187.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="74.82">
            <comment>
              <narrative>Numerator: 380.73; Denominator: 508.88.</narrative>
            </comment>
          </target>
          <actual value="-17.59">
            <comment>
              <narrative>Numerator: -98; Denominator: 557.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2026-06-30" />
          <target value="80.7">
            <comment>
              <narrative>Numerator: 777.2; Denominator: 963.2.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="80.69">
            <comment>
              <narrative>Numerator: 388.61; Denominator: 481.6.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="80.69">
            <comment>
              <narrative>Numerator: 388.61; Denominator: 481.6.</narrative>
            </comment>
          </target>
          <actual value="152.28">
            <comment>
              <narrative>Numerator: 935; Denominator: 614.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 418.21; Denominator: 464.68.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-01-01" />
          <period-end iso-date="2027-06-30" />
          <target value="90">
            <comment>
              <narrative>Numerator: 418.21; Denominator: 464.68.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of registered new and relapse TB patients with documented HIV status</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of registered new and relapse TB patients with documented HIV status</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31">
          <comment>
            <narrative>Numerator: 12154; Denominator: 19128; Percentage: 63.54%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Positive" />
          <comment>
            <narrative>Numerator: 221; Denominator: 4675; Percentage: 4.73%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Positive" />
          <comment>
            <narrative>Numerator: 221; Denominator: 4675; Percentage: 4.73%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 15752.4; Denominator: 19750; Percentage: 79.8%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 18840; Denominator: 19469; Percentage: 96.77%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 7876.3; Denominator: 9875; Percentage: 79.76%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 7876.14; Denominator: 9875; Percentage: 79.76%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 9362; Denominator: 9638; Percentage: 97.14%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Positive" />
            <comment>
              <narrative>Numerator: 1187.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 17345.6; Denominator: 20401.8; Percentage: 85%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 8672.78; Denominator: 10200.88; Percentage: 85.02%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 8672.78; Denominator: 10200.88; Percentage: 85.02%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 8838; Denominator: 9261; Percentage: 95.43%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Positive" />
            <comment>
              <narrative>Numerator: 1158.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 9758.78; Denominator: 10537.5; Percentage: 92.61%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-01-01" />
          <period-end iso-date="2027-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 9758.78; Denominator: 10537.5; Percentage: 92.61%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>TB/HIV-other 1  Percentage of people living with HIV newly enrolled on ART who started TB preventive treatment (TPT) during the reporting period</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>TB/HIV-other 1  Percentage of people living with HIV newly enrolled on ART who started TB preventive treatment (TPT) during the reporting period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="35.29">
          <comment>
            <narrative>Numerator: 2583; Denominator: 7320.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2025-06-30" />
          <target value="50">
            <comment>
              <narrative>Numerator: 1930; Denominator: 3860.</narrative>
            </comment>
          </target>
          <actual value="61.83">
            <comment>
              <narrative>Numerator: 5078; Denominator: 8213.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="50">
            <comment>
              <narrative>Numerator: 965; Denominator: 1930.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="50">
            <comment>
              <narrative>Numerator: 965; Denominator: 1930.</narrative>
            </comment>
          </target>
          <actual value="60.35">
            <comment>
              <narrative>Numerator: 2654; Denominator: 4398.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="65.99">
            <comment>
              <narrative>Numerator: 1498; Denominator: 2270.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2026-06-30" />
          <target value="66">
            <comment>
              <narrative>Numerator: 2996; Denominator: 4540.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="65.99">
            <comment>
              <narrative>Numerator: 1498; Denominator: 2270.</narrative>
            </comment>
          </target>
          <actual value="49.15">
            <comment>
              <narrative>Numerator: 2086; Denominator: 4244.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="76.38">
            <comment>
              <narrative>Numerator: 1785; Denominator: 2337.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-01-01" />
          <period-end iso-date="2027-06-30" />
          <target value="76.38">
            <comment>
              <narrative>Numerator: 1785; Denominator: 2337.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of adults (15 and above) on ART among all adults living with HIV at the end of the reporting period</narrative>
      </title>
      <description>
        <narrative>Module: Treatment, care and support.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of adults (15 and above) on ART among all adults living with HIV at the end of the reporting period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2024" iso-date="2024-12-31" value="30.63">
          <comment>
            <narrative>Numerator: 16267; Denominator: 53101.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2025-06-30" />
          <target value="55.5">
            <comment>
              <narrative>Numerator: 31720; Denominator: 57196.</narrative>
            </comment>
          </target>
          <actual value="40.46">
            <comment>
              <narrative>Numerator: 23144; Denominator: 57196.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="47.39">
            <comment>
              <narrative>Numerator: 27105; Denominator: 57196.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="55.46">
            <comment>
              <narrative>Numerator: 31720; Denominator: 57196.</narrative>
            </comment>
          </target>
          <actual value="40.46">
            <comment>
              <narrative>Numerator: 23144; Denominator: 57196.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="57.65">
            <comment>
              <narrative>Numerator: 33915; Denominator: 58833.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2026-06-30" />
          <target value="47.5">
            <comment>
              <narrative>Numerator: 27945.7; Denominator: 58833.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="47.5">
            <comment>
              <narrative>Numerator: 27945.67; Denominator: 58833.</narrative>
            </comment>
          </target>
          <actual value="50.12">
            <comment>
              <narrative>Numerator: 29486; Denominator: 58833.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="51.5">
            <comment>
              <narrative>Numerator: 31142.05; Denominator: 60470.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-01-01" />
          <period-end iso-date="2027-06-30" />
          <target value="55.5">
            <comment>
              <narrative>Numerator: 33560.85; Denominator: 60470.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of children (under 15) on ART among all children living with HIV at the end of the reporting period</narrative>
      </title>
      <description>
        <narrative>Module: Treatment, care and support.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of children (under 15) on ART among all children living with HIV at the end of the reporting period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2024" iso-date="2024-12-31" value="11.23">
          <comment>
            <narrative>Numerator: 737; Denominator: 6562.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="24.66">
            <comment>
              <narrative>Numerator: 1743; Denominator: 7068.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2025-06-30" />
          <target value="34.2">
            <comment>
              <narrative>Numerator: 2418; Denominator: 7068.</narrative>
            </comment>
          </target>
          <actual value="15.63">
            <comment>
              <narrative>Numerator: 1105; Denominator: 7068.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="34.21">
            <comment>
              <narrative>Numerator: 2418; Denominator: 7068.</narrative>
            </comment>
          </target>
          <actual value="15.63">
            <comment>
              <narrative>Numerator: 1105; Denominator: 7068.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2026-06-30" />
          <target value="37.4">
            <comment>
              <narrative>Numerator: 2720.5; Denominator: 7272.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="37.75">
            <comment>
              <narrative>Numerator: 2745; Denominator: 7272.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="37.41">
            <comment>
              <narrative>Numerator: 2720.51; Denominator: 7272.</narrative>
            </comment>
          </target>
          <actual value="20.63">
            <comment>
              <narrative>Numerator: 1500; Denominator: 7272.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="41.41">
            <comment>
              <narrative>Numerator: 3095.04; Denominator: 7474.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-01-01" />
          <period-end iso-date="2027-06-30" />
          <target value="45.41">
            <comment>
              <narrative>Numerator: 3394; Denominator: 7474.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of pregnant women living with HIV who received antiretroviral medicine to reduce the risk of vertical transmission of HIV</narrative>
      </title>
      <description>
        <narrative>Module: Treatment, care and support.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of pregnant women living with HIV who received antiretroviral medicine to reduce the risk of vertical transmission of HIV</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - special.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="59.04">
          <comment>
            <narrative>Numerator: 3571; Denominator: 6048.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="37.9">
            <comment>
              <narrative>Numerator: 2439; Denominator: 6436.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2025-06-30" />
          <target value="75.8">
            <comment>
              <narrative>Numerator: 4878; Denominator: 6436.</narrative>
            </comment>
          </target>
          <actual value="48.28">
            <comment>
              <narrative>Numerator: 3107; Denominator: 6436.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="37.9">
            <comment>
              <narrative>Numerator: 2439; Denominator: 6436.</narrative>
            </comment>
          </target>
          <actual value="21.8">
            <comment>
              <narrative>Numerator: 1403; Denominator: 6436.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="41.32">
            <comment>
              <narrative>Numerator: 2729; Denominator: 6605.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2026-06-30" />
          <target value="82.6">
            <comment>
              <narrative>Numerator: 5458; Denominator: 6605.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="41.32">
            <comment>
              <narrative>Numerator: 2729; Denominator: 6605.</narrative>
            </comment>
          </target>
          <actual value="44.81">
            <comment>
              <narrative>Numerator: 2960; Denominator: 6605.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="45.09">
            <comment>
              <narrative>Numerator: 3057; Denominator: 6780.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-01-01" />
          <period-end iso-date="2027-06-30" />
          <target value="45.09">
            <comment>
              <narrative>Numerator: 3057; Denominator: 6780.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of insecticide-treated nets distributed to populations at risk of malaria transmission through mass campaigns</narrative>
      </title>
      <description>
        <narrative>Module: Vector control.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of insecticide-treated nets distributed to populations at risk of malaria transmission through mass campaigns</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="2837430" />
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="3798675" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of insecticide-treated nets distributed to targeted risk groups through continuous distribution</narrative>
      </title>
      <description>
        <narrative>Module: Vector control.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of insecticide-treated nets distributed to targeted risk groups through continuous distribution</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31">
          <comment>
            <narrative>Numerator: 76186.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Target / Risk population group" value="Children 0-5" />
          <comment>
            <narrative>Numerator: 36814; Denominator: 75375; Percentage: 48.84%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Target / Risk population group" value="Children 0-5" />
          <comment>
            <narrative>Numerator: 36814; Denominator: 75375; Percentage: 48.84%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Target / Risk population group" value="Pregnant women" />
          <comment>
            <narrative>Numerator: 38561; Denominator: 75375; Percentage: 51.16%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Target / Risk population group" value="Pregnant women" />
          <comment>
            <narrative>Numerator: 38561; Denominator: 75375; Percentage: 51.16%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 274899.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 246207.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 137449.5.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 137449.5.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 121172.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Target / Risk population group" value="Children 0-5" />
            <comment>
              <narrative>Numerator: 95469.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Target / Risk population group" value="Pregnant women" />
            <comment>
              <narrative>Numerator: 150738.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 321126.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 160563.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 160563.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 35510.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Target / Risk population group" value="Children 0-5" />
            <comment>
              <narrative>Numerator: 29584.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Target / Risk population group" value="Pregnant women" />
            <comment>
              <narrative>Numerator: 63081.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 160563.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-01-01" />
          <period-end iso-date="2027-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 160563.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
  </iati-activity>
</iati-activities>